Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,mRNA processing (GO:0006397),-0.7736862399839802,-3.221463161843977,0.0,0.0,0.0,64/99,13.94%,NUDT21;SNRPG;LSM5;SF3B5;LSM6;LSM4;SNRPC;RALY;TRA2B;HNRNPL;PUF60;SNRPD2;AURKAIP1;PCBP2;DNAJC8;SF1;BCAS2;SF3B6;GTF2H5;PABPN1;POLR2J;SNRNP27;POLR2K;CCNH;SF3B1;ELAVL1;CWC15;ZCRB1;U2AF1L4;SMNDC1;ISY1;CHTOP;SRSF11;ZMAT2;CDC5L;THOC7;FRG1;FIP1L1;CD2BP2;POLR2G;PAPOLA;POLR2I;GEMIN7;RNGTT;IK;WBP4;POLR2D;TRA2A;PRPF18;AQR;WDR33;RBM22;SNW1;CPSF7;ZRSR2;SNIP1;CRNKL1;SNRPB2;CTNNBL1;KIN;PPIL3;XAB2;WDR83;GPKOW
gsea,"mRNA splicing, via spliceosome (GO:0000398)",-0.7853427424903132,-3.1891809706375915,0.0,0.0,0.0,60/88,13.94%,NUDT21;SNRPG;LSM5;SF3B5;LSM6;LSM4;SNRPC;RALY;TRA2B;HNRNPL;PUF60;SNRPD2;PCBP2;DNAJC8;SF1;BCAS2;SF3B6;PABPN1;POLR2J;SNRNP27;POLR2K;DCPS;SF3B1;ELAVL1;CWC15;ZCRB1;U2AF1L4;SMNDC1;ISY1;SRSF11;ZMAT2;CDC5L;FRG1;FIP1L1;CD2BP2;POLR2G;PAPOLA;POLR2I;GEMIN7;IK;WBP4;POLR2D;TRA2A;TGS1;AQR;WDR33;RBM22;SNW1;SCNM1;CPSF7;ZRSR2;SNIP1;CRNKL1;SNRPB2;CTNNBL1;PPIL3;XAB2;GEMIN4;WDR83;GPKOW
gsea,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.7864815654963269,-3.131110829291549,0.0,0.0,0.0,56/81,13.94%,NUDT21;SNRPG;LSM5;SF3B5;LSM6;LSM4;SNRPC;RALY;TRA2B;HNRNPL;PUF60;SNRPD2;PCBP2;DNAJC8;SF1;BCAS2;SF3B6;PABPN1;POLR2J;SNRNP27;POLR2K;SF3B1;ELAVL1;CWC15;ZCRB1;U2AF1L4;SMNDC1;ISY1;SRSF11;ZMAT2;CDC5L;FRG1;FIP1L1;CD2BP2;POLR2G;PAPOLA;POLR2I;GEMIN7;IK;WBP4;POLR2D;TRA2A;AQR;WDR33;RBM22;SNW1;CPSF7;ZRSR2;SNIP1;CRNKL1;SNRPB2;CTNNBL1;PPIL3;XAB2;WDR83;GPKOW
gsea,proteasomal protein catabolic process (GO:0010498),-0.7377089954422632,-3.118138832640102,0.0,0.0,0.0,43/92,13.75%,RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PCBP2;PSMA2;PSMB4;PSMA7;RNF187;PSMB8;GSK3A;UBE2A;PCNP;UBXN1;UBE2K;PSMD5;GID8;PSMD4;BAG6;PSMB1;ARRB2;PSMF1;PSMD9;PSMD8;RNF4;WWP2;KBTBD6;DERL1;UBE2D3;MAEA;SPOP;KCTD5;PPP2R5C;ATE1;UBE2G1;TOPORS;RBCK1;RMND5B;KAT5;PSMB10;SPSB3
gsea,regulation of establishment of planar polarity (GO:0090175),-0.8385279852501117,-2.997044765999256,0.0,0.0,0.0,21/42,5.63%,PSMC3;RHOA;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;AP2S1;RAC1;PSMA7;CDC42;PSMB8;PSMD5;AP2M1;PSMD4;PSMB1;ARRB2;PSMF1;PSMD9;PSMD8
gsea,non-canonical Wnt signaling pathway (GO:0035567),-0.7855924839087466,-2.9841537533784206,0.0,0.0,0.0,23/54,5.63%,PSMC3;RHOA;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;CALM1;GNB1;AP2S1;RAC1;PSMA7;CDC42;PSMB8;PSMD5;AP2M1;PSMD4;PSMB1;ARRB2;PSMF1;PSMD9;PSMD8
gsea,double-strand break repair (GO:0006302),-0.8018190660826543,-2.969137889556626,0.0,0.0,0.0,20/43,13.10%,HMGB2;HMGB1;RAD21;SWI5;NSMCE2;MAD2L2;BABAM1;RAD51B;UBXN1;NABP2;MORF4L1;BABAM2;XRCC3;ERCC1;SUMO1;SMARCAD1;SFR1;YY1;RMI1;KAT5
gsea,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.6608049578668889,-2.953157710449259,0.0,0.0,0.0,58/134,15.47%,ANAPC11;RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PCBP2;PSMA2;PSMB4;PSMA7;RNF187;PSMB8;GSK3A;UBE2A;PCNP;UBXN1;UBE2K;PSMD5;GID8;PSMD4;BAG6;PSMB1;ANAPC2;ARRB2;PSMF1;PSMD9;PSMD8;RNF4;WWP2;KBTBD6;DERL1;UBE2D3;FAF2;MAEA;UBE2J2;SPOP;KCTD5;ANAPC16;PTTG1;CUL2;PPP2R5C;RNF121;UBE2G1;SGTA;TOPORS;RBCK1;RMND5B;KAT5;CDC26;AUP1;ANAPC10;PSMB10;UFD1;SPSB3;UBXN8;UBE2J1;TBX21
gsea,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.8405874955988565,-2.9487150795671675,0.0,0.0,0.0,21/40,5.63%,PSMC3;RHOA;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;AP2S1;RAC1;PSMA7;CDC42;PSMB8;PSMD5;AP2M1;PSMD4;PSMB1;ARRB2;PSMF1;PSMD9;PSMD8
gsea,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.8435899728913552,-2.9052074499601894,0.0,0.0,0.0,24/41,6.02%,MAPRE1;SSNA1;RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PAFAH1B1;PSMB8;RAD51B;PSMD5;DYNLL1;PSMD4;PSMB1;BRD4;RAB11A;PSMF1;PSMD9;PSMD8;DCTN3
gsea,Fc receptor signaling pathway (GO:0038093),-0.8008543023398068,-2.8593553125364695,0.0,0.0,0.0,21/42,7.00%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;CALM1;RAC1;PSMA7;PSMB8;PSMD5;PAK2;PSMD4;GRB2;PSMB1;PSMF1;PSMD9;PSMD8;MAPK1;MAPK3
gsea,transcription by RNA polymerase II (GO:0006366),-0.6361457550008681,-2.8220664886984532,0.0,0.0,0.0,49/103,20.42%,NUDT21;SNRPG;TAF10;CBFB;MED18;GTF2H5;PABPN1;POLR2J;POLR2K;CCNH;ELOB;TAF12;NABP2;SSU72;GTF2A2;HDAC3;FIP1L1;TCEA1;POLR2G;PAPOLA;ARRB2;POLR2I;PAF1;RNGTT;CDK9;TAF11;POLR2D;MED27;NELFA;NCOR1;GTF2B;WDR33;WDR61;RTF1;SNW1;CPSF7;ABT1;DRAP1;SNAPC3;INTS12;NELFB;TBPL1;SNAPC1;MED17;SNAPC2;TAF4;RXRB;MNAT1;NR2C2
gsea,regulation of primary metabolic process (GO:0080090),-0.7750422193961992,-2.778612587563558,0.0,0.0,0.0,29/45,17.40%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;ID2;PSMA7;PSMB8;PSMD5;HDAC3;PSMD4;PSMB1;EDF1;PSMF1;PSMD9;PSMD8;GPS2;OAZ1;CERS2;TGS1;NCOR1;PSMB10;ZFP69;SIN3B;SREBF1;PSMD10;ADIPOR1
gsea,RNA processing (GO:0006396),-0.7062542957394834,-2.7709718222762905,0.0,0.0,0.0,26/59,13.63%,NUDT21;SNRPG;LSM5;RBM3;LSM6;LSM4;HNRNPL;SNRPD2;AURKAIP1;BCAS2;PABPN1;SF3B1;ZCRB1;PPP2CA;SRSF11;RBMS1;RNGTT;WBP4;LSM1;XRN2;PRPF18;TENT2;SCNM1;ZRSR2;KIN;PPP2R1A
gsea,ubiquitin-dependent protein catabolic process (GO:0006511),-0.5940648134539992,-2.764836966271731,0.0,0.0,0.0,67/159,17.76%,ANAPC11;UBE2I;RBX1;PSMC3;PSMB9;UBE2L3;PSMD13;PSMA1;PSMB3;PCBP2;PSMA2;PSMB4;RNF7;PSMA7;TSG101;RNF187;PSMB8;GSK3A;UBE2A;PCNP;UBXN1;UBE2K;PSMD5;GID8;PSMD4;BAG6;PSMB1;ANAPC2;PPP1R11;ARRB2;PSMF1;PSMD9;PSMD8;RNF4;WWP2;NEDD8;KBTBD6;UBE2D3;RNF115;MAEA;SPOP;KCTD5;NTAN1;ANAPC16;PTTG1;PPP2R5C;UBL7;ATE1;UBE2G1;TOPORS;VPS4B;RBCK1;RMND5B;KAT5;CDC26;ANAPC10;PSMB10;MVB12A;UFD1;SPSB3;VPS4A;NDFIP2;TBX21;ARMC8;PSMD10;FBXO7;UBE2E1
gsea,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.6887223277741126,-2.7646866778888803,0.0,0.0,0.0,21/64,8.92%,RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;EMD;PSMB4;PSMA7;MAD2L2;PSMB8;GSK3A;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;CSNK1A1;STK11
gsea,Fc-epsilon receptor signaling pathway (GO:0038095),-0.7667778234454311,-2.762636251495964,0.0,0.0,0.0,21/43,7.00%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;CALM1;RAC1;PSMA7;PSMB8;PSMD5;PAK2;PSMD4;GRB2;PSMB1;PSMF1;PSMD9;PSMD8;MAPK1;MAPK3
gsea,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.8816629189787263,-2.755460305857812,0.0,0.0,0.0,17/27,5.63%,RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PSMD4;PSMB1;CDK2AP2;PSMF1;PSMD9;PSMD8
gsea,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.7763735004292546,-2.725600138068742,0.0,0.0,0.0,17/37,5.83%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PAK2;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;KRAS
gsea,cellular response to lectin (GO:1990858),-0.7763735004292546,-2.725600138068742,0.0,0.0,0.0,17/37,5.83%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PAK2;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;KRAS
gsea,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.7763735004292546,-2.725600138068742,0.0,0.0,0.0,17/37,5.83%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PAK2;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;KRAS
gsea,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.7927797690846958,-2.7227253841645647,0.0,0.0,0.0,16/36,5.63%,RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8
gsea,regulation of mitotic cell cycle (GO:0007346),-0.7085416588901845,-2.714563616169467,0.0,0.0,0.0,31/56,13.39%,ANAPC11;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PSMD4;PSMB1;ANAPC2;RPS6KB1;PSMF1;PSMD9;PSMD8;CDK9;PKN2;SRA1;DAPK3;CDK11B;MAEA;ANAPC16;CYLD;IQGAP1;SDCBP;CDC26;ANAPC10;PSMB10
gsea,negative regulation of Wnt signaling pathway (GO:0030178),-0.6554959187955661,-2.7102285601856546,0.0,0.0,0.0,21/70,8.92%,RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;EMD;PSMB4;PSMA7;MAD2L2;PSMB8;GSK3A;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;CSNK1A1;STK11
gsea,regulation of mitotic cell cycle phase transition (GO:1901990),-0.7505581885075528,-2.7096996049865045,0.0,0.0,0.0,29/50,13.63%,ANAPC11;MAPRE1;SSNA1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;ID2;PSMA7;PAFAH1B1;PSMB8;PSMD5;DYNLL1;PSMD4;PSMB1;ANAPC2;PSMF1;PSMD9;PSMD8;DCTN3;ANAPC16;APPL1;CDC26;ANAPC10;PSMB10;PPP2R1A
gsea,regulation of stem cell differentiation (GO:2000736),-0.8372058780775841,-2.7058130140847365,0.0,0.0,0.0,18/32,5.63%,NUDT21;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;CBFB;PSMB4;PSMA7;PSMB8;TCF3;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8
gsea,RNA metabolic process (GO:0016070),-0.7459738116208454,-2.697629872506708,0.0,0.0,0.0,18/39,10.49%,RNASEH2C;RBM3;HNRNPL;PCBP2;PABPN1;POLR2J;POLR2K;LAGE3;POLR2G;PAPOLA;POLR2I;RBMS1;RNGTT;POLR2D;LSM1;XRN2;TENT2;SKIV2L
gsea,nuclear-transcribed mRNA catabolic process (GO:0000956),0.8130914272328104,2.695224747977542,0.0,0.0,0.0,47/89,3.16%,RPS27;RPL34;RPL37A;RPS24;RPS15A;RPL37;RPL30;RPL19;RPL18A;RPL17;RPL24;RPS21;RPS11;RPL27A;RPL39;RPS7;RPL9;RPL38;RPL36;RPS13;RPS10;RPL23;RPL21;RPL13A;RPL11;RPS28;RPS14;RPS29;RPS9;RPL6;RPL35A;RPL22;RPL27;RPS4X;RPS16;RPL18;RPS3;UBA52;RPS12;RPS23;RPL32;RPL26;TUT4;RPL29;EIF3E;DDX5;RPS5
gsea,protein-DNA complex assembly (GO:0065004),-0.8365037455415071,-2.6952103410050006,0.0,0.0,0.0,19/31,5.63%,HMGB2;RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;GTF2H5;PSMA7;CCNH;PSMB8;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8
gsea,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.6307213442487821,-2.689689191313208,0.0,0.0,0.0,50/93,19.17%,TMED10;CAPZB;ACTR10;SEC13;YIF1B;DYNLL1;VAPA;BCAP31;CNIH1;TRAPPC5;CAPZA1;DCTN3;TRAPPC6B;RAB2A;PREB;TRAPPC1;ERGIC2;TEX261;PEF1;SAR1B;TMED3;COPB1;YIF1A;VTI1B;PDCD6;SAR1A;IER3IP1;KDELR1;BET1;RAB1A;NAPA;TRAPPC6A;SCFD1;ARFGAP2;GOSR1;SEC22B;RAB29;VTI1A;COG8;TMED7;COG4;RAB1B;TRAPPC2L;COPZ1;TMED5;YKT6;F2;GOSR2;COPE;DCTN5
gsea,mitochondrial respiratory chain complex assembly (GO:0033108),-0.7525066572909955,-2.6698745044987104,0.0,0.0,0.0,32/52,9.10%,NDUFC2;NDUFB6;NDUFC1;NDUFS7;NDUFA11;NDUFA2;NDUFB9;NDUFB8;UQCRFS1;NDUFV2;NDUFS6;NDUFA9;NDUFA10;NDUFB7;NDUFB5;NDUFS5;NDUFS3;NDUFB10;NDUFA8;NDUFB2;NDUFS8;COA3;NDUFB4;UQCC2;NDUFB11;NDUFS4;NDUFA3;NDUFS2;NDUFB3;SDHAF4;NDUFAF3;NDUFAF8
gsea,post-translational protein modification (GO:0043687),-0.6141225769741907,-2.666804391905719,0.0,0.0,0.0,41/107,17.54%,RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;DDA1;COPS6;PSMB4;COMMD1;RNF7;PSMA7;RAB11B;PSMB8;ELOB;PSMD5;PSMD4;PSMB1;RAB11A;BTBD1;PSMF1;PSMD9;PSMD8;RAB2A;RAB8A;ATG5;NEDD8;KBTBD6;DNAJC3;CUL2;FBXW2;RAB1A;PSMB10;SPSB3;COPS8;ASB8;CCDC22;RAB1B;PSMD10;FBXO7
gsea,mitochondrial translation (GO:0032543),-0.7907265513762813,-2.66099931810233,0.0,0.0,0.0,29/41,12.19%,MRPL23;AURKAIP1;MRPS26;MRPL57;MRPS24;MRPS17;MRPS18C;MRPS14;MRPS36;MRPS15;MRPL54;MRPL10;MRPL33;MRPL58;MRPL14;MRPL27;MRPL21;MRPS33;MRPS11;MRPL4;MRPL43;MRPS23;MRPL34;MRPL41;MRPS9;MRPL46;MTRF1L;MRPS21;MRPS16
gsea,positive regulation of Wnt signaling pathway (GO:0030177),-0.681700875493564,-2.6575608596350544,0.0,0.0,0.0,24/59,14.95%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;CSNK2A1;PSMA7;PSMB8;ILK;PSMD5;GID8;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;DAPK3;PPM1B;ATP6AP2;PSMB10;CSNK1G2;RNF220
gsea,translational termination (GO:0006415),-0.7968970675291798,-2.6564639076985817,0.0,0.0,0.0,30/41,12.19%,MRPL23;AURKAIP1;MRPS26;MRPL57;MRPS24;MRPS17;MRPS18C;MRPS14;MRPS36;MRPS15;TRMT112;MRPL54;MRPL10;MRPL33;MRPL58;MRPL14;MRPL27;MRPL21;MRPS33;MRPS11;MRPL4;MRPL43;MRPS23;MRPL34;MRPL41;MRPS9;MRPL46;MTRF1L;MRPS21;MRPS16
gsea,mitochondrial translational termination (GO:0070126),-0.7996502311278579,-2.6520045081312307,0.0,0.0,0.0,29/39,12.19%,MRPL23;AURKAIP1;MRPS26;MRPL57;MRPS24;MRPS17;MRPS18C;MRPS14;MRPS36;MRPS15;MRPL54;MRPL10;MRPL33;MRPL58;MRPL14;MRPL27;MRPL21;MRPS33;MRPS11;MRPL4;MRPL43;MRPS23;MRPL34;MRPL41;MRPS9;MRPL46;MTRF1L;MRPS21;MRPS16
gsea,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.7893528477405054,-2.6517629572755164,0.0,0.0,0.0,17/32,5.63%,RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;ELOB;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8
gsea,regulation of canonical Wnt signaling pathway (GO:0060828),-0.6001821498201395,-2.6490465082752936,0.0,0.0,0.0,37/103,19.71%,RBX1;PPP1CA;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;EMD;PSMB4;PSMA7;MAD2L2;PSMB8;GSK3A;ILK;PSMD5;GID8;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;DAPK3;CSNK1A1;STK11;CYLD;PPM1B;ATP6AP2;PSMB10;CSNK1G2;RNF220;PSEN1;PSMD10;GSK3B;TNKS;SDHAF2;CAPRIN2
gsea,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.6940934000936956,-2.6419966774277857,0.0,0.0,0.0,23/53,14.95%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;ILK;PSMD5;GID8;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;DAPK3;PPM1B;ATP6AP2;PSMB10;CSNK1G2;RNF220
gsea,mitochondrial translational elongation (GO:0070125),-0.8055820876446179,-2.6390530395524197,0.0,0.0,0.0,28/37,12.19%,MRPL23;AURKAIP1;MRPS26;MRPL57;MRPS24;MRPS17;MRPS18C;MRPS14;MRPS36;MRPS15;MRPL54;MRPL10;MRPL33;MRPL58;MRPL14;MRPL27;MRPL21;MRPS33;MRPS11;MRPL4;MRPL43;MRPS23;MRPL34;MRPL41;MRPS9;MRPL46;MRPS21;MRPS16
gsea,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.8458549056097463,-2.633743979832282,0.0,0.0,0.0,19/27,9.96%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;CBFB;PSMB4;PSMA7;PSMB8;TCF3;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;YTHDF2;MYB
gsea,NIK/NF-kappaB signaling (GO:0038061),-0.8568351798920864,-2.6327953282844296,0.0,0.0,0.0,15/26,5.63%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8
gsea,translational elongation (GO:0006414),-0.7839264270965595,-2.6277386891061165,0.0,0.0,0.0,29/40,12.19%,MRPL23;AURKAIP1;MRPS26;MRPL57;MRPS24;MRPS17;MRPS18C;MRPS14;MRPS36;MRPS15;MRPL54;MRPL10;MRPL33;MRPL58;MRPL14;MRPL27;MRPL21;MRPS33;MRPS11;MRPL4;MRPL43;GTPBP1;MRPS23;MRPL34;MRPL41;MRPS9;MRPL46;MRPS21;MRPS16
gsea,cellular response to lipid (GO:0071396),-0.7000258243773861,-2.6244864622380586,0.0,0.0,0.0,8/42,8.32%,HMGB2;HMGB1;RHOA;UBE2L3;PABPN1;PDK3;PAF1;GSTP1
gsea,ncRNA processing (GO:0034470),0.8754914832475228,2.617077386803157,0.0,0.0,0.0,35/59,2.35%,RPS27;RPL34;RPL37A;RPS24;RPL37;RPL30;RPL19;RPL18A;RPL17;RPL24;RPL27A;RPL39;RPS7;RPL9;RPL38;RPL36;RPL23;RPL21;RPL13A;RPL11;RPS28;RPS14;RPS9;RPL6;RPL35A;RPL22;RPL27;RPS16;RPL18;UBA52;RPL32;NOP53;RPL26;TUT4;RPL29
gsea,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.7916935641436262,-2.614295319203605,0.0,0.0,0.0,17/31,5.63%,RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;ELOB;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8
gsea,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.8699827813779812,-2.6141693091844416,0.0,0.0,0.0,17/25,5.63%,RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;NABP2;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8
gsea,regulation of cellular ketone metabolic process (GO:0010565),-0.8953929740224669,-2.6065472160077903,0.0,0.0,0.0,17/22,6.32%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PANK2;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;OAZ1
gsea,regulation of mRNA stability (GO:0043488),-0.7415261940309887,-2.6050217842129593,0.0,0.0,0.0,24/40,13.39%,PSMC3;YWHAB;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;ELAVL1;PSMB8;PSMD5;YWHAZ;PSMD4;CARHSP1;PSMB1;PSMF1;PSMD9;PSMD8;CIRBP;YTHDF2;YTHDF1;ZC3H14;PSMB10
gsea,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.8324446486195661,-2.6001752384090104,0.0,0.0,0.0,19/28,9.96%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;CBFB;PSMB4;PSMA7;PSMB8;TCF3;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;YTHDF2;MYB
gsea,protein modification by small protein removal (GO:0070646),-0.6034477658915985,-2.596103748104779,0.0,0.0,0.0,47/94,21.60%,PSMC3;SNX3;RHOA;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;TAF10;COPS6;PSMB4;PSMA7;BABAM1;PSMB8;OTUB1;PSMD5;SUDS3;PSMD4;PSMB1;ARRB2;BABAM2;PSMF1;TOR1A;PSMD9;PSMD8;NEDD8;USP4;CYLD;SMAD2;RCE1;SENP2;USP21;YY1;USP48;PSMB10;UFD1;COPS8;RHOT1;PSMD10;OTUD5;TFPT;USP50;JOSD2;BECN1;POLB;PTEN;ACTR8
gsea,regulation of stress fiber assembly (GO:0051492),-0.8276797864870998,-2.5935693737755328,0.0,0.0,0.0,6/20,6.20%,RHOA;RAC1;CDC42;CD47;PAK2;WASF2
gsea,RNA splicing (GO:0008380),-0.762354267025147,-2.5928313203846254,0.0,0.0,0.0,18/31,13.82%,SNRPG;LSM6;LSM4;TRA2B;SNRPD2;BCAS2;SF3B1;ZCRB1;SMNDC1;PPP2CA;SRSF11;WBP4;LSM1;PRPF18;SCNM1;ZRSR2;PPP2R1A;WDR83
gsea,MAPK cascade (GO:0000165),-0.5907641227226524,-2.5853452482349466,0.0,0.0,0.0,37/96,17.36%,RBX1;PSMC3;YWHAB;PPP1CC;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;CALM1;PABPN1;PSMA7;PSMB8;PSMD5;PSMD4;GRB2;PSMB1;PSMF1;PSMD9;PSMD8;KRAS;ABHD17A;MAPK1;PTPRA;MAPK3;CCM2;MAP2K2;LAMTOR3;RCE1;IL2RB;PSMB10;WDR83;FNTA;LAMTOR2;PSMD10;TAOK3
gsea,ribosome biogenesis (GO:0042254),0.8874390786428868,2.5849832837888926,0.0,0.0,0.0,34/54,2.35%,RPS27;RPL34;RPL37A;RPS24;RPL37;RPL30;RPL19;RPL18A;RPL17;RPL24;RPL27A;RPL39;RPS7;RPL9;RPL38;RPL36;RPL23;RPL21;RPL13A;RPL11;RPS28;RPS14;RPS9;RPL6;RPL35A;RPL22;RPL27;RPS16;RPL18;UBA52;RPL32;NOP53;RPL26;RPL29
gsea,cellular protein modification process (GO:0006464),-0.4985957066902199,-2.5764691954217516,0.0,0.0,0.0,128/349,22.07%,UBE2I;RBX1;PPP1CA;PSMC3;UBL4A;PPP1CC;PSMB9;UBE2L3;PSMD13;PSMA1;PSMB3;PSMA2;DDA1;COPS6;PSMB4;COMMD1;GPAA1;CSNK2A1;RNF7;PSMA7;RAB11B;PSMB8;GSK3A;ILK;ELOB;PDK3;PPP2CA;CTBP1;PSMD5;YWHAZ;PAK2;PPP6C;ILKAP;PSMD4;PSMB1;RAB11A;BTBD1;PSMF1;PSMD9;PSMD8;PRKAG1;CDK9;MAPK1;GRK6;RAB2A;RAB8A;WWP2;PKN2;ATG5;PTPRA;LCK;MAPK3;PIGT;NEDD8;DAPK3;SETD3;ATG3;CDK11B;KBTBD6;UBE2D3;LCMT1;CSNK1A1;STK11;STK24;PPP2R5E;PPP3CC;MORC3;CLK3;FASTK;ATG4B;DNAJC3;RUNX3;ALG5;CUL2;PPP2R5C;STK26;PPM1D;ATE1;FBXW2;RCE1;RAB1A;PPM1B;NGLY1;MTMR2;VRK2;PSMB10;PPP2R1A;CAMK4;SPSB3;CSNK1G2;COPS8;ALG1;CSK;ASB8;DAD1;PPP2R2A;CCDC22;RAB1B;MAPK9;PSMD10;MARK2;TAOK3;STK19;FBXO7;WIPI2;UBE2E1;GSK3B;TBK1;TNKS;CDK5;STK38;PRKACA;SDHAF2;CDK10;FBXO2;MAP4K2;SIRT7;DCAF10;ASB3;PTEN;MAN2B1;PIGK;JAK3;PRPF4B;NUCB1;WFS1;AKT2;TESK2
gsea,"DNA-templated transcription, elongation (GO:0006354)",-0.8143363169857573,-2.571832741146712,0.0,0.0,0.0,14/23,10.79%,GTF2H5;POLR2J;POLR2K;CCNH;ELOB;TCEA1;POLR2G;POLR2I;PAF1;CDK9;POLR2D;NELFA;WDR61;RTF1
gsea,positive regulation of intracellular protein transport (GO:0090316),-0.6389337523233886,-2.5714329805377822,0.0,0.0,0.0,28/62,18.28%,YWHAH;YWHAB;UBE2L3;TPR;YWHAQ;EMD;GSK3A;YWHAZ;HDAC3;MFF;SH3GLB1;OAZ1;UBE2D3;UBE2J2;SAR1B;TOMM7;PPP3CC;CASP8;ITGB2;RBM22;SAR1A;CHP1;RAB29;TMEM30A;PSEN1;PPP3R1;GSK3B;LEPROT
gsea,regulation of mRNA catabolic process (GO:0061013),-0.733209090479103,-2.569135311639979,0.0,0.0,0.0,26/39,13.39%,PSMC3;YWHAB;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;ELAVL1;PSMB8;PSMD5;YWHAZ;PSMD4;CARHSP1;PSMB1;PSMF1;PSMD9;PSMD8;GTPBP1;YTHDF2;CNOT7;YTHDF1;CNOT8;ZC3H14;PSMB10
gsea,COPII-coated vesicle budding (GO:0090114),-0.7108541518689038,-2.5674736917627956,0.0,0.0,0.0,23/37,18.71%,TMED10;SEC13;PPP6C;VAPA;CNIH1;TRAPPC5;TRAPPC6B;PREB;TRAPPC1;PEF1;SAR1B;PDCD6;SAR1A;BET1;RAB1A;NAPA;TRAPPC6A;SCFD1;TRAPPC10;SEC22B;RAB1B;TRAPPC2L;GOSR2
gsea,regulation of cellular amino acid metabolic process (GO:0006521),-0.8930986863232024,-2.5647609509843083,0.0,0.0,0.0,16/21,6.32%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;OAZ1
gsea,regulation of cellular amine metabolic process (GO:0033238),-0.8930986863232024,-2.5647609509843083,0.0,0.0,0.0,16/21,6.32%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;OAZ1
gsea,NADH dehydrogenase complex assembly (GO:0010257),-0.8165589068681212,-2.563624589329038,0.0,0.0,0.0,28/37,9.10%,NDUFC2;NDUFB6;NDUFC1;NDUFS7;NDUFA11;NDUFA2;NDUFB9;NDUFB8;NDUFV2;NDUFS6;NDUFA9;NDUFA10;NDUFB7;NDUFB5;NDUFS5;NDUFS3;NDUFB10;NDUFA8;NDUFB2;NDUFS8;NDUFB4;NDUFB11;NDUFS4;NDUFA3;NDUFS2;NDUFB3;NDUFAF3;NDUFAF8
gsea,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.8165589068681212,-2.563624589329038,0.0,0.0,0.0,28/37,9.10%,NDUFC2;NDUFB6;NDUFC1;NDUFS7;NDUFA11;NDUFA2;NDUFB9;NDUFB8;NDUFV2;NDUFS6;NDUFA9;NDUFA10;NDUFB7;NDUFB5;NDUFS5;NDUFS3;NDUFB10;NDUFA8;NDUFB2;NDUFS8;NDUFB4;NDUFB11;NDUFS4;NDUFA3;NDUFS2;NDUFB3;NDUFAF3;NDUFAF8
gsea,cellular response to molecule of bacterial origin (GO:0071219),-0.7747386313719207,-2.5574107128854084,0.0,0.0,0.0,6/26,8.32%,HMGB2;HMGB1;RHOA;PABPN1;PAF1;GSTP1
gsea,cellular response to hypoxia (GO:0071456),-0.7286231768382602,-2.550917164741841,0.0,0.0,0.0,17/36,5.63%,RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;ELOB;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8
gsea,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.8177023710455255,-2.544004990574512,0.0,0.0,0.0,14/22,10.79%,GTF2H5;POLR2J;POLR2K;CCNH;ELOB;TCEA1;POLR2G;POLR2I;PAF1;CDK9;POLR2D;NELFA;WDR61;RTF1
gsea,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.8486858853249943,-2.5409475326830893,0.0,0.0,0.0,26/31,7.39%,NDUFC2;NDUFB6;NDUFC1;NDUFS7;NDUFA11;NDUFA2;NDUFB9;NDUFB8;NDUFV2;NDUFS6;NDUFA9;NDUFA10;NDUFB7;NDUFB5;NDUFS5;NDUFS3;NDUFB10;NDUFA8;NDUFB2;NDUFS8;NDUFB4;NDUFB11;NDUFS4;NDUFA3;NDUFS2;NDUFB3
gsea,protein ubiquitination (GO:0016567),-0.5220706401795135,-2.540346309045035,0.0,0.0,0.0,67/206,18.54%,ANAPC11;RBX1;PSMC3;PSMB9;UBE2L3;PSMD13;PSMA1;PSMB3;PSMA2;CBFB;DDA1;PSMB4;COMMD1;RNF181;RNF7;PSMA7;RNF187;PSMB8;UBE2A;PCNP;ELOB;UBE2K;PSMD5;TRIM27;PSMD4;PSMB1;ARRB2;PSMF1;PAF1;PSMD9;PSMD8;RNF4;TRAF7;WWP2;NEDD8;ATG3;DERL1;UBE2D3;RNF115;TPP2;UBE2J2;SPOP;ANAPC16;WDR61;CUL2;RTF1;FBXW2;UBE2G1;TOPORS;RBCK1;PSMB10;UBE2Z;RNF220;UBE2J1;PEX14;UBE3A;LZTR1;PPIL2;CCDC22;PSMD10;UBOX5;FBXO7;UBE2V1;RNF26;UBE2E1;TNKS;UBE3C
gsea,regulation of protein serine/threonine kinase activity (GO:0071900),-0.69870158425734,-2.5387093490656385,0.0,0.0,0.0,9/37,5.17%,EZH2;CALM3;RHOA;CALM1;TSG101;CCNH;PPP2CA;CDC37;SNF8
gsea,"transcription, DNA-templated (GO:0006351)",-0.6152293081284593,-2.5337227048162485,0.0,0.0,0.0,31/69,16.17%,TAF10;CBFB;GTF2H5;POLR2J;POLR2K;CCNH;ELOB;TAF12;GTF2A2;TCEA1;POLR2G;ARRB2;POLR2I;PAF1;RNGTT;CDK9;TAF11;POLR2D;NELFA;GTF2B;WDR61;RTF1;ABT1;BRF1;TOPORS;XAB2;DRAP1;SNAPC3;NELFB;TBPL1;GTF3C6
gsea,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.7101721456888683,-2.531709242781629,0.0,0.0,0.0,21/34,18.71%,TMED10;SEC13;PPP6C;CNIH1;TRAPPC5;TRAPPC6B;PREB;TRAPPC1;PEF1;SAR1B;PDCD6;BET1;RAB1A;NAPA;TRAPPC6A;SCFD1;TRAPPC10;SEC22B;RAB1B;TRAPPC2L;GOSR2
gsea,COPII vesicle coating (GO:0048208),-0.7101721456888683,-2.531709242781629,0.0,0.0,0.0,21/34,18.71%,TMED10;SEC13;PPP6C;CNIH1;TRAPPC5;TRAPPC6B;PREB;TRAPPC1;PEF1;SAR1B;PDCD6;BET1;RAB1A;NAPA;TRAPPC6A;SCFD1;TRAPPC10;SEC22B;RAB1B;TRAPPC2L;GOSR2
gsea,vesicle coating (GO:0006901),-0.7101721456888683,-2.531709242781629,0.0,0.0,0.0,21/34,18.71%,TMED10;SEC13;PPP6C;CNIH1;TRAPPC5;TRAPPC6B;PREB;TRAPPC1;PEF1;SAR1B;PDCD6;BET1;RAB1A;NAPA;TRAPPC6A;SCFD1;TRAPPC10;SEC22B;RAB1B;TRAPPC2L;GOSR2
gsea,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.9032337597577007,-2.5226916714243828,0.0,0.0,0.0,16/20,5.63%,RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8
gsea,double-strand break repair via nonhomologous end joining (GO:0006303),-0.8361847313813224,-2.522458596050769,0.0,0.0,0.0,7/18,9.49%,HMGB2;HMGB1;NSMCE2;BABAM1;BABAM2;ERCC1;SUMO1
gsea,cellular response to tumor necrosis factor (GO:0071356),-0.6921306698184702,-2.5222506038020627,0.0,0.0,0.0,19/44,8.80%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;ILK;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;LIMS1;ZFAND6;TRADD
gsea,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.9092759822521455,2.5193729958062856,0.0,0.0,0.0,45/63,3.16%,RPS27;RPL34;RPL37A;RPS24;RPS15A;RPL37;RPL30;RPL19;RPL18A;RPL17;RPL24;RPS21;RPS11;RPL27A;RPL39;RPS7;RPL9;RPL38;RPL36;RPS13;RPS10;RPL23;RPL21;RPL13A;RPL11;RPS28;RPS14;RPS29;RPS9;RPL6;RPL35A;RPL22;RPL27;RPS4X;RPS16;RPL18;RPS3;UBA52;RPS12;RPS23;RPL32;RPL26;RPL29;EIF3E;RPS5
gsea,mitotic cell cycle phase transition (GO:0044772),-0.6515944404351044,-2.5190386956468473,0.0,0.0,0.0,24/51,20.24%,FOXM1;MAPRE1;SSNA1;ARPP19;CCNH;PAFAH1B1;PPP2R2D;DYNLL1;PPP6C;KHDRBS1;RPS6KB1;DCTN3;LCMT1;CHMP2A;CUL2;DNM2;CRLF3;PPP2R1A;PPP2R2A;CHMP7;CEP63;PRKACA;CEP131;MNAT1
gsea,protein deubiquitination (GO:0016579),-0.5868992951263581,-2.5182093114558626,0.0,0.0,0.0,44/92,21.60%,PSMC3;SNX3;RHOA;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;TAF10;PSMB4;PSMA7;BABAM1;PSMB8;OTUB1;ENY2;PSMD5;SUDS3;PSMD4;PSMB1;ARRB2;BABAM2;PSMF1;PSMD9;PSMD8;NEDD8;USP4;CYLD;SMAD2;RCE1;USP21;YY1;USP48;PSMB10;UFD1;RHOT1;PSMD10;OTUD5;TFPT;USP50;JOSD2;BECN1;POLB;PTEN;ACTR8
gsea,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.7775007765467183,-2.5180888796692895,0.0,0.0,0.0,10/23,7.00%,POLR2J;TIAL1;POLR2K;GRB2;POLR2G;POLR2I;MAPK1;POLR2D;RAB14;MAPK3
gsea,"DNA-templated transcription, termination (GO:0006353)",-0.8556012882860745,-2.5172426010795887,0.0,0.0,0.0,10/18,4.89%,NUDT21;SNRPG;MED18;GTF2H5;PABPN1;POLR2K;CCNH;SSU72;FIP1L1;PAPOLA
gsea,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.7386376104261397,-2.517196684143209,0.0,0.0,0.0,18/35,8.80%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;ILK;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;LIMS1;TRADD
gsea,response to lipopolysaccharide (GO:0032496),-0.6655046155629077,-2.511291976434971,0.0,0.0,0.0,6/42,8.32%,HMGB2;HMGB1;RHOA;PABPN1;PAF1;GSTP1
gsea,regulation of cell cycle phase transition (GO:1901987),-0.8191553728752995,-2.505918140251439,0.0,0.0,0.0,17/27,5.63%,ANAPC11;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PSMD4;PSMB1;ANAPC2;PSMF1;PSMD9;PSMD8
gsea,protein polyubiquitination (GO:0000209),-0.5477347702138418,-2.505297973069805,0.0,0.0,0.0,58/140,22.75%,ANAPC11;RBX1;PSMC3;PSMB9;UBE2L3;PSMD13;PSMA1;PSMB3;PSMA2;CBFB;DDA1;PSMB4;PSMA7;RNF187;PSMB8;UBE2A;UBE2K;PSMD5;TRIM27;PSMD4;PSMB1;ANAPC2;PSMF1;PSMD9;PSMD8;RNF4;WWP2;KBTBD6;UBE2D3;RNF115;TPP2;UBE2J2;SPOP;FBXW2;UBE2G1;TOPORS;RBCK1;CDC26;ANAPC10;PSMB10;UBE2J1;UBE3A;PPIL2;PSMD10;UBOX5;FBXO7;UBE2V1;RNF26;UBE2E1;TNKS;UBE3C;HECTD1;FBXO2;ANAPC13;AMFR;MKRN1;RNF34;TRIM68
gsea,rRNA processing (GO:0006364),0.8783781015940704,2.499521994435101,0.0,0.0,0.0,35/52,2.35%,RPS27;RPL34;RPL37A;RPS24;RPL37;RPL30;RPL19;RPL18A;RPL17;RPL24;RPL27A;RPL39;RPS7;RPL9;RPL38;RPL36;RPL23;RPL21;RPL13A;RPL11;RPS28;RPS14;RPS9;RPL6;RPL35A;RPL22;RPL27;NSA2;RPS16;RPL18;UBA52;RPL32;NOP53;RPL26;RPL29
gsea,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.7703064597498055,-2.4992593983588898,0.0,0.0,0.0,12/24,9.80%,YWHAH;YWHAB;UBE2L3;YWHAQ;GSK3A;YWHAZ;SH3GLB1;UBE2D3;UBE2J2;TOMM7;PPP3CC;CASP8
gsea,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.7691032007413592,-2.490566700083895,0.0,0.0,0.0,38/53,8.44%,COX5A;COX6A1;COX5B;NDUFC2;NDUFB6;UQCR11;UQCR10;NDUFC1;NDUFS7;NDUFA11;NDUFA2;NDUFB9;NDUFB8;UQCRFS1;NDUFV2;UQCRQ;UQCRB;NDUFS6;NDUFA9;NDUFA10;NDUFB7;NDUFB5;SDHC;COX8A;NDUFS5;NDUFS3;NDUFB10;NDUFA8;NDUFB2;NDUFS8;NDUFB4;NDUFB11;NDUFS4;NDUFA3;COX6B1;NDUFS2;NDUFB3;UQCRC2
gsea,mRNA 3'-end processing (GO:0031124),-0.7737995446856013,-2.4902685791553716,0.0,0.0,0.0,16/24,16.02%,NUDT21;PABPN1;U2AF1L4;SSU72;CHTOP;SRSF11;THOC7;FIP1L1;PAPOLA;PAF1;POLR2D;TENT2;WDR33;CPSF7;POLDIP3;SLU7
gsea,double-strand break repair via homologous recombination (GO:0000724),-0.7584795139217966,-2.4840835172589486,0.0,0.0,0.0,10/24,12.81%,RAD21;SWI5;NSMCE2;RAD51B;NABP2;MORF4L1;XRCC3;SFR1;YY1;RMI1
gsea,regulation of gene silencing by miRNA (GO:0060964),-0.8471124164343986,-2.4823991222379314,0.0,0.0,0.0,9/17,6.35%,TPR;POLR2J;POLR2K;ELAVL1;NUP50;SEC13;POLR2G;POLR2I;POLR2D
gsea,protein targeting to ER (GO:0045047),0.8978553755542054,2.4792139273030993,0.0,0.0,0.0,43/63,2.35%,RPS27;RPL34;RPL37A;RPS24;RPS15A;RPL37;RPL30;RPL19;RPL18A;RPL17;RPL24;RPS21;RPS11;RPL27A;RPL39;RPS7;RPL9;RPL38;RPL36;RPS13;RPS10;RPL23;RPL21;RPL13A;RPL11;RPS28;RPS14;RPS29;RPS9;RPL6;RPL35A;RPL22;RPL27;RPS4X;RPS16;RPL18;RPS3;UBA52;RPS12;RPS23;RPL32;RPL26;RPL29
gsea,DNA metabolic process (GO:0006259),-0.5934037081088231,-2.479104898159724,0.0,0.0,0.0,28/63,21.44%,HMGB2;HMGB1;RAD21;POLE4;RAD51B;UBE2A;NABP2;TERF1;INIP;XRCC3;ERCC1;GLRX2;SUMO1;PNKP;SMARCAD1;TOP2B;KAT5;ALKBH3;MPG;ATRIP;STN1;ACD;MNAT1;SIRT7;TOP1;POLB;TOP3B;REXO4
gsea,aerobic electron transport chain (GO:0019646),-0.7749077761131902,-2.4789283807586537,0.0,0.0,0.0,38/52,8.44%,COX5A;COX6A1;COX5B;NDUFC2;NDUFB6;UQCR11;UQCR10;NDUFC1;NDUFS7;NDUFA11;NDUFA2;NDUFB9;NDUFB8;UQCRFS1;NDUFV2;UQCRQ;UQCRB;NDUFS6;NDUFA9;NDUFA10;NDUFB7;NDUFB5;SDHC;COX8A;NDUFS5;NDUFS3;NDUFB10;NDUFA8;NDUFB2;NDUFS8;NDUFB4;NDUFB11;NDUFS4;NDUFA3;COX6B1;NDUFS2;NDUFB3;UQCRC2
gsea,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.8201128861895977,-2.477992777427653,0.0,0.0,0.0,10/19,7.00%,POLR2J;TIAL1;POLR2K;GRB2;POLR2G;POLR2I;MAPK1;POLR2D;RAB14;MAPK3
gsea,substantia nigra development (GO:0021762),-0.8289061906409239,-2.477379159162338,0.0,0.0,0.0,11/18,8.54%,YWHAH;CALM3;RHOA;YWHAQ;CALM1;CDC42;NDUFS3;SUDS3;DYNLL1;COX6B1;MAPKAP1
gsea,cellular protein metabolic process (GO:0044267),0.6202266404550464,2.475761975775274,0.0,0.0,0.0,48/146,4.10%,RPS27;RPL34;RPL37A;RPS24;RPS15A;RPL37;RPL30;RPL19;RPL18A;RPL17;RPL24;RPS21;RPS11;RPL27A;RPL39;RPS7;SHISA5;RPL9;RPL38;RPL36;RPS13;RPS10;RPL23;RPL21;RPL13A;RPL11;RPS28;RPS14;RPS29;RPS9;RPL6;RPL35A;RPL22;RPL27;RPS4X;RPS16;RPL18;RPS3;UBA52;RPS12;RPS23;RPL32;RPL26;RPL29;RPS5;UBL5;RPL35;MRPL52
gsea,positive regulation of endothelial cell proliferation (GO:0001938),-0.8163911351672751,-2.471403320622985,0.0,0.0,0.0,2/17,0.04%,HMGB2;HMGB1
gsea,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.5336065026571944,-2.465639898145622,0.0,0.0,0.0,40/140,19.19%,HMGB2;YWHAH;FOXM1;ID2;MAD2L2;RNF187;ILK;PCBD2;YAF2;ENY2;TCF3;BRD4;EDF1;YEATS4;PSMD9;ELF2;RNF4;SP3;SETD3;MAP2K2;MYB;RUNX3;LHX2;SMAD2;SFR1;WBP2;DNM2;USP21;KAT5;CRLF3;ING2;CAMK4;TBX21;CXXC1;PSEN1;UBE2V1;EOMES;MED17;NSD1;RXRB
gsea,positive regulation of hydrolase activity (GO:0051345),-0.6700952523684778,-2.460258684388779,0.0,0.0,0.0,15/36,18.16%,HMGB2;EZH2;CALM3;RHOA;CALM1;LIMS1;ZC3H15;RALBP1;MTMR9;FNTA;MAPRE2;SEMA4D;DOCK10;RAP1A;GSK3B
gsea,rRNA metabolic process (GO:0016072),0.8732301818297471,2.456735627864105,0.0,0.0,0.0,34/51,2.35%,RPS27;RPL34;RPL37A;RPS24;RPL37;RPL30;RPL19;RPL18A;RPL17;RPL24;RPL27A;RPL39;RPS7;RPL9;RPL38;RPL36;RPL23;RPL21;RPL13A;RPL11;RPS28;RPS14;RPS9;RPL6;RPL35A;RPL22;RPL27;RPS16;RPL18;UBA52;RPL32;NOP53;RPL26;RPL29
gsea,cellular macromolecule biosynthetic process (GO:0034645),0.6856539974311199,2.442930357287762,0.0,0.0,0.0,50/109,5.14%,RPS27;RPL34;RPL37A;RPS24;RPS15A;RPL37;RPL30;RPL19;RPL18A;RPL17;RPL24;RPS21;RPS11;RPL27A;RPL39;RPS7;RPL9;RPL38;RPL36;RPS13;RPS10;RPL23;RPL21;RPL13A;RPL11;RPS28;RPS14;RPS29;RPS9;RPL6;RPL35A;RPL22;RPL27;RPS4X;RPS16;RPL18;RPS3;PTMS;NR4A2;RPS12;RPS23;RPL32;RPL26;RPL29;EEF2;RPS5;RPL35;MRPL52;CREBL2;EPC1
gsea,regulation of cytoskeleton organization (GO:0051493),-0.6491317278412339,-2.4398130436378547,0.0,0.0,0.0,15/39,19.52%,RHOA;PFDN2;RAC1;PAK2;CDK2AP2;KATNBL1;MAPK1;MAPK3;CYLD;ARHGAP18;IQGAP1;MARK2;GSK3B;PTK2;CDK10
gsea,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.5246507439094457,-2.439380547130376,0.0,0.0,0.0,38/133,15.74%,HMGB2;EZH2;FOXM1;UBE2I;SAP18;YWHAQ;ID2;NKAP;YAF2;MBD2;CTBP1;HDAC3;SUDS3;KHDRBS1;SNX6;LIMS1;SMARCE1;WWP2;SP3;KDM1A;MLX;MPHOSPH8;GATAD2A;SUMO1;NCOR1;CNOT7;MYB;SNW1;SMAD2;DPF2;THAP7;BRMS1;KAT5;MTA3;LDB1;PEX14;TBX21;PHF12
gsea,cellular response to lipopolysaccharide (GO:0071222),-0.7305246803109895,-2.4387287309350056,0.0,0.0,0.0,6/27,8.32%,HMGB2;HMGB1;RHOA;PABPN1;PAF1;GSTP1
gsea,cellular response to oxygen-containing compound (GO:1901701),-0.573912984171002,-2.4357139911895387,0.0,0.0,0.0,25/80,18.96%,HMGB2;HMGB1;RHOA;GNB1;PABPN1;LAMTOR1;PDK3;PAF1;MAPK1;MAPK3;LAMTOR4;GSTP1;LAMTOR3;SNW1;LAMTOR5;ROMO1;KAT5;GNG2;DHX36;LAMTOR2;MAPK9;RAP1A;HCN2;TIRAP;PYCARD
gsea,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.7103501971650789,-2.4354807591028003,0.0,0.0,0.0,5/28,3.49%,EZH2;CALM3;RHOA;CALM1;PPP2CA
gsea,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.9193518860588819,2.4267513088137456,0.0,0.0,0.0,43/58,2.35%,RPS27;RPL34;RPL37A;RPS24;RPS15A;RPL37;RPL30;RPL19;RPL18A;RPL17;RPL24;RPS21;RPS11;RPL27A;RPL39;RPS7;RPL9;RPL38;RPL36;RPS13;RPS10;RPL23;RPL21;RPL13A;RPL11;RPS28;RPS14;RPS29;RPS9;RPL6;RPL35A;RPL22;RPL27;RPS4X;RPS16;RPL18;RPS3;UBA52;RPS12;RPS23;RPL32;RPL26;RPL29
gsea,regulation of neuron differentiation (GO:0045664),-0.7813379762235935,-2.4234731489698125,0.0,0.0,0.0,4/19,3.90%,YWHAH;RHOA;ID2;TCF3
gsea,pre-replicative complex assembly (GO:0036388),-0.8252552592519904,-2.4233596105072857,0.0,0.0,0.0,15/21,5.63%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8
gsea,cotranslational protein targeting to membrane (GO:0006613),0.9134775486722111,2.421455649055468,0.0,0.0,0.0,43/59,2.35%,RPS27;RPL34;RPL37A;RPS24;RPS15A;RPL37;RPL30;RPL19;RPL18A;RPL17;RPL24;RPS21;RPS11;RPL27A;RPL39;RPS7;RPL9;RPL38;RPL36;RPS13;RPS10;RPL23;RPL21;RPL13A;RPL11;RPS28;RPS14;RPS29;RPS9;RPL6;RPL35A;RPL22;RPL27;RPS4X;RPS16;RPL18;RPS3;UBA52;RPS12;RPS23;RPL32;RPL26;RPL29
gsea,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.7776039261043101,-2.4208186433269887,0.0,0.0,0.0,22/28,13.39%,ANAPC11;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PSMD4;PSMB1;ANAPC2;PSMF1;PSMD9;PSMD8;ANAPC16;PTTG1;CDC26;ANAPC10;PSMB10
gsea,G2/M transition of mitotic cell cycle (GO:0000086),-0.6771419536266294,-2.410163152044559,0.0,0.0,0.0,17/35,20.24%,FOXM1;MAPRE1;SSNA1;ARPP19;CCNH;PAFAH1B1;DYNLL1;KHDRBS1;DCTN3;LCMT1;DNM2;PPP2R1A;PPP2R2A;CEP63;PRKACA;CEP131;MNAT1
gsea,protein modification by small protein conjugation (GO:0032446),-0.5115564366730667,-2.4091880855486543,0.0,0.0,0.0,53/143,22.81%,ANAPC11;UBE2I;RBX1;UBE2L3;TPR;NSMCE2;COMMD1;RNF181;RNF7;RNF187;UBE2A;NUP50;PCNP;ELOB;UBE2K;TRIM27;ARRB2;PAF1;DCUN1D5;TRAF7;WWP2;NEDD8;ATG3;DERL1;UBE2D3;UBE2J2;SUMO1;ANAPC16;WDR61;CUL2;RTF1;UBE2G1;TOPORS;UFM1;UBE2Z;UFC1;RNF220;PIAS1;PEX14;LZTR1;CCDC22;DDRGK1;FBXO7;RNF26;UBE2E1;SDE2;FBXO2;ARRDC1;AMFR;MKRN1;RNF34;TRIM68;UHRF2
gsea,DNA-dependent DNA replication (GO:0006261),-0.7233640257680507,-2.403337549956772,0.0,0.0,0.0,17/31,7.14%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;POLE4;PSMB4;PSMA7;PSMB8;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;SSBP1
gsea,cytoplasmic translation (GO:0002181),0.9075756701122331,2.3996255832407347,0.0,0.0,0.0,43/57,2.35%,RPS27;RPL34;RPL37A;RPS24;RPS15A;RPL37;RPL30;RPL19;RPL18A;RPL17;RPL24;RPS21;RPS11;RPL27A;RPL39;RPS7;RPL9;RPL38;RPL36;RPS13;RPS10;RPL23;RPL21;RPL13A;RPL11;RPS28;RPS14;RPS29;RPS9;RPL6;RPL35A;RPL22;RPL27;RPS4X;RPS16;RPL18;RPS3;UBA52;RPS12;RPS23;RPL32;RPL26;RPL29
gsea,regulation of DNA binding (GO:0051101),-0.8050386378330626,-2.3899753780104507,0.0,0.0,0.0,7/18,9.49%,HMGB2;HMGB1;CSNK2B;CEBPG;EDF1;KDM1A;SUMO1
gsea,peptide biosynthetic process (GO:0043043),0.7698137773847313,2.389081010093919,0.0,0.0,0.0,45/79,4.10%,RPS27;RPL34;RPL37A;RPS24;RPS15A;RPL37;RPL30;RPL19;RPL18A;RPL17;RPL24;RPS21;RPS11;RPL27A;RPL39;RPS7;RPL9;RPL38;RPL36;RPS13;RPS10;RPL23;RPL21;RPL13A;RPL11;RPS28;RPS14;RPS29;RPS9;RPL6;RPL35A;RPL22;RPL27;RPS4X;RPS16;RPL18;RPS3;RPS12;RPS23;RPL32;RPL26;RPL29;RPS5;RPL35;MRPL52
gsea,mRNA export from nucleus (GO:0006406),-0.7681120562020494,-2.388182030686567,0.0,0.0,0.0,16/22,16.02%,TPR;PABPN1;NUP50;U2AF1L4;SEC13;CHTOP;ENY2;SRSF11;THOC7;FIP1L1;POLR2D;WDR33;SMG5;AGFG1;POLDIP3;SLU7
gsea,cell chemotaxis (GO:0060326),-0.7783870768287816,-2.3859930554398203,0.0,0.0,0.0,2/17,5.24%,HMGB2;ARRB2
gsea,interleukin-1-mediated signaling pathway (GO:0070498),-0.6575657243656768,-2.379052706666368,0.0,0.0,0.0,17/41,7.00%,RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;MAPK3
gsea,cellular response to interleukin-1 (GO:0071347),-0.632075771212252,-2.3701248387004235,0.0,0.0,0.0,18/49,7.00%,RBX1;PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;CD47;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8;MAPK3
gsea,nucleic acid metabolic process (GO:0090304),-0.7682239951824822,-2.362413343155358,0.0,0.0,0.0,9/19,7.36%,HNRNPL;PCBP2;POLR2J;POLR2K;POLR2G;POLR2I;POLR2D;LSM1;XRN2
gsea,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.5019846431043717,-2.3615454535805402,0.0,0.0,0.0,63/154,23.62%,HMGB2;EZH2;FOXM1;UBE2I;SAP18;YWHAQ;ID2;GSK3A;NKAP;YAF2;MBD2;CTBP1;TERF1;HDAC3;SUDS3;KHDRBS1;SNX6;PCIF1;LIMS1;SMARCE1;WWP2;WAPL;SP3;DAPK3;KDM1A;MLX;MPHOSPH8;GATAD2A;SUMO1;NCOR1;CNOT7;MYB;MALSU1;SNW1;CNOT8;SMAD2;DPF2;THAP7;BRMS1;EIF4E2;KAT5;MTA3;LSM14A;LDB1;PEX14;TBX21;PHF12;DHX36;ARID4A;GSK3B;CDK5;RING1;SAMD4B;DPF3;TSC22D4;HMGA2;FXR1;EIF2AK1;DEAF1;NR1H2;RBM4;RCOR1;MECP2
gsea,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.6072670147224221,-2.3472478887284813,0.0,0.0,0.0,22/50,20.42%,TAF10;GTF2H5;POLR2J;POLR2K;CCNH;TAF12;GTF2A2;HDAC3;POLR2G;POLR2I;CDK9;TAF11;POLR2D;MED27;NCOR1;GTF2B;SNW1;MED17;TAF4;RXRB;MNAT1;NR2C2
gsea,neutrophil activation involved in immune response (GO:0002283),-0.5243700253090099,-2.343419960988669,0.0,0.0,0.0,67/141,22.77%,HMGB1;PSMC3;RHOA;NDUFC2;PSMD13;PSMA2;COMMD3;RAC1;CD47;CSNK2B;LAMTOR1;ACTR10;LTA4H;PNP;DYNLL1;VAPA;RAB10;PSMB1;DBNL;MAPK1;KCMF1;TRAPPC1;CYB5R3;RAB14;ERP44;HEXB;PAFAH1B2;GSTP1;FAF2;ARL8A;RAB24;COPB1;RAB5C;ITGB2;DNAJC3;RAB18;LAMTOR3;DERA;IQGAP1;SDCBP;BRI3;ATP6V1D;NCSTN;COTL1;ATP6AP2;DNAJC5;CANT1;GGH;RAB4B;LAMTOR2;TMEM30A;ARMC8;PRDX6;PSEN1;TMEM179B;RAP1A;ARPC5;CAP1;PYCARD;CREG1;SURF4;STXBP2;MAN2B1;GSDMD;APEH;ACTR1B;VPS35L
gsea,neutrophil degranulation (GO:0043312),-0.525771250945568,-2.3427443456600634,0.0,0.0,0.0,67/140,22.77%,HMGB1;PSMC3;RHOA;NDUFC2;PSMD13;PSMA2;COMMD3;RAC1;CD47;CSNK2B;LAMTOR1;ACTR10;LTA4H;PNP;DYNLL1;VAPA;RAB10;PSMB1;DBNL;MAPK1;KCMF1;TRAPPC1;CYB5R3;RAB14;ERP44;HEXB;PAFAH1B2;GSTP1;FAF2;ARL8A;RAB24;COPB1;RAB5C;ITGB2;DNAJC3;RAB18;LAMTOR3;DERA;IQGAP1;SDCBP;BRI3;ATP6V1D;NCSTN;COTL1;ATP6AP2;DNAJC5;CANT1;GGH;RAB4B;LAMTOR2;TMEM30A;ARMC8;PRDX6;PSEN1;TMEM179B;RAP1A;ARPC5;CAP1;PYCARD;CREG1;SURF4;STXBP2;MAN2B1;GSDMD;APEH;ACTR1B;VPS35L
gsea,cell cycle G2/M phase transition (GO:0044839),-0.6516471730270735,-2.341029605414436,0.0,0.0,0.0,17/36,20.24%,FOXM1;MAPRE1;SSNA1;ARPP19;CCNH;PAFAH1B1;DYNLL1;KHDRBS1;DCTN3;LCMT1;DNM2;PPP2R1A;PPP2R2A;CEP63;PRKACA;CEP131;MNAT1
gsea,positive regulation of binding (GO:0051099),-0.6895714307050557,-2.339333898321216,0.0,0.0,0.0,7/26,8.28%,HMGB2;HMGB1;DPH3;CEBPG;EDF1;FKBP1A;DERL1
gsea,"regulation of transcription, DNA-templated (GO:0006355)",-0.44125813074871667,-2.336016261824562,0.0,0.0,0.0,189/483,29.48%,HMGB2;HMGB1;EZH2;RAD21;YWHAH;FOXM1;UBE2I;SAP18;UBE2L3;YWHAQ;CBFB;MED18;ID2;TIAL1;POLR2K;MAD2L2;MLF2;RNF187;CCNH;ILK;NKAP;PCBD2;YAF2;PPP2CA;ENY2;BRD9;MED21;CDC5L;MBD2;CTBP1;TCF3;HDAC3;CEBPG;SUDS3;PRKAR1A;KHDRBS1;SNX6;BRD4;EDF1;YEATS4;SNF8;PSMD9;SMARCD2;LIMS1;ELF2;SMARCE1;SAP30L;RNF4;WWP2;SRA1;MED31;SP3;MED27;UXT;DAPK3;SMARCD1;SETD3;KDM1A;MLX;CDK11B;MPHOSPH8;SUB1;MED29;GLRX2;MAP2K2;GATAD2A;CAMTA1;SUMO1;PHF20L1;MSL3;NCOR1;CNOT7;MYB;UBP1;MED6;POLR3C;RUNX3;PHF6;ATF6B;SNW1;LHX2;SMAD2;TADA1;PRDM1;SFR1;DPF2;THAP7;WBP2;DNM2;USP21;TOX;BRMS1;YY1;GPBP1;KAT5;CRLF3;DRAP1;ING2;MTA3;PPP2R1A;MRGBP;CAMK4;LDB1;VEZF1;ZFP69;ZFPL1;SETD5;PIAS1;PEX14;TBX21;CXXC1;PHF12;ZIK1;DHX36;IRF3;PSEN1;SREBF1;UBE2V1;EOMES;MED17;PHF14;ARID4A;CDK5;NSD1;SBNO1;BBS7;MED12L;RING1;RXRB;CREG1;PQBP1;RGS14;PURB;MNAT1;NR2C2;DPF3;TSC22D4;SP110;HMGA2;LRP5;REXO4;ACTR8;DVL1;ZFX;FOXJ3;CCNL2;MAFG;DEAF1;NR1H2;LRRFIP1;STAT3;RCOR1;MECP2;MAP2K7;DVL2;SPIN1;MEF2A;RPS6KA4;MAPK14;TRAPPC2;RELA;CNOT2;ZFP82;SKAP1;ZBTB3;CITED1;KLF2;DMTF1;RFXAP;HTATIP2;USP16;PROX2;CELSR2;HAS3;NR4A1;BCL6B;CBFA2T2;MED26;USF1;ZBTB8A;LCOR;KLF5;TGFBR1;SP9;SAMD13;TBR1;RFX2;THAP11;NR2C1
gsea,regulation of protein dephosphorylation (GO:0035304),-0.7948314652797936,-2.3300731663894267,0.0,0.0,0.0,8/16,9.48%,ARPP19;CALM3;YWHAB;CALM1;PTPA;PPP1R2;CNEP1R1;CAMTA1
gsea,snRNA transcription (GO:0009301),-0.7480924689532629,-2.329777324411431,0.0,0.0,0.0,14/22,18.83%,POLR2J;POLR2K;NABP2;GTF2A2;POLR2G;POLR2I;CDK9;TAF11;POLR2D;GTF2B;SNAPC3;INTS12;SNAPC1;SNAPC2
gsea,snRNA transcription by RNA polymerase II (GO:0042795),-0.7480924689532629,-2.329777324411431,0.0,0.0,0.0,14/22,18.83%,POLR2J;POLR2K;NABP2;GTF2A2;POLR2G;POLR2I;CDK9;TAF11;POLR2D;GTF2B;SNAPC3;INTS12;SNAPC1;SNAPC2
gsea,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.7260050898109259,-2.3295808863902825,0.0,0.0,0.0,16/29,5.63%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;TAP1;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.718110017533756,-2.3294305923430745,0.0,0.0,0.0,16/30,5.63%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;TAP1;PSMD5;PSMD4;PSMB1;PSMF1;PSMD9;PSMD8
gsea,cellular protein localization (GO:0034613),-0.5143400743347003,-2.327830515881451,0.0,0.0,0.0,62/123,25.34%,YWHAH;TMED10;ARF6;TM9SF1;LAMTOR1;SEC13;VPS29;SNX6;ABHD17A;RAB14;SNX1;ARF1;TM9SF3;GGA1;ARFRP1;SAR1B;TMED3;RAB24;AP2A1;USP4;TM9SF2;RAB5C;PDCD6;TBC1D15;ARL5A;STX12;RAB18;LAMTOR3;SNX17;SAR1A;ARL6;RAB1A;NAPA;SCFD1;CROCC;UNC50;ARF3;RAB29;ERP29;TMED7;SLU7;LAMTOR2;RAB1B;ARF5;COPZ1;WIPI2;TMED5;ACD;TBC1D9B;SNX8;STXBP2;CPLANE2;ARFIP1;TRAPPC8;PIGK;TMED9;STX8;RABGAP1L;NPHP1;TLK1;NAPG;SNX15
gsea,protein N-linked glycosylation (GO:0006487),-0.7027390545063354,-2.3158741711654827,0.0,0.0,0.0,13/25,15.48%,KRTCAP2;OSTC;DPM3;TMEM258;TUSC3;ALG5;OST4;MGAT2;ALG1;TMEM165;UBE2J1;DPM2;DAD1
gsea,chromatin organization (GO:0006325),-0.6424764041998949,-2.3106606899686057,0.0,1.3414710250193019e-05,0.001,12/33,17.07%,HMGB2;EZH2;GATAD1;HDAC3;SMARCD2;SMARCE1;SMARCD1;MYB;SMARCAD1;SETD5;FAM50A;CHRAC1
gsea,"DNA-templated transcription, initiation (GO:0006352)",-0.5862341396679778,-2.3106303733937357,0.0,1.3309082610427719e-05,0.001,26/57,21.48%,TAF10;GTF2H5;POLR2J;POLR2K;CCNH;TAF12;GTF2A2;HDAC3;POLR2G;POLR2I;CDK9;TAF11;POLR2D;MAPK3;MED27;NCOR1;GTF2B;SNW1;BRF1;TBPL1;MED17;TAF4;RXRB;MNAT1;NR2C2;CRCP
gsea,regulation of immune response (GO:0050776),0.6816430704667034,2.3103933682540023,0.0,2.3110406876615493e-05,0.001,16/37,8.56%,HCST;CD3D;CD3E;LAG3;B2M;KLRD1;CD3G;CD8A;CD96;ADCY7;FOXP1;PTPN22;CD247;ITGAL;CD22;PDCD1
gsea,translation (GO:0006412),0.7105427638786831,2.306217219269043,0.0,2.1569713084841127e-05,0.001,47/87,4.10%,RPS27;RPL34;RPL37A;RPS24;RPS15A;RPL37;RPL30;RPL19;RPL18A;RPL17;RPL24;RPS21;RPS11;RPL27A;RPL39;RPS7;RPL9;RPL38;RPL36;RPS13;RPS10;RPL23;RPL21;RPL13A;RPL11;RPS28;RPS14;RPS29;RPS9;RPL6;RPL35A;RPL22;RPL27;RPS4X;RPS16;RPL18;RPS3;UBA52;RPS12;RPS23;RPL32;RPL26;RPL29;EEF2;RPS5;RPL35;MRPL52
gsea,neutrophil mediated immunity (GO:0002446),-0.5160078633998822,-2.3019623246587826,0.0,1.3205105402533752e-05,0.001,67/143,22.77%,HMGB1;PSMC3;RHOA;NDUFC2;PSMD13;PSMA2;COMMD3;RAC1;CD47;CSNK2B;LAMTOR1;ACTR10;LTA4H;PNP;DYNLL1;VAPA;RAB10;PSMB1;DBNL;MAPK1;KCMF1;TRAPPC1;CYB5R3;RAB14;ERP44;HEXB;PAFAH1B2;GSTP1;FAF2;ARL8A;RAB24;COPB1;RAB5C;ITGB2;DNAJC3;RAB18;LAMTOR3;DERA;IQGAP1;SDCBP;BRI3;ATP6V1D;NCSTN;COTL1;ATP6AP2;DNAJC5;CANT1;GGH;RAB4B;LAMTOR2;TMEM30A;ARMC8;PRDX6;PSEN1;TMEM179B;RAP1A;ARPC5;CAP1;PYCARD;CREG1;SURF4;STXBP2;MAN2B1;GSDMD;APEH;ACTR1B;VPS35L
gsea,recombinational repair (GO:0000725),-0.7371825682063006,-2.3008651223511487,0.0,1.3102740244374577e-05,0.001,9/20,12.81%,SWI5;NSMCE2;RAD51B;NABP2;MORF4L1;XRCC3;SFR1;YY1;RMI1
gsea,organelle organization (GO:0006996),-0.4975962635547669,-2.297958537229858,0.0,1.3001949934802463e-05,0.001,51/134,21.77%,TMED10;CDC42;CAPZB;VAPA;CHCHD2;TOR1A;RAB2A;RAB14;SSBP1;FAF2;PDCD6IP;CSNK1A1;CHMP6;SAR1B;TMED3;YTHDF2;CHMP2A;RAB18;YTHDF1;SAR1A;MCOLN1;RAB1A;VPS4B;AUP1;PLAAT3;REEP5;VPS4A;TJAP1;TMEM11;RHOT1;DNM1L;PEX14;RAB29;PEX11B;TMED7;COG4;CHMP3;FAM161B;TMED5;CHMP7;VMP1;ARHGAP4;SIPA1;SURF4;VPS51;TANGO2;GOLGA5;RANBP9;TRAPPC8;TMED9;WDPCP
gsea,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.6752828166879279,-2.2974231639680203,0.0,1.2902698408582599e-05,0.001,14/30,16.42%,RBM3;TRA2B;HNRNPL;PUF60;SAP18;SF1;KHDRBS1;CIRBP;TRA2A;FAM172A;SNW1;WTAP;TIA1;PRDX6
gsea,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.45990551916058875,-2.2946244125501245,0.0,1.2804950693366061e-05,0.001,85/247,23.16%,HMGB2;HMGB1;EZH2;FOXM1;UBE2I;SAP18;TPR;YWHAQ;CBFB;ID2;MAD2L2;NKAP;YAF2;MBD2;CTBP1;CGGBP1;TCF3;HDAC3;TRIM27;SUDS3;KHDRBS1;SNX6;PAF1;GPS2;LIMS1;SMARCE1;WWP2;VPS72;SP3;UXT;KDM1A;MLX;UBE2D3;MPHOSPH8;MAP2K5;GATAD2A;SUMO1;NCOR1;CNOT7;MYB;RUNX3;PHF6;RTF1;SNW1;SMAD2;HSBP1;PRDM1;DPF2;THAP7;SDCBP;BRMS1;YY1;KAT5;DRAP1;MTA3;MED25;CBX2;LDB1;ZFP69;PEX14;TBX21;PHF12;SEMA4D;SLA2;SIN3B;PSEN1;PSMD10;EOMES;ARID4A;CDK5;NSD1;CBX8;RING1;TCF25;SIRT7;NR2C2;DPF3;TSC22D4;HMGA2;WFS1;DEAF1;NR1H2;LRRFIP1;STAT3;RCOR1
gsea,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.7926660679869171,-2.2913943123262284,0.0,1.2708672868603913e-05,0.001,7/15,5.97%,CALM3;CALM1;PTPA;CSNK2B;PPP1R2;PPP1R11;FKBP1A
gsea,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.4452827834424421,-2.28515879589606,0.0,1.2613832026300897e-05,0.001,114/314,27.56%,HMGB2;HMGB1;YWHAH;FOXM1;PSMC3;ID2;MAD2L2;RNF187;ILK;LAGE3;PCBD2;YAF2;ACTR3;ENY2;MED21;CDC5L;TCF3;HDAC3;CEBPG;TCEA1;CHCHD2;BRD4;EDF1;YEATS4;MED19;PSMD9;GPS2;CDK9;SMARCD2;ELF2;BCL2L12;RNF4;SSBP4;MAPK3;SP3;SMARCD1;SETD3;KDM1A;MLX;MAP2K5;MAP2K2;MYB;UBP1;MED6;RUNX3;ATF6B;SNW1;LHX2;SMAD2;SFR1;DPF2;WBP2;DNM2;USP21;YY1;KAT5;CRLF3;DRAP1;ING2;MED25;CAMK4;LDB1;RTRAF;VEZF1;MLLT10;WAS;TBX21;CXXC1;DHX36;IRF3;PSEN1;SREBF1;TRIAP1;DDRGK1;UBE2V1;EOMES;MED17;PPP3R1;TBK1;TNKS;NSD1;RXRB;CAPRIN2;SIRT7;NR2C2;CRTC2;DPF3;HMGA2;LRP5;FIZ1;DVL1;FOXJ3;DEAF1;NR1H2;STAT3;MED10;MAP2K7;DVL2;SPIN1;MEF2A;RPS6KA4;KANSL3;PPP3CA;RELA;EFCAB7;SKAP1;CITED1;KLF2;RFXAP;HTATIP2;USP16;ASXL2;HAS3;NR4A1
gsea,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.6813826872845755,-2.2771074734083743,0.0,2.5040792467026968e-05,0.002,16/28,17.21%,LSM5;LSM6;LSM4;NT5C3B;DCPS;CNOT11;POLR2D;CNOT6;LSM1;CNOT7;SKIV2L;WDR61;CNOT8;CNOT3;PDE12;EDC3
gsea,protein complex oligomerization (GO:0051259),-0.6445070726307829,-2.2715154862546387,0.0,3.7285003489507063e-05,0.003,12/31,18.96%,NUDT21;ELAVL1;G3BP2;PDCD6IP;MPP2;CHMP2A;CPSF7;MICU1;LRRC8C;DNM1L;UGDH;PYCARD
gsea,regulation of autophagy (GO:0010506),-0.5171573872500069,-2.2698832580456845,0.0,3.701285017936468e-05,0.003,37/92,24.40%,HMGB1;ATP6V1G1;GSK3A;LAMTOR1;VPS29;RHEB;TRIM27;SH3GLB1;SNX6;PRKAG1;RAB8A;LAMTOR4;DAPK3;ATP6V1C1;STK11;CISD2;LAMTOR3;MTMR9;LAMTOR5;ATP6V1D;KAT5;EXOC7;DNM1L;ATP6V1A;LAMTOR2;SREBF1;NPRL2;GSK3B;CDK5;PRKACA;WASHC1;ATG101;UBQLN2;TRIM68;STAT3;PIP4K2A;PIP4K2C
gsea,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.47469439150894643,-2.265701590634738,0.0,3.674464112009392e-05,0.003,70/175,24.53%,HMGB1;EZH2;FOXM1;UBE2I;TPR;CBFB;ID2;MAD2L2;NKAP;MBD2;CTBP1;CGGBP1;TCF3;HDAC3;TRIM27;SUDS3;PAF1;GPS2;WWP2;VPS72;UXT;KDM1A;MLX;UBE2D3;MAP2K5;GATAD2A;SUMO1;NCOR1;MYB;RUNX3;PHF6;RTF1;SNW1;SMAD2;HSBP1;PRDM1;DPF2;THAP7;SDCBP;BRMS1;YY1;KAT5;DRAP1;MTA3;MED25;CBX2;LDB1;ZFP69;TBX21;PHF12;SEMA4D;SLA2;SIN3B;PSEN1;PSMD10;EOMES;NSD1;CBX8;TCF25;SIRT7;NR2C2;HMGA2;WFS1;DEAF1;NR1H2;LRRFIP1;STAT3;MECP2;MEF2A;LIN37
gsea,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.7485269135308398,-2.2656772064115915,0.0,3.621971767552115e-05,0.003,13/19,16.02%,TPR;NUP50;U2AF1L4;SEC13;CHTOP;SRSF11;THOC7;FIP1L1;WDR33;SMG5;AGFG1;POLDIP3;SLU7
gsea,mRNA transport (GO:0051028),-0.7485269135308398,-2.2656772064115915,0.0,3.621971767552115e-05,0.003,13/19,16.02%,TPR;NUP50;U2AF1L4;SEC13;CHTOP;SRSF11;THOC7;FIP1L1;WDR33;SMG5;AGFG1;POLDIP3;SLU7
gsea,histone modification (GO:0016570),-0.6102933519066994,-2.2638218863014035,0.0,3.596284024519831e-05,0.003,16/37,20.30%,EZH2;TAF10;UBE2A;ENY2;SUDS3;MORF4L1;PHF20L1;MSL3;USP21;BRMS1;KAT5;MTA3;MRGBP;SIN3B;NSD1;SIRT7
gsea,regulation of transcription by RNA polymerase II (GO:0006357),-0.421603499380801,-2.2633550842245684,0.0,3.570958080685184e-05,0.003,192/490,29.48%,HMGB2;HMGB1;EZH2;RAD21;FOXM1;UBE2I;PSMC3;SAP18;TPR;CBFB;MED18;ID2;GTF2H5;TIAL1;MAD2L2;CCNH;NKAP;LAGE3;ACTR3;SSU72;ENY2;BRD9;MED21;CDC5L;MBD2;CTBP1;CGGBP1;TCF3;HDAC3;TRIM27;CEBPG;SUDS3;PRKAR1A;TCEA1;CHCHD2;BRD4;YEATS4;SNF8;MED19;PAF1;GPS2;CDK9;SMARCD2;ELF2;SMARCE1;BCL2L12;RNF4;WWP2;SSBP4;VPS72;MAPK3;SRA1;MED31;SP3;MED27;UXT;SMARCD1;SETD3;KDM1A;MLX;UBE2D3;SUB1;MAP2K5;MED29;GATAD2A;CAMTA1;SUMO1;PHF20L1;NCOR1;MYB;UBP1;MED6;RUNX3;PHF6;RTF1;ATF6B;SNW1;LHX2;PPM1D;SMAD2;TADA1;HSBP1;PRDM1;DPF2;THAP7;WBP2;SDCBP;PPIL4;TOX;BRMS1;YY1;KAT5;CRLF3;DRAP1;MTA3;MED25;MRGBP;CBX2;LDB1;RTRAF;VEZF1;ZFP69;MLLT10;PIAS1;WAS;TBX21;PHF12;ZIK1;DHX36;SEMA4D;SLA2;SIN3B;IRF3;PSEN1;SREBF1;TRIAP1;PSMD10;DDRGK1;EOMES;MED17;PPP3R1;PHF14;ARID4A;TBK1;TNKS;NSD1;BBS7;MED12L;CBX8;RXRB;CREG1;TCF25;CAPRIN2;PURB;MNAT1;SIRT7;NR2C2;CRTC2;DPF3;SP110;PTEN;HMGA2;LRP5;FIZ1;DVL1;ZFX;WFS1;FOXJ3;CCNL2;MAFG;DEAF1;NR1H2;LRRFIP1;STAT3;RCOR1;MED10;MECP2;DVL2;MEF2A;RPS6KA4;KANSL3;LIN37;MAPK14;PPP3CA;RELA;EFCAB7;CNOT2;ZFP82;SKAP1;ZBTB3;CITED1;KLF2;DMTF1;RFXAP;HTATIP2;USP16;MED15;PROX2;ASXL2;NR4A1;BCL6B;MED26;USF1;SLC30A9;ZBTB8A;LCOR;KLF5;SP9;TBR1;RFX2;THAP11;NR2C1
gsea,ephrin receptor signaling pathway (GO:0048013),-0.653454276248898,-2.260319790559446,0.0,4.7279817944736227e-05,0.004,16/34,20.85%,RHOA;AP2S1;RAC1;CDC42;ACTR3;AP2M1;ARPC4;AP2A1;ARPC1A;SDCBP;NCSTN;ARPC2;PSEN1;ARPC5;PTK2;CHN1
gsea,regulation of cytokinesis (GO:0032465),-0.720310929417271,-2.256770343746509,0.0,4.695148587567556e-05,0.004,7/21,6.72%,CALM3;RHOA;CALM1;CDC42;SH3GLB1;RAB11A;PKN2
gsea,protein insertion into ER membrane (GO:0045048),-0.7367537939012675,-2.2558264611651033,0.0,4.662768252480883e-05,0.004,11/20,12.06%,UBL4A;EMD;EMC7;VAPA;BAG6;EMC3;WDR83OS;UBE2J2;EMC10;EMC6;SGTA
gsea,positive regulation of protein modification process (GO:0031401),-0.5767310030127756,-2.2544199510977747,0.0,4.630831483628275e-05,0.004,22/53,22.06%,CALM3;CALM1;RAC1;PTPA;ILK;HDAC3;KRAS;CNEP1R1;MAPK3;RALBP1;CAMTA1;CHP1;BRMS1;ASPSCR1;KAT5;ERP29;SEMA4D;CRKL;F2;PTK2;FXR1;AKT2
gsea,mRNA metabolic process (GO:0016071),-0.6992883737772786,-2.2534079525595483,0.0,4.5993292286376056e-05,0.004,10/25,12.70%,NUDT21;SNRPG;LSM5;LSM6;AURKAIP1;PCBP2;SRSF11;PRPF18;YTHDF2;KIN
gsea,RNA export from nucleus (GO:0006405),-0.7369003085890222,-2.252705994467015,0.0,4.5682526797954604e-05,0.004,13/20,16.02%,TPR;NUP50;U2AF1L4;SEC13;CHTOP;SRSF11;THOC7;FIP1L1;WDR33;SMG5;AGFG1;POLDIP3;SLU7
gsea,neuron projection development (GO:0031175),-0.558749991431959,-2.2462962715055945,0.0,4.5375932658371017e-05,0.004,19/56,20.92%,HMGB1;CDC42;ATXN10;VAPA;RAB11A;DBNL;TOR1A;DTNBP1;DNM2;RAB35;DOCK10;MARK2;BLOC1S6;TAOK3;GSK3B;CDK5;PQBP1;BLOC1S4;PTEN
gsea,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.8082718244621909,-2.2462046788229624,0.001941747572815534,4.507342644064854e-05,0.004,12/16,11.24%,LSM5;LSM6;LSM4;NT5C3B;DCPS;POLR2G;CNOT6;LSM1;CNOT7;SKIV2L;WDR61;CNOT8
gsea,cell junction assembly (GO:0034329),-0.6651549492711902,-2.2459378720686924,0.0,4.4774926927796565e-05,0.004,12/26,20.92%,RHOA;CDC42;ILK;DBNL;CAPZA1;LIMS1;TLN1;RAB29;CDK5;VMP1;TLN2;PTEN
gsea,sphingolipid metabolic process (GO:0006665),-0.5876638409518835,-2.236488311525821,0.0,5.560044380014212e-05,0.005,18/47,21.11%,GLTP;SPTSSA;PPP2CA;VAPA;ORMDL2;HEXB;CERS2;B4GALNT1;TECR;ELOVL1;ESYT1;CERS5;SPTLC2;PPP2R1A;CSNK1G2;CLN8;ELOVL5;SPTLC1
gsea,generation of neurons (GO:0048699),-0.5849883733739832,-2.233704957478423,0.0,5.523704220667714e-05,0.005,11/44,18.34%,HMGB2;RAC1;PAFAH1B1;DTNB;MTPN;YTHDF2;RUNX3;LHX2;LDB1;MARK2;CDK5
gsea,response to ionizing radiation (GO:0010212),-0.7480877002797613,-2.227816949285977,0.0,6.585403213731119e-05,0.006,8/17,13.10%,SWI5;BABAM1;NABP2;GRB2;BABAM2;INIP;STK11;KAT5
gsea,gene expression (GO:0010467),0.5880984830435522,2.2252586375045675,0.0,0.00016177284813630844,0.008,53/127,7.55%,RPS27;RPL34;RPL37A;RPS24;RPS15A;RPL37;RPL30;RPL19;RPL18A;RPL17;RPL24;RPS21;RPS11;RPL27A;RPL39;RPS7;RPL9;RPL38;RPL36;RPS13;RPS10;RPL23;RPL21;RPL13A;RPL11;RPS28;RPS14;RPS29;RPS9;RPL6;RPL35A;RPL22;RPL27;RPS4X;RPS16;RPL18;RPS3;NR4A2;RPS12;RPS23;RPL32;RPL26;RPL29;RPS5;RPL35;SRSF5;MRPL52;CREBL2;EPC1;MRPL9;TSPAN14;TSPAN17;DEDD2
gsea,intracellular protein transport (GO:0006886),-0.4909076712489797,-2.225127291817185,0.0,6.542916741384466e-05,0.006,65/124,25.52%,YWHAH;TPR;TMED10;ARF6;VPS36;NUP50;SEC13;VPS29;CDC37;SNX6;SNF8;PREB;RAB14;SNX1;ARF1;GGA1;ARFRP1;SAR1B;TMED3;RAB24;AP2A1;RAB5C;PDCD6;TBC1D15;ARL5A;STX12;RAB18;SNX17;SAR1A;ARL6;APPL1;RAB1A;CHP1;NAPA;SCFD1;NXT2;ARF3;RAB29;ERP29;TMED7;SLU7;RAB1B;ARF5;COPZ1;TMED5;MAIP1;ACD;TBC1D9B;SNX8;VPS28;SURF4;STXBP2;ARFIP1;TMED9;STX8;AKT2;STAT3;RABGAP1L;AP4S1;RANBP17;TLK1;TRAK2;NAPG;SNX15;NUP62CL
gsea,regulation of viral transcription (GO:0046782),-0.7648042390232557,-2.219564793370886,0.0,6.500974967401232e-05,0.006,9/16,9.98%,POLR2J;POLR2K;TRIM27;POLR2G;POLR2I;CDK9;POLR2D;NELFA;UBP1
gsea,Golgi organization (GO:0007030),-0.5924307541045807,-2.2177793474524647,0.0,6.459567483532434e-05,0.006,29/44,26.61%,TMED10;CDC42;YWHAZ;RAB2A;CSNK1A1;TMED3;VTI1B;BET1;RAB1A;TJAP1;SEC22B;RAB29;VTI1A;TMED7;COG4;TMED5;GOSR2;VMP1;SURF4;VPS51;TANGO2;GOLGA5;TRAPPC8;TMED9;STK25;VAMP4;COG2;GOLPH3L;PDCD10
gsea,nucleotide-excision repair (GO:0006289),-0.6370350049443547,-2.2146083678394466,0.0,6.418684145029064e-05,0.006,17/30,14.15%,RBX1;COPS6;GTF2H5;COMMD1;POLR2J;POLR2K;CCNH;ISY1;TCEA1;POLR2G;POLR2I;POLR2D;ERCC1;AQR;PNKP;XAB2;COPS8
gsea,organonitrogen compound biosynthetic process (GO:1901566),-0.568494875617946,-2.2102503091305836,0.0,6.378315062355926e-05,0.006,20/52,22.25%,SPTSSA;CSNK2A1;CSNK2B;VAPA;ESD;CERS2;GSTP1;ELOVL1;CERS5;AKR1A1;SPTLC2;CEPT1;CSNK1G2;CHKB;PCYT1B;LPCAT3;ELOVL5;MOCS2;SPTLC1;NFS1
gsea,chromosome organization (GO:0051276),-0.6733672383032067,-2.210183007576301,0.0,6.338450593216201e-05,0.006,6/24,4.08%,HMGB2;EZH2;RBX1;COPS6;GATAD1;HDAC3
gsea,RNA 3'-end processing (GO:0031123),-0.6977928346026361,-2.2090312571608925,0.0,6.299081334873243e-05,0.006,13/22,16.02%,NUDT21;PABPN1;U2AF1L4;CHTOP;SRSF11;THOC7;FIP1L1;PAPOLA;TENT2;WDR33;CPSF7;POLDIP3;SLU7
gsea,regulation of cell cycle process (GO:0010564),-0.6692972210431823,-2.2089374146173557,0.0,6.260198116756742e-05,0.006,8/26,9.88%,CALM3;CALM1;CSNK2A1;CDC42;SH3GLB1;RAB11A;DAPK3;YTHDF2
gsea,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.803017589189029,-2.2023743962369484,0.0019342359767891683,8.295722657788075e-05,0.007,11/15,11.24%,LSM5;LSM6;LSM4;NT5C3B;DCPS;CNOT6;LSM1;CNOT7;SKIV2L;WDR61;CNOT8
gsea,ciliary basal body-plasma membrane docking (GO:0097711),-0.6704765973154518,-2.200629511470209,0.0,9.275781355926148e-05,0.008,13/25,23.69%,MAPRE1;SSNA1;PAFAH1B1;DYNLL1;RAB11A;DCTN3;B9D2;PPP2R1A;CEP63;PRKACA;CEP131;NPHP4;NPHP1
gsea,plasma membrane bounded cell projection organization (GO:0120036),-0.5749885976841966,-2.1990463510206277,0.0,9.219564499223564e-05,0.008,14/43,19.72%,HMGB1;RAC1;ATXN10;VAPA;RAB11A;TOR1A;DTNBP1;RAB35;FAM161B;BLOC1S6;GSK3B;CDK5;PQBP1;BLOC1S4
gsea,positive regulation of protein kinase activity (GO:0045860),-0.5718501136482242,-2.1967078083172935,0.0,9.16402495404752e-05,0.008,14/46,19.30%,EZH2;CALM3;RHOA;CALM1;PPP2CA;PAK2;PRKAG1;STK11;MAP2K2;IQGAP1;MARK2;TAOK3;RAP1A;PTK2
gsea,histone acetylation (GO:0016573),-0.6761013949155009,-2.194955740399356,0.0019723865877712033,0.000101212783923612,0.009,11/23,13.65%,TAF10;MEAF6;TAF12;MORF4L1;YEATS4;PHF20L1;MSL3;TADA1;BRD1;KAT5;MRGBP
gsea,cell junction organization (GO:0034330),-0.6750472541419361,-2.1919454406986763,0.0,0.00010061032687644765,0.009,5/23,6.18%,RHOA;CDC42;ILK;CAPZA1;LIMS1
gsea,regulation of cellular response to stress (GO:0080135),-0.7078732566197048,-2.1905257093629795,0.0,0.0001000149994984805,0.009,10/20,14.44%,TPR;BAG1;NUP50;SEC13;CHCHD2;MAPK1;MAPK3;HSBP1;ING2;ARMT1
gsea,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.7478912987918895,-2.1899654615858464,0.0,9.942667597201884e-05,0.009,7/16,8.89%,CDC42;TSG101;GRB2;SNX6;PTPN2;RNF115;CHMP6
gsea,membrane organization (GO:0061024),-0.5131607574552386,-2.189882490253107,0.0,9.884523342247489e-05,0.009,51/95,26.45%,GLTP;SNX3;EMD;AP2S1;ACTR3;MTCH1;AP2M1;FCHO1;GRB2;SH3GLB1;VAPA;ARRB2;TOR1A;CLTA;ARPC4;FNBP1;PDCD6IP;CHMP6;SAR1B;AP2A1;CHMP2A;VTI1B;SAR1A;ARPC1A;DNM2;CHP1;NAPA;VPS4B;AGFG1;SLC2A8;VPS4A;ARPC2;VAMP3;DNM1L;TOR1AIP1;CHMP3;ARPC5;CHMP7;EPN1;ATP2C1;LPCAT3;STX18;MITD1;RABEP1;SUN1;DVL2;SNAP29;NAPG;VAPB;VAMP4;DNAJC6
gsea,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.6094799347115738,-2.1814890187016496,0.0,0.00011792466219937119,0.011,21/36,21.67%,RER1;TMED10;ERGIC2;TMED3;COPB1;KDELR1;RAB1A;NAPA;SCFD1;ARFGAP2;ARF3;SEC22B;TMED7;COG4;RAB1B;ARF5;COPZ1;COPE;STX18;SURF4;TMED9
gsea,mitochondrial transport (GO:0006839),-0.7017342873095251,-2.1774116041136393,0.0,0.00011724301675313206,0.011,15/21,19.22%,DNAJC19;AIP;TMEM14C;TIMM10B;MFF;TOMM22;BCAP31;TIMM22;TOMM7;SLC25A16;TIMM17B;SLC25A4;FBXO7;STARD3;MAIP1
gsea,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.6128336827911032,-2.175922837986174,0.0,0.00012484826926031911,0.012,14/34,12.28%,AP2S1;CAPZB;ACTR10;SEC13;AP2M1;AP1S1;DYNLL1;CAPZA1;DCTN3;CLTA;ARF1;SAR1B;AP2A1;DNM2
gsea,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.6128336827911032,-2.175922837986174,0.0,0.00012484826926031911,0.012,14/34,12.28%,AP2S1;CAPZB;ACTR10;SEC13;AP2M1;AP1S1;DYNLL1;CAPZA1;DCTN3;CLTA;ARF1;SAR1B;AP2A1;DNM2
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.6128336827911032,-2.175922837986174,0.0,0.00012484826926031911,0.012,14/34,12.28%,AP2S1;CAPZB;ACTR10;SEC13;AP2M1;AP1S1;DYNLL1;CAPZA1;DCTN3;CLTA;ARF1;SAR1B;AP2A1;DNM2
gsea,nuclear membrane reassembly (GO:0031468),-0.7055179327095222,-2.173116078025246,0.0,0.00013369236656124567,0.013,12/21,17.95%,UBE2I;EMD;SEC13;PPP2CA;CHMP6;SUMO1;CHMP2A;PPP2R1A;VPS4A;PPP2R2A;CHMP3;CHMP7
gsea,neuron development (GO:0048666),-0.5818946959900994,-2.1730065006347905,0.0,0.00013294128585022744,0.013,15/43,19.72%,HMGB1;ATXN10;VAPA;RAB11A;TOR1A;DTNBP1;RUNX3;TBCD;RAB35;UGDH;BLOC1S6;GSK3B;CDK5;PQBP1;BLOC1S4
gsea,regulation of endothelial cell proliferation (GO:0001936),-0.7180704881068438,-2.164946154918988,0.0,0.0001794123817819111,0.017,5/17,11.83%,HMGB2;PDCL3;EMC10;PDCD6;SYNJ2BP
gsea,DNA repair (GO:0006281),-0.5329554252092261,-2.162374075998821,0.0,0.00018780594350270227,0.018,28/62,21.60%,RAD21;CENPX;GTF2H5;COMMD1;MAD2L2;BABAM1;RAD51B;UBE2A;UBXN1;NABP2;BABAM2;INIP;XRCC3;ERCC1;SUMO1;WDR33;PNKP;FAAP20;KAT5;ALKBH3;MPG;ATRIP;UBE2V1;MNAT1;POLB;HMGA2;REXO4;ACTR8
gsea,"retrograde transport, endosome to Golgi (GO:0042147)",-0.5989208901105891,-2.1617139165021024,0.0,0.00018676834160489728,0.018,22/39,21.67%,SNX3;VPS29;TRIM27;SNX6;SNX1;PLEKHJ1;GGA1;ARFRP1;VTI1B;SNX12;GOSR1;TRAPPC10;VAMP3;RAB29;VTI1A;YKT6;GOSR2;WASHC1;SNX8;SURF4;VPS51;TMED9
gsea,apical junction assembly (GO:0043297),-0.6626684932812301,-2.1587259501513665,0.0,0.0001857421419257495,0.018,6/19,11.70%,RHOA;PAK2;PKN2;WDR1;PDCD6IP;TBCD
gsea,import into nucleus (GO:0051170),-0.7037192391191948,-2.156468029949374,0.002004008016032064,0.00019396351542082366,0.019,9/19,13.19%,SNRPG;SNRPD2;TPR;NUP50;SEC13;GEMIN7;APPL1;GEMIN4;NXT2
gsea,endocytic recycling (GO:0032456),-0.6309016588237175,-2.1539145309613534,0.0,0.00020209552616051656,0.02,16/28,22.77%,SNX3;ARF6;RAB11B;VPS29;SNF8;RAB14;SNX17;SNX12;RAB35;CCDC22;DENND1A;ACAP2;ENTR1;WASHC1;VPS51;VPS35L
gsea,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.637667395159068,-2.1537534656498,0.0,0.00020100311791100027,0.02,8/26,11.25%,HMGB1;BEX3;CSNK2A1;PDCD5;BCAP31;MAP2K5;PDCD6;LAMTOR5
gsea,negative regulation of protein modification process (GO:0031400),-0.6508121360312271,-2.149650572790842,0.0,0.00022718460907584953,0.022,9/24,18.16%,ARPP19;YWHAB;PTPA;FKBP8;PNKP;CHP1;PPP1R15B;CRKL;GSK3B
gsea,mitotic nuclear membrane organization (GO:0101024),-0.7080735233710421,-2.147278821528195,0.0,0.00023375846159378897,0.022,12/20,17.95%,UBE2I;EMD;SEC13;PPP2CA;CHMP6;SUMO1;CHMP2A;PPP2R1A;VPS4A;PPP2R2A;CHMP3;CHMP7
gsea,mitotic nuclear membrane reassembly (GO:0007084),-0.7080735233710421,-2.147278821528195,0.0,0.00023375846159378897,0.022,12/20,17.95%,UBE2I;EMD;SEC13;PPP2CA;CHMP6;SUMO1;CHMP2A;PPP2R1A;VPS4A;PPP2R2A;CHMP3;CHMP7
gsea,negative regulation of cell cycle process (GO:0010948),-0.7399228750170489,-2.1449661643697615,0.0,0.000232521644336679,0.022,8/16,14.30%,EZH2;AURKAIP1;YAF2;TERF1;WAPL;UXT;CHMP2A;VPS4A
gsea,cellular response to interleukin-12 (GO:0071349),-0.7114445162474372,-2.1403542602275367,0.0,0.00026688213024068214,0.025,10/18,10.14%,AIP;BOLA2;CDC42;CD47;PAK2;CAPZA1;TALDO1;ARF1;SOD1;PITPNA
gsea,protein-containing complex assembly (GO:0065003),-0.4922900287765258,-2.1398551134963797,0.0,0.00026548484160067855,0.025,45/98,21.97%,RBX1;TMED10;GPAA1;CSNK2B;ELOB;SEC13;AP2M1;PPP6C;CNIH1;DBNL;TRAPPC5;CAPZA1;TRAPPC6B;PREB;TRAPPC1;PEF1;CSNK1A1;TRADD;SAR1B;CASP8;PDCD6;BET1;RAB1A;IL2RB;NAPA;TRAPPC6A;SCFD1;KAT5;PPP2R1A;TRAPPC10;SKAP2;VAMP3;DNM1L;PEX14;SEC22B;WAS;AIM2;RAB1B;TRAPPC2L;GSK3B;GOSR2;MNAT1;RANBP9;TRAPPC3;GSDMD
gsea,regulation of protein phosphorylation (GO:0001932),-0.5145517941866768,-2.1371489888289945,0.0,0.00027290551165236424,0.025,29/68,22.06%,RAC1;ILK;PPP2CA;HDAC3;ANKRD54;FKBP8;BRD4;NDUFS4;KRAS;MAPK3;RALBP1;PDCL3;SOD1;PPP2R5E;ITGB2;PPP2R5C;CHP1;PPIL4;PPP1R15B;ERP29;SEMA4D;CRKL;NSD1;F2;PTK2;PTEN;TWF1;FXR1;AKT2
gsea,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.4755105446255384,-2.135951161581757,0.0,0.00028024928356879924,0.026,52/124,24.97%,RHOA;ATP6V1G1;AP2S1;POLR2J;TIAL1;RAC1;POLR2K;CDC42;GSK3A;ACTR3;AP2M1;PAK2;GRB2;POLR2G;POLR2I;PTPN2;WASF2;MAPK1;POLR2D;RAB14;LCK;MAPK3;ARPC4;ATP6V1C1;CYFIP2;AP2A1;ARPC1A;SH2D2A;APPL1;SDCBP;ATP6V1D;NCSTN;ARPC2;ATP6V1A;TIA1;PSEN1;FIBP;ARPC5;GSK3B;NCF4;PTK2;TYRO3;BRK1;RGS14;STAP1;CHN1;AKT2;ANGPT2;STAT3;FGFRL1;MAPK14;VAV1
gsea,protein methylation (GO:0006479),-0.7320186699154271,-2.135648643825664,0.0,0.0002788046996328776,0.026,7/16,14.89%,EZH2;PCMT1;TRMT112;SETD3;LCMT1;EEF1AKMT1;EEF1AKMT2
gsea,positive regulation of viral process (GO:0048524),-0.6843181271652461,-2.1327192862813504,0.0,0.00029471086518885584,0.027,12/21,15.97%,POLR2J;POLR2K;POLR2G;POLR2I;CDK9;POLR2D;PKN2;NELFA;CNOT7;VPS4A;NELFB;PDE12
gsea,establishment of protein localization to mitochondrion (GO:0072655),-0.717364322642531,-2.131682721959758,0.0,0.0003018309806293429,0.028,14/18,17.54%,DNAJC19;AIP;PAM16;TIMM10B;MFF;TOMM22;BCAP31;TIMM22;TOMM7;ROMO1;DNLZ;TIMM17B;GRPEL2;FBXO7
gsea,antigen receptor-mediated signaling pathway (GO:0050851),-0.5522868318257224,-2.1310185665850097,0.0,0.0003088788106338859,0.029,26/57,17.20%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PAK2;PSMD4;KHDRBS1;PSMB1;PSMF1;PSMD9;PSMD8;LCK;SPG21;EIF2B2;RBCK1;PSMB10;CSK;WAS;SLA2;PSMD10
gsea,receptor-mediated endocytosis (GO:0006898),-0.6148408892225621,-2.1274047417186206,0.0,0.0003073188166407855,0.029,11/30,12.28%,AP2S1;AP2M1;AP1S1;FCHO1;GRB2;ARRB2;CLTA;SNX1;AP2A1;ITGB2;DNM2
gsea,regulation of cell motility (GO:2000145),-0.5734949426839508,-2.1266891643994974,0.0,0.000305774500979274,0.029,10/39,16.46%,RHOA;CFAP20;RAC1;PKN2;DAPK3;CCDC25;ARHGAP18;LDB1;WAS;DOCK10
gsea,positive regulation of cell growth (GO:0030307),-0.6295331362316371,-2.126573470768779,0.0,0.00030424562847437765,0.029,8/26,17.46%,CSNK2A1;CDC42;DBNL;MTPN;SDCBP;SEMA4D;PSMD10;ITSN2
gsea,cortical cytoskeleton organization (GO:0030865),-0.7139720119262131,-2.126398230907423,0.0,0.00030273196863122155,0.029,3/16,2.47%,RHOA;RAC1;ARF6
gsea,response to molecule of bacterial origin (GO:0002237),-0.6455779818655871,-2.123156465067331,0.0,0.0003263360701457846,0.031,1/24,0.03%,HMGB2
gsea,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.4247025220796869,-2.122097796808147,0.0,0.0003413812470566362,0.032,88/242,27.56%,HMGB2;HMGB1;FOXM1;PSMC3;LAGE3;ACTR3;MED21;CDC5L;TCF3;HDAC3;CEBPG;TCEA1;CHCHD2;BRD4;YEATS4;MED19;GPS2;CDK9;SMARCD2;BCL2L12;RNF4;SSBP4;MAPK3;SP3;SMARCD1;SETD3;KDM1A;MLX;SUB1;MAP2K5;MYB;UBP1;MED6;ATF6B;SNW1;SMAD2;DPF2;WBP2;YY1;KAT5;CRLF3;DRAP1;MED25;LDB1;RTRAF;VEZF1;MLLT10;WAS;DHX36;IRF3;SREBF1;TRIAP1;DDRGK1;EOMES;MED17;PPP3R1;TBK1;TNKS;EAPP;RXRB;CAPRIN2;SIRT7;NR2C2;CRTC2;DPF3;HMGA2;LRP5;FIZ1;DVL1;FOXJ3;NR1H2;STAT3;MED10;DVL2;MEF2A;RPS6KA4;KANSL3;PPP3CA;RELA;EFCAB7;SKAP1;CITED1;KLF2;RFXAP;HTATIP2;USP16;ASXL2;NR4A1
gsea,regulation of TOR signaling (GO:0032006),-0.6097048852242684,-2.1219295643074316,0.0,0.0003397078095710644,0.032,11/30,16.92%,GSK3A;LAMTOR1;SEC13;RHEB;HDAC3;LAMTOR4;PDCD6;LAMTOR3;LAMTOR5;LAMTOR2;NPRL2
gsea,T cell receptor signaling pathway (GO:0050852),-0.5592043719237273,-2.1197930534204623,0.0,0.0003380506983048641,0.032,24/53,17.20%,PSMC3;PSMB9;PSMD13;PSMA1;PSMB3;PSMA2;PSMB4;PSMA7;PSMB8;PSMD5;PAK2;PSMD4;KHDRBS1;PSMB1;PSMF1;PSMD9;PSMD8;LCK;EIF2B2;RBCK1;PSMB10;CSK;WAS;PSMD10
gsea,regulation of heart contraction (GO:0008016),-0.6817878711626644,-2.1153945739881443,0.0,0.00035281990357061057,0.034,4/19,7.60%,CALM3;CALM1;GSK3A;ATP1B3
gsea,post-Golgi vesicle-mediated transport (GO:0006892),-0.5515641167451888,-2.114980701432881,0.0,0.0003511154595920086,0.034,28/45,27.08%,COMMD1;AP1S1;RAB10;CLTA;RAB14;ARF1;DTNBP1;AP2A1;CHMP2A;DNM2;VPS13A;NAPA;SCFD1;ACBD3;CCDC22;BLOC1S6;SCAMP2;SCAMP3;EXOC5;BLOC1S4;RABEP1;VPS35L;AP4S1;EXOC6;SYS1;EXOC1;DNAJC6;MON2
gsea,peptide metabolic process (GO:0006518),-0.6296752582000072,-2.111768201823813,0.0,0.0003819322793348224,0.037,10/26,16.56%,SEC11C;SPCS1;LTA4H;ETHE1;SEC11A;GSTP1;SOD1;GLRX2;DNPEP;PSEN1
gsea,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.6775425504925805,-2.111308048458934,0.0,0.00038010485216097154,0.037,6/20,8.24%,TRA2B;HNRNPL;PUF60;SAP18;KHDRBS1;FAM172A
gsea,intracellular protein transmembrane transport (GO:0065002),-0.6867131888271697,-2.1101527461950083,0.0,0.0003863436552055589,0.037,11/18,22.52%,DNAJC19;PAM16;ROMO1;SEC63;DNLZ;PEX14;TIMM17B;GRPEL2;SEC61G;AKT2;SEC61B
gsea,regulation of protein localization (GO:0032880),-0.6899783910792112,-2.1085764576436183,0.0,0.0003845126426216464,0.037,11/18,23.06%,TPR;TRIM27;FKBP1A;RAB14;KDM1A;SUMO1;VPS4A;DVL1;WDPCP;TRIM68;RABGAP1L
gsea,receptor metabolic process (GO:0043112),-0.6720811441662234,-2.107414324316009,0.0,0.00039067179756930047,0.037,10/21,13.53%,RAB11B;AP2M1;GRB2;SH3GLB1;ARRB2;SNX1;PLEKHJ1;ITGB2;DNM2;MVB12A
gsea,positive regulation of protein phosphorylation (GO:0001934),-0.4925381289271666,-2.1014242165133656,0.0,0.000428514969682222,0.042,33/86,26.61%,CALM3;CALM1;RAC1;MAD2L2;ILK;CSNK2B;UBE2K;HDAC3;PAK2;PRKAG1;KRAS;CDK9;MAPK1;MAPK3;RALBP1;IQGAP1;SDCBP;ERP29;SEMA4D;CRKL;DDRGK1;RAP1A;TBK1;F2;PTK2;CAPRIN2;FXR1;AKT2;DVL2;RPS6KA4;LAT;ARAF;PDCD10
gsea,regulation of cell division (GO:0051302),-0.6568147008642742,-2.096145827421598,0.0,0.0004344109440833534,0.043,5/21,5.30%,CALM3;CALM1;SH3GLB1;RAB11A;CDK2AP2
gsea,cytokine-mediated signaling pathway (GO:0019221),-0.4609036493992997,-2.0947327703398546,0.0,0.0004481137163576106,0.044,50/142,19.64%,RBX1;PSMC3;PSMB9;PSMD13;PSMA1;AIP;PSMB3;PSMA2;PSMB4;BOLA2;PSMA7;CDC42;PSMB8;ILK;CSNK2B;IFNGR1;PSMD5;YWHAZ;PAK2;PSMD4;GRB2;PSMB1;PSMF1;PSMD9;PSMD8;CAPZA1;LIMS1;TALDO1;LCK;MAPK3;ARF1;TRADD;SOD1;PITPNA;ITGB2;APPL1;IL2RB;PSMB10;CSK;AIM2;SLA2;IRF3;CRKL;PSMD10;ADIPOR1;UBE2V1;CNTF;PYCARD;PRKACA;IL20RA
gsea,cellular response to amino acid starvation (GO:0034198),-0.5911713685805118,-2.0934721635624696,0.0019646365422396855,0.00045177282261940356,0.045,15/33,16.92%,ATP6V1G1;LAMTOR1;SEC13;RHEB;SH3GLB1;MAPK1;MAPK3;LAMTOR4;ATP6V1C1;LAMTOR3;LAMTOR5;ATP6V1D;ATP6V1A;LAMTOR2;NPRL2
gsea,response to amino acid starvation (GO:1990928),-0.5911713685805118,-2.0934721635624696,0.0019646365422396855,0.00045177282261940356,0.045,15/33,16.92%,ATP6V1G1;LAMTOR1;SEC13;RHEB;SH3GLB1;MAPK1;MAPK3;LAMTOR4;ATP6V1C1;LAMTOR3;LAMTOR5;ATP6V1D;ATP6V1A;LAMTOR2;NPRL2
gsea,regulation of cell cycle G2/M phase transition (GO:1902749),-0.733643442536077,-2.0933757790868284,0.0,0.0004497004702220669,0.045,9/15,20.00%,MAPRE1;SSNA1;PAFAH1B1;DYNLL1;DCTN3;PPP2R1A;CEP63;PRKACA;CEP131
gsea,regulation of JNK cascade (GO:0046328),-0.6166995136692276,-2.0926655082166348,0.0,0.0004630831483628275,0.046,10/28,19.94%,HMGB1;HDAC3;GPS2;NCOR1;CYLD;SDCBP;TAOK3;TIRAP;PYCARD;MAP4K2
gsea,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.5683183121459906,-2.0922668700139746,0.0,0.00046097822496117823,0.046,15/35,19.35%,RBX1;PSMC3;DDA1;GSK3A;ELOB;BAG6;CSNK1A1;SUMO1;TMEM259;PIAS1;PSMD10;DDRGK1;GSK3B;BBS7;HECTD1
gsea,ribonucleoprotein complex biogenesis (GO:0022613),0.7559089206934829,2.091084726346751,0.0,0.0011609580866252724,0.054,8/18,2.31%,RPS24;RPS7;RPL38;RPL11;RPS28;RPL35A;RPS16;RPL26
gsea,positive regulation of protein localization to membrane (GO:1905477),-0.5957296444990862,-2.0894186614488786,0.0,0.0004741887623280898,0.047,11/34,12.31%,YWHAH;YWHAB;YWHAQ;ARF6;PDCD5;YWHAZ;MFF;PPP3CC;CASP8;ITGB2;CHP1
gsea,transcription-coupled nucleotide-excision repair (GO:0006283),-0.6657379298894732,-2.088779861689894,0.0,0.0004796665313785234,0.047,15/21,14.15%,RBX1;COPS6;GTF2H5;POLR2J;POLR2K;CCNH;ISY1;TCEA1;POLR2G;POLR2I;POLR2D;ERCC1;AQR;XAB2;COPS8
gsea,positive regulation of cytoskeleton organization (GO:0051495),-0.6794694018820198,-2.0765292899130836,0.0,0.000568470905221184,0.055,8/19,20.08%,PFDN2;CDC42;ARF6;KATNBL1;WDR1;CDK5;PYCARD;STAP1
gsea,fatty acid biosynthetic process (GO:0006633),-0.7083787206504586,-2.0734242592068877,0.0,0.0006112077357744194,0.06,5/15,9.08%,GPX4;LTA4H;ACOT7;TECR;ELOVL1
gsea,cellular protein-containing complex assembly (GO:0034622),-0.5220492205466407,-2.0731208694739256,0.0,0.0006084912569487554,0.06,23/56,16.84%,PSMD13;TPR;COX7A2;AP2S1;GPX4;RAB5IF;CSNK2B;AP2M1;FCHO1;SRP19;PSMD4;FKBP1A;CLTA;POMP;CHMP2A;GTF2B;TBCC;SMAD2;ARL6;TBCD;VAMP3;COG4;CHMP3
gsea,positive regulation of epithelial cell proliferation (GO:0050679),-0.626479889016029,-2.071072405396723,0.001953125,0.0006282358110090394,0.061,4/24,10.32%,HMGB2;PDCL3;EMC10;PDCD6
gsea,regulation of lipid metabolic process (GO:0019216),-0.6071022035101714,-2.0690762608577997,0.0,0.0006626985054875088,0.062,12/26,17.40%,ID2;PANK2;HDAC3;EDF1;GPS2;CERS2;TGS1;NCOR1;ZFP69;SIN3B;SREBF1;ADIPOR1
gsea,mitochondrion organization (GO:0007005),-0.528171343907937,-2.0655573250229664,0.0,0.0007413392506685615,0.068,24/53,17.54%,DNAJC19;AIP;COX7A2;RAB5IF;CHCHD3;TIMM10B;MFF;SLIRP;TOMM22;BCAP31;CHCHD2;TIMM22;SSBP1;TOMM7;FMC1;DNM2;ATPAF1;TMEM11;RHOT1;DNM1L;RAB29;TIMM17B;SLC25A4;FBXO7
gsea,response to metal ion (GO:0010038),-0.6335250474024612,-2.0644664226888128,0.0,0.0007454829809779754,0.068,9/23,16.53%,CALM3;PPP1CA;CALM1;PPP2CA;PEF1;PDCD6;SLC25A12;SLC30A5;ANXA11
gsea,regulation of translational initiation (GO:0006446),-0.5976949004175826,-2.0629606353845205,0.0,0.000749590678849916,0.068,13/28,13.85%,TPR;POLR2G;KHDRBS1;RPS6KB1;POLR2D;EIF1B;YTHDF2;EIF2B2;DNAJC3;YTHDF1;EIF1;RPS6KB2;PPP1R15B
gsea,regulation of MAPK cascade (GO:0043408),-0.5715899245013047,-2.0613419198488416,0.0,0.0007609799269200403,0.07,15/34,17.43%,HMGB1;LAMTOR1;YWHAZ;PAK2;MAPK1;TRAF7;MAPK3;GSTP1;MAP2K2;IQGAP1;ATP6AP2;VRK2;PSMD10;TAOK3;STYX
gsea,protein dephosphorylation (GO:0006470),-0.5094561770937447,-2.060143456711271,0.0,0.0007649854164226451,0.071,19/57,15.80%,PPP1CA;PPP1CC;PPP2R2D;SSU72;PPP2CA;PPP6C;ILKAP;PTPN2;PTPRA;STK11;PPP2R5E;PPP3CC;PPP2R5C;PPM1D;PPM1B;MTMR2;PPP2R1A;PPP1R15B;PPP2R2A
gsea,establishment of protein localization to organelle (GO:0072594),-0.6383715842314198,-2.0526396418916417,0.0,0.0008197366718551425,0.077,7/20,13.19%,TPR;NUP50;SEC13;RAB11A;NEURL1B;APPL1;NXT2
gsea,mitotic sister chromatid segregation (GO:0000070),-0.6190665302865713,-2.0508996927383567,0.0,0.0008595733568008295,0.082,13/26,20.72%,RAD21;CSNK2A1;CSNK2B;RAB11A;PDCD6IP;CHMP6;CHMP2A;VPS4B;VPS4A;CHMP3;CHMP7;EML4;BECN1
gsea,cilium assembly (GO:0060271),-0.45269718949290655,-2.0479074493285627,0.0,0.0008774933019828386,0.083,35/108,25.32%,MAPRE1;SSNA1;CFAP20;PAFAH1B1;ACTR3;DYNLL1;RAB11A;DCTN3;RAB8A;NUDCD3;BBIP1;ARL6;RAB1A;ATP6V1D;B9D2;EXOC7;PPP2R1A;DYNLRB1;EXOC3;BBS7;EXOC5;CEP63;PRKACA;CEP131;INTU;CPLANE2;BBS5;WDPCP;NPHP4;EXOC6;NPHP1;WDR35;SNAP29;CCDC96;EXOC1
gsea,peptidyl-lysine modification (GO:0018205),-0.5940194029189508,-2.047224098695822,0.0,0.0008809372010910653,0.083,11/29,15.02%,UBE2I;TPR;NSMCE2;NUP50;SUMO1;SENP2;TOPORS;KAT5;EEF1AKMT1;EEF1AKMT2;PIAS1
gsea,regulation of Wnt signaling pathway (GO:0030111),-0.5749262291520426,-2.04704647647509,0.0,0.0008772201664873054,0.083,16/33,26.78%,PPP1CA;SNX3;CBFB;EMD;CSNK2A1;PPP2CA;SENP2;ATP6AP2;PPP2R1A;PSEN1;CTNNBIP1;NKD1;OTULIN;SPIN1;CITED1;DACT3
gsea,protein targeting to mitochondrion (GO:0006626),-0.6757245331149616,-2.044596735888412,0.0,0.000916145800027888,0.088,15/20,17.54%,DNAJC19;AIP;PAM16;TIMM10B;MFF;TOMM22;BCAP31;TIMM22;TOMM7;IMMP1L;ROMO1;DNLZ;TIMM17B;GRPEL2;FBXO7
gsea,positive regulation of endothelial cell migration (GO:0010595),-0.6246634192975303,-2.0442279825107748,0.0,0.0009123125540026665,0.088,4/21,10.32%,HMGB1;RAC1;EMC10;PDCD6
gsea,protein modification process (GO:0036211),-0.5752950749327783,-2.044119158486736,0.0,0.0009085112516943223,0.088,16/31,25.84%,UBE2I;UBL4A;UBE2L3;WWP2;NEDD8;ATG3;UBE2D3;LCMT1;FBXW2;STK38;FBXO2;MAN2B1;AKT2;MSRA;FBXO22;ARAF
gsea,protein transport (GO:0015031),-0.4376980718092852,-2.0427014862637267,0.0,0.0009398089952873815,0.092,70/157,26.37%,YWHAH;TMED10;ATP6V1G1;ARF6;RAB11B;SEC13;VPS29;RAB10;SNX6;PREB;RAB8A;RAB14;SNX1;ARF1;NEURL1B;GGA1;ATP6V1C1;ARFRP1;SAR1B;TMED3;RAB24;AP2A1;RAB5C;CHMP2A;PDCD6;TBC1D15;ARL5A;STX12;RAB18;SNX17;SLC10A7;SAR1A;ARL6;MCOLN1;RAB1A;DNM2;ATP6V1D;NAPA;SCFD1;ARF3;RAB29;ATP6V1A;ERP29;TMED7;SLU7;CHMP3;RAB1B;ARF5;SCAMP2;COPZ1;TMED5;SCAMP3;ACD;VMP1;TBC1D9B;SNX8;TANGO2;ARRDC1;STXBP2;ARFIP1;TMED9;STX8;RABGAP1L;TLK1;SYS1;NAPG;SNX15;VAMP4;SNX4;GOLPH3L
gsea,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.7017108662138394,-2.0426619428254416,0.0021008403361344537,0.0009359254870423923,0.092,7/16,9.12%,UBE2L3;GSK3A;PDCD5;SH3GLB1;UBE2D3;UBE2J2;TOMM7
gsea,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.682836321407474,-2.0387429278807514,0.0019305019305019305,0.000980764371625223,0.097,8/16,19.80%,CDC42;TSG101;GRB2;PTPN2;RNF115;MVB12A;EPN1;SHKBP1
gsea,regulation of proteasomal protein catabolic process (GO:0061136),-0.6755946085365617,-2.0358781819389384,0.0,0.001004453919143551,0.098,3/17,5.41%,PSMC3;COMMD1;PSMF1
gsea,positive regulation of TOR signaling (GO:0032008),-0.6329226306120006,-2.0352777581307246,0.0,0.0010072531010716357,0.099,9/22,17.62%,LAMTOR1;SEC13;RHEB;HDAC3;LAMTOR4;LAMTOR3;LAMTOR5;LAMTOR2;PIP4P1
gsea,response to endoplasmic reticulum stress (GO:0034976),-0.569284789975262,-2.0351734956510907,0.0,0.0010031585762705316,0.099,13/32,18.16%,TMX1;TMCO1;BAG6;BCAP31;ERP44;DERL1;ATF6B;UFM1;PPP1R15B;TMEM259;UFC1;DDRGK1;GSK3B
gsea,interleukin-12-mediated signaling pathway (GO:0035722),-0.6907107269511438,-2.032733856767738,0.0,0.0010264697316949315,0.101,9/17,10.14%,AIP;BOLA2;CDC42;PAK2;CAPZA1;TALDO1;ARF1;SOD1;PITPNA
gsea,regulation of cellular component organization (GO:0051128),-0.5762833406215262,-2.0310948767990578,0.0,0.0010495928939304247,0.104,14/33,17.65%,AP2S1;MAD2L2;LAMTOR1;DCUN1D5;CDK11B;STK11;RAB5C;SNX17;SNX12;SETD5;RAB4B;LAMTOR2;SEMA4D;RAP1A
gsea,regulation of GTPase activity (GO:0043087),-0.5233832918466764,-2.030836827746088,0.0,0.0010453776614246801,0.104,14/45,20.85%,EZH2;LIMS1;ZC3H15;RALBP1;SOD1;TBC1D15;MAPRE2;SEMA4D;DOCK10;KLRK1;RAP1A;GSK3B;PTK2;CHN1
gsea,regulation of cell population proliferation (GO:0042127),-0.41876356328845804,-2.0293969536746084,0.0,0.0010682402066433704,0.106,50/168,26.61%,HMGB2;EZH2;FOXM1;RHOA;ID2;CSNK2A1;RNF187;CD47;CSNK2B;UBE2A;PDCD5;CHTOP;CTBP1;GID8;PTPN2;GNAI2;KRAS;LIMS1;CNOT6;SSR1;RPS6;STK11;CNOT7;MCTS1;PPP2R5C;CNOT8;PPM1D;ROMO1;SDCBP;NMI;COPS8;PIAS1;CRKL;DDRGK1;COPS9;RTKN2;CNTF;EAPP;PTK2;CDK10;CEP131;PTEN;LRP5;AKT2;STAT3;MECP2;ADAM10;RELA;TMEM115;PDCD10
gsea,regulation of interleukin-6 production (GO:0032675),-0.6501973656228702,-2.028995357575387,0.0,0.0010841865025315361,0.107,2/20,2.67%,HMGB1;CD47
gsea,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.6581879387224322,-2.028776001059819,0.0,0.001079884175140538,0.107,4/19,6.18%,RAC1;CDC42;ILK;LIMS1
gsea,actin filament organization (GO:0007015),-0.5632757849168842,-2.0249176433065568,0.0,0.00114242429664292,0.113,7/34,15.22%,RHOA;RAC1;MAD2L2;CDC42;ARPC4;TMOD3;WAS
gsea,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.7111295315480263,-2.01672741508148,0.0,0.0012310901414645642,0.122,4/15,6.18%,RAC1;CDC42;ILK;LIMS1
gsea,regulation of neurogenesis (GO:0050767),-0.6724516555892038,-2.0157146975019025,0.0020325203252032522,0.0012461476721826363,0.124,3/17,11.21%,HMGB2;YTHDF2;SNW1
gsea,phosphate-containing compound metabolic process (GO:0006796),-0.49272922227432,-2.0135764288027396,0.0,0.0012610875659419733,0.126,22/59,25.41%,PPP1CA;CALM1;GPX4;PANK2;PAK2;IMPA1;MAPK3;IMPA2;PNKP;PLAAT3;NT5C;XYLB;MINPP1;PIP4P1;CLN8;CDK5;TOP1;PTEN;STAT3;PIP4K2A;NUDT3;PPP3CA
gsea,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.6553406553217004,-2.008514488005903,0.0,0.0013416798142838963,0.129,4/19,6.18%,RAC1;CDC42;ILK;LIMS1
gsea,regulation of protein secretion (GO:0050708),-0.5822114423001823,-2.00628857172504,0.0,0.001382339095781518,0.133,16/29,27.54%,TMED10;ARF6;DPH3;UQCC2;SERGEF;IER3IP1;DNM1L;ERP29;RAP1A;DNAJC1;ARFIP1;ENSA;EIPR1;EXOC1;GOLPH3L;KCNB1
gsea,sulfur compound biosynthetic process (GO:0044272),-0.5484252963496836,-2.0049910699671054,0.0,0.0014161583307365927,0.137,14/36,22.91%,GCLM;SLC35B2;ESD;GSTP1;SLC10A7;AKR1A1;CNDP2;UGDH;MPST;CHST12;B4GALT3;OGN;OMD;B4GALT2
gsea,response to calcium ion (GO:0051592),-0.6274460553767317,-2.002625636841036,0.0021598272138228943,0.0014367154677956723,0.138,11/21,25.41%,CALM3;CALM1;PEF1;PDCD6;IQGAP1;MCOLN1;SLC25A12;ANXA11;STIM1;MEF2A;PPP3CA
gsea,regulation of cell differentiation (GO:0045595),-0.5195355090386424,-2.0026169414093666,0.0,0.0014312108108309378,0.138,22/49,31.21%,YWHAH;CBFB;ID2;PPP2CA;UQCC2;GPS2;CDK9;RUNX3;PPP2R1A;MCRIP1;PTK2;PRKACA;PURB;OCIAD1;BCL6B;LTBP4;TGFBR1;BIN1;MOSMO;RPS6KA1;TFAP2A;CDK5RAP3
gsea,protein import (GO:0017038),-0.5712567118768717,-1.9971690158412827,0.0,0.0014709076185784164,0.142,14/28,26.42%,TPR;NUP50;SEC13;TOMM22;ATAD1;APPL1;NXT2;PEX14;PEX11B;STAT3;RANBP17;NUP62CL;PEX19;PXMP4
gsea,positive regulation of MAPK cascade (GO:0043410),-0.519632276977081,-1.9968915574823702,0.0,0.0014717416333044461,0.142,13/47,18.96%,HMGB1;EZH2;LAMTOR1;ARRB2;TRAF7;MAPK3;KLHDC10;IQGAP1;CRKL;TAOK3;RAP1A;TIRAP;PYCARD
gsea,negative regulation of response to external stimulus (GO:0032102),-0.580934321283001,-1.9968167157457613,0.0,0.0014661668543904142,0.142,16/27,27.70%,PCBP2;PTPN2;GPS2;CERS2;NMI;PPM1B;RNF26;CD109;TYRO3;LPCAT3;PTEN;SHARPIN;OTULIN;CASK;NFKBIL1;FNDC4
gsea,organelle assembly (GO:0070925),-0.41326679684100576,-1.9950566096975022,0.0,0.001473390779404219,0.143,69/169,26.19%,LSM4;MAPRE1;CFAP20;TSG101;VPS36;ACTR3;HDAC3;DYNLL1;RAB11A;SNF8;DBNL;CIRBP;RAB8A;ATG5;TMEM41B;NUDCD3;ATG3;PDCD6IP;CHMP6;NCOR1;YTHDF2;BBIP1;CHMP2A;STX12;EMC6;YTHDF1;ARL6;RAB1A;ATP6V1D;TRAPPC6A;VPS4B;B9D2;AUP1;TMOD3;MVB12A;EXOC7;VTA1;LSM14A;VPS4A;EXOC3;MAPRE2;CDS2;CHMP3;RAB1B;EDC3;WIPI2;CHMP7;TNKS;BBS7;EXOC5;CEP63;VMP1;CEP131;BECN1;VPS28;INTU;CPLANE2;BBS5;WDPCP;ATG101;UBQLN2;EXOC6;HPS1;WDR35;SNAP29;CCDC96;EXOC1;WDR45B;BIN2
gsea,response to lipid (GO:0033993),-0.5503052862016596,-1.9925537937041993,0.0,0.0015250407442324696,0.15,10/37,27.57%,HMGB2;VPS4B;TIRAP;RXRB;OTUD5;STAT3;TMEM161A;CITED1;OVCA2;IRAK1
gsea,protein localization to membrane (GO:0072657),-0.47435049991278017,-1.9902110842451992,0.0,0.0015699732805169715,0.156,21/70,22.67%,TM9SF1;RAB11B;SH3GLB1;RAB10;RAB11A;ABHD17A;RAB8A;ZDHHC3;TM9SF3;ATP1B3;TM9SF2;ITGB2;ARL5A;SYNJ2BP;RAB29;PPIL2;RAP1A;EFR3B;EFR3A;DVL1;RABEP1
gsea,positive regulation of protein ubiquitination (GO:0031398),-0.5683828168296229,-1.9793233499301017,0.0,0.0017659364836821255,0.177,17/33,17.20%,RBX1;CENPX;UBE2L3;COMMD1;GSK3A;HDAC3;FKBP1A;DCUN1D5;KDM1A;PEF1;DERL1;PDCD6;SENP2;TOPORS;NDFIP2;UBE3A;PSMD10
gsea,protein phosphorylation (GO:0006468),-0.41673373238321926,-1.9782573337184448,0.0,0.0017719386044976148,0.178,70/164,29.03%,GTF2H5;CSNK2A1;CCNH;GSK3A;ILK;CSNK2B;PDK3;CTBP1;YWHAZ;PAK2;RPS6KB1;PRKAG1;CDK9;MAPK1;GRK6;PKN2;LCK;MAPK3;DAPK3;CDK11B;CSNK1A1;STK11;STK16;STK24;MORC3;CLK3;FASTK;RUNX3;STK26;RPS6KB2;SMAD2;VRK2;CAMK4;CSNK1G2;COPS8;CSK;MAPK9;MARK2;TAOK3;STK19;GSK3B;TBK1;TNKS;CDK5;STK38;PTK2;PRKACA;TYRO3;CDK10;MAP4K2;TOP1;JAK3;PRPF4B;AKT2;TESK2;EIF2AK1;STK25;PXK;RPS6KA4;TLK1;MAPK14;ADAM10;HTATIP2;IRAK1;CDC42BPG;CDC42BPA;PKN3;RSKR;PRKAB1;TGFBR1
gsea,positive regulation of neuron projection development (GO:0010976),-0.5898306056997763,-1.9761533037093584,0.001976284584980237,0.001846758444443239,0.186,8/26,21.04%,SNX3;DBNL;TOX;DHX36;MARK2;RAP1A;CAPRIN2;TWF1
gsea,multivesicular body assembly (GO:0036258),-0.5827862488258934,-1.975725699650376,0.00196078431372549,0.0018393935054823484,0.187,14/25,20.82%,TSG101;VPS36;RAB11A;SNF8;PDCD6IP;CHMP6;CHMP2A;VPS4B;MVB12A;VTA1;VPS4A;CHMP3;CHMP7;VPS28
gsea,multivesicular body organization (GO:0036257),-0.5827862488258934,-1.975725699650376,0.00196078431372549,0.0018393935054823484,0.187,14/25,20.82%,TSG101;VPS36;RAB11A;SNF8;PDCD6IP;CHMP6;CHMP2A;VPS4B;MVB12A;VTA1;VPS4A;CHMP3;CHMP7;VPS28
gsea,phosphorylation (GO:0016310),-0.4234426945668599,-1.9691202202114162,0.0,0.002043163561183244,0.204,63/139,30.18%,CSNK2A1;GSK3A;ILK;PDK3;PANK2;CTBP1;YWHAZ;PAK2;PRKAG1;CDK9;MAPK1;GRK6;PKN2;LCK;MAPK3;DAPK3;CDK11B;CSNK1A1;STK11;STK24;MORC3;CLK3;FASTK;RUNX3;PNKP;STK26;VRK2;CAMK4;CSNK1G2;COPS8;XYLB;CSK;MAPK9;MARK2;TAOK3;STK19;GSK3B;TBK1;CDK5;STK38;PRKACA;CDK10;MAP4K2;TOP1;GNPTG;JAK3;PRPF4B;TESK2;STAT3;STK25;PXK;RPS6KA4;TLK1;ADAM10;IRAK1;CDC42BPG;CDC42BPA;PKN3;RSKR;PRKAB1;TGFBR1;LIMK2;NRBP1
gsea,regulation of MAP kinase activity (GO:0043405),-0.6045743205542085,-1.9681627940854571,0.0021141649048625794,0.0020603819933179674,0.207,4/22,8.32%,EZH2;TSG101;SNF8;GSTP1
gsea,positive regulation of interleukin-1 production (GO:0032732),-0.628304352779795,-1.9670459725667593,0.001953125,0.0020959143294901573,0.212,9/18,23.03%,HMGB1;TMED10;CASP8;AIM2;PYCARD;USP50;GSDMD;PANX1;STAT3
gsea,positive regulation of cellular component biogenesis (GO:0044089),-0.6071690442612114,-1.9660069374949671,0.00408997955010225,0.0020944445438453537,0.213,15/24,20.52%,TPR;TSG101;SH3GLB1;SNF8;ERCC1;PDCD6IP;SUMO1;CHMP2A;SDCBP;VPS4B;VPS4A;GSK3B;TIRAP;BRK1;STX18
gsea,positive regulation of catalytic activity (GO:0043085),-0.6650484847606526,-1.9639125515352194,0.0,0.0021601073501790954,0.22,10/18,25.31%,YWHAB;CHTOP;MAPK3;SSBP1;SOD1;NCSTN;PSEN1;B3GAT3;MAPK14;NHEJ1
gsea,positive regulation of transferase activity (GO:0051347),-0.5403787818552102,-1.962841479228056,0.0,0.002170577325446699,0.22,12/35,19.48%,UBE2I;UBE2L3;PABPN1;GSK3A;MAPK1;DCUN1D5;MAPK3;PNKP;TOPORS;TNKS;ACD;TYRO3
gsea,regulation of ion transport (GO:0043269),-0.6217629739754365,-1.962293467272122,0.0,0.002187030503370178,0.222,6/19,7.72%,YWHAH;RAB11B;SNX6;TOR1A;WWP2;DTNBP1
gsea,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6883546699503369,1.957786449611227,0.0,0.0055002768366344875,0.218,5/16,4.83%,HIF1A;DDX5;ETS1;NR3C1;TGFB1
gsea,small GTPase mediated signal transduction (GO:0007264),-0.5397516413553879,-1.9567614791018366,0.0,0.002336171790071114,0.235,18/36,25.47%,GNB1;RAC1;RHEB;GRB2;KRAS;G3BP2;ARHGAP33;RALBP1;RAB18;ARHGAP18;CHP1;CRKL;RGS19;USP50;RASSF1;NUCB1;MAPK14;LAT
gsea,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.5487843464663722,-1.9543310674273435,0.0,0.0024060547922054383,0.242,18/30,26.00%,RBX1;DDA1;GSK3A;ELOB;BCAP31;CSNK1A1;SUMO1;SGTA;PIAS1;PSMD10;DDRGK1;GSK3B;BBS7;HECTD1;DVL1;UBQLN2;FBXO22;DET1
gsea,brain development (GO:0007420),-0.529031364766894,-1.9454911369980978,0.0,0.002589324497654278,0.262,15/38,20.93%,PAFAH1B1;BAG6;TMX2;NDUFS4;PAFAH1B2;UGP2;RAB18;IER3IP1;UFM1;UFC1;UBE3A;EOMES;DNAJC30;PTEN;VPS51
gsea,cellular component assembly (GO:0022607),-0.4500489395200819,-1.9447942475111257,0.0,0.0025861475683039955,0.263,34/86,28.31%,RAD21;RHOA;GPAA1;RAC1;CDC42;ILK;ELOB;YWHAZ;BAG6;CAPZA1;LIMS1;YTHDF2;YTHDF1;IL2RB;PPP2R1A;SKAP2;VAMP3;DNM1L;PEX14;WAS;ACD;VMP1;MNAT1;RANBP9;DVL1;AIF1L;STK25;STAG3;NAPG;DET1;PDCD10;HAS3;PARVG;TAPBP
gsea,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.5604820454092715,-1.940000196167427,0.0,0.0027020249477184557,0.276,10/29,10.32%,HMGB1;BEX3;PDCD5;MTCH1;BCAP31;LCK;TRADD;DIABLO;CASP8;PDCD6
gsea,cell-cell junction assembly (GO:0007043),-0.5970694008512897,-1.9312468307189266,0.0,0.002971287716679595,0.295,7/22,19.61%,RHOA;PAK2;PKN2;WDR1;TBCD;TLN1;TLN2
gsea,dephosphorylation (GO:0016311),-0.46662908867340347,-1.9306670637167649,0.0,0.0029904484850045666,0.298,23/59,27.79%,PPP1CA;PPP1CC;PPP2CA;PPP6C;ILKAP;PTPRA;STK11;PPP2R5E;PPP3CC;PPP2R5C;PNKP;PPM1D;PPM1B;MTMR2;PPP2R1A;NT5C;PPP2R2A;SDHAF2;PTEN;PHPT1;PPP3CA;CDC14B;SGPP1
gsea,positive regulation of JNK cascade (GO:0046330),-0.6448055406720591,-1.930527521369488,0.0,0.002980028803872147,0.298,6/17,19.94%,HMGB1;SDCBP;TAOK3;TIRAP;PYCARD;MAP4K2
gsea,positive regulation of autophagy (GO:0010508),-0.5869948619805718,-1.9304770759319032,0.002,0.0029696814816364795,0.298,12/24,18.89%,HMGB1;GSK3A;TRIM27;SH3GLB1;PAFAH1B2;STK11;KAT5;NPRL2;FBXO7;GSK3B;TBK1;GNAI3
gsea,negative regulation of protein phosphorylation (GO:0001933),-0.49515652361361046,-1.9302808576033308,0.0,0.0029652543951655033,0.299,16/47,21.66%,CALM3;CALM1;TRIM27;PAK2;FKBP8;DTNBP1;GSTP1;DNAJC3;CHP1;PPP1R15B;RTRAF;SEMA4D;CRKL;PTEN;CAMK2N2;DVL1
gsea,histone deacetylation (GO:0016575),-0.660380344690709,-1.9262145386272176,0.0,0.0030890839672685854,0.309,10/16,23.16%,HDAC3;SUDS3;MORF4L1;MSL3;SMARCAD1;BRMS1;MTA3;SIN3B;SIRT7;RCOR1
gsea,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.6232891881958575,-1.9260085158160694,0.0020242914979757085,0.003078468558446357,0.309,9/19,20.07%,HMGB1;PDCD5;BCAP31;CYFIP2;CASP8;PDCD6;AIM2;PYCARD;USP50
gsea,nuclear export (GO:0051168),-0.6313973787951422,-1.925040077588745,0.0019342359767891683,0.0030852914759673384,0.311,9/18,19.49%,TPR;U2AF1L4;CHTOP;SRSF11;THOC7;CHP1;POLDIP3;SLU7;CDC40
gsea,modification-dependent protein catabolic process (GO:0019941),-0.44490296536329865,-1.9223079784240948,0.0,0.003184368352632849,0.316,33/84,24.59%,ANAPC11;UBE2I;RBX1;UBE2L3;PSMD13;RNF7;UBE2A;UBE2K;BAG6;ANAPC2;PPP1R11;PSMF1;PSMD9;NEDD8;NTAN1;ANAPC16;PTTG1;UBL7;UBE2G1;TOPORS;CDC26;ANAPC10;UFD1;NDFIP2;FBXO7;UBE2E1;UBE3C;ARRDC1;AMFR;RNF34;UBQLN2;FBXO22;WDR91
gsea,positive regulation of organelle assembly (GO:1902117),-0.6543152345577254,-1.9217643247217933,0.0,0.0031907846523673393,0.317,11/15,25.64%,SH3GLB1;CNOT6;G3BP2;PDCD6IP;SDCBP;CROCC;ENTR1;STX18;PIP4K2A;PIP4K2C;CNOT2
gsea,regulation of cellular component size (GO:0032535),-0.634645930048054,-1.9215132335987672,0.0,0.003197157451764647,0.318,7/17,15.34%,PPP1CA;RAC1;AP2M1;MTPN;LAMTOR4;LAMTOR5;PEX11B
gsea,positive regulation of cell differentiation (GO:0045597),-0.46128851909983154,-1.921339722560212,0.0,0.0032034871917065665,0.319,23/68,27.46%,EZH2;NUDT21;RHOA;ID2;CDC42;BNIP2;TCF3;SMAD2;SDCBP;DHX36;MAPK9;BLOC1S6;RAP1A;SUCO;ATRAID;LRP5;CTNNBIP1;RBM4;MEF2A;ZC4H2;MAPK14;ASXL2;ATP6AP1
gsea,regulation of tumor necrosis factor production (GO:0032680),-0.5691914989773942,-1.9129044428845923,0.0,0.0034260356966250532,0.333,8/27,18.96%,HMGB1;CD47;IFNGR1;TRIM27;GSTP1;PSEN1;TIRAP;PYCARD
gsea,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.49220993725621215,-1.9102506442240463,0.001968503937007874,0.0035393227473529396,0.341,16/49,21.14%,HMGB1;YWHAZ;ARRB2;PTPN2;TRAF7;MAPK3;GSTP1;SYNJ2BP;CRKL;STYX;RAP1A;TIRAP;PYCARD;RGS14;PTEN;RANBP9
gsea,regulation of protein catabolic process (GO:0042176),-0.515820794475102,-1.9075134356918597,0.0,0.003657505046877041,0.349,14/36,24.59%,SNX3;CSNK2A1;MAD2L2;GSK3A;SNF8;OAZ1;WWP2;CHMP6;SNX12;SEC22B;GSK3B;VPS28;NKD1;WDR91
gsea,membrane lipid biosynthetic process (GO:0046467),-0.6278965599483647,-1.9069742980127504,0.0,0.003667850076607775,0.349,9/18,21.11%,SPTSSA;VAPA;CERS2;ELOVL1;CERS5;SPTLC2;CSNK1G2;ELOVL5;SPTLC1
gsea,intra-Golgi vesicle-mediated transport (GO:0006891),-0.6227798817670254,-1.9047599507366637,0.001996007984031936,0.003773589190379878,0.358,17/20,29.74%,COPB1;VTI1B;NAPA;GOSR1;TRAPPC10;VTI1A;COG8;COPZ1;GOSR2;COPE;GOLGA5;TRAPPC3;COG6;NAPG;COG2;COG1;RAB6A
gsea,protein K48-linked ubiquitination (GO:0070936),-0.5484006983684672,-1.9041260442414654,0.002070393374741201,0.00378348132539881,0.361,14/31,22.62%,RBX1;RNF187;UBE2A;UBE2K;RNF4;KBTBD6;UBE2D3;RNF115;UBE2G1;TOPORS;UBE3A;UBE2E1;AMFR;RNF34
gsea,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.6192444967179139,-1.9039736022034506,0.0,0.003770994588351289,0.361,7/19,17.18%,BEX3;CSNK2A1;PAK2;BCL2L12;MAP2K5;LAMTOR5;TRIAP1
gsea,positive regulation of interleukin-8 production (GO:0032757),-0.6486836161128645,-1.9032758709572284,0.0019723865877712033,0.0038030703559297206,0.365,5/15,18.96%,HMGB1;LAMTOR5;RAB1A;TIRAP;PYCARD
gsea,peptidyl-serine phosphorylation (GO:0018105),-0.47271445110002297,-1.9000112797658335,0.0,0.003945772085132184,0.376,26/59,24.93%,CSNK2A1;PDK3;PAK2;RPS6KB1;MAPK1;PKN2;CSNK1A1;MAP2K2;MORC3;RPS6KB2;VRK2;CAMK4;CSNK1G2;MAPK9;MARK2;GSK3B;TBK1;TNKS;CDK5;STK38;PRKACA;TOP1;AKT2;RPS6KA4;TLK1;MAPK14
gsea,negative regulation of developmental process (GO:0051093),-0.667387485709076,-1.8959181785146908,0.0,0.004120683348618114,0.387,1/15,0.14%,FOXM1
gsea,regulation of protein targeting to mitochondrion (GO:1903214),-0.6364071342469353,-1.8957725771628742,0.002066115702479339,0.004123778062383439,0.39,8/17,18.28%,UBE2L3;GSK3A;SH3GLB1;UBE2D3;UBE2J2;TOMM7;SREBF1;LEPROT
gsea,spindle assembly (GO:0051225),-0.6313236768201589,-1.8956863464500766,0.0020161290322580645,0.004115877008581949,0.391,10/17,19.12%,MAPRE1;RHOA;HDAC3;RAB11A;NCOR1;MZT1;LSM14A;MAPRE2;TNKS;CEP63
gsea,phosphatidylcholine metabolic process (GO:0046470),-0.5779281450106878,-1.8925433057051568,0.001937984496124031,0.004283069527066482,0.403,9/23,22.82%,CSNK2A1;CSNK2B;PLAAT3;CEPT1;CHKB;PCYT1B;LPCAT3;MBOAT7;NR1H2
gsea,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.4766162449108621,-1.8880102261170733,0.0,0.004460088245377077,0.411,28/47,31.21%,ID2;COMMD1;MAD2L2;CEBPG;ARRB2;TAX1BP1;WWP2;KDM1A;MAP2K5;SUMO1;CYLD;CHP1;BRMS1;RBCK1;PEX14;AIM2;PSMD10;EOMES;PYCARD;WFS1;CTNNBIP1;OTULIN;NFKBIL1;IRAK1;PKD2;FOXJ1;SUFU;CDK5RAP3
gsea,cytoplasmic microtubule organization (GO:0031122),-0.6362255520284931,-1.8874598244549297,0.006048387096774193,0.004462051821676742,0.412,8/17,25.02%,RHOA;RAB11A;CHP1;VPS4B;SLAIN2;KATNA1;CRIPT;KATNAL1
gsea,regulation of DNA metabolic process (GO:0051052),-0.6306806897206463,-1.8872984558392143,0.005847953216374269,0.004447750373530342,0.412,8/16,20.30%,CDK9;MPHOSPH8;SUB1;WDR70;SMARCAD1;SMG5;UBE2V1;SIRT7
gsea,negative regulation of defense response (GO:0031348),-0.592449394795989,-1.884350288878701,0.0,0.004509142701031334,0.415,10/20,24.02%,PCBP2;PTPN2;GPS2;NMI;PPM1B;RNF26;TYRO3;LPCAT3;SHARPIN;OTULIN
gsea,cytoskeleton organization (GO:0007010),-0.5078704598557763,-1.8793481008050716,0.0,0.0047746969649110575,0.432,11/39,31.71%,RHOA;RAC1;CAPZB;ARHGAP4;SIPA1;RANBP9;WDPCP;BIN1;CSPG5;FGD1;WTIP
gsea,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.539104421400086,-1.8789676960196922,0.006048387096774193,0.004791734501368946,0.432,7/30,18.96%,HMGB1;ARRB2;MAPK3;CRKL;RAP1A;TIRAP;PYCARD
gsea,cellular response to insulin stimulus (GO:0032869),-0.4944022350528801,-1.878701550155517,0.0,0.004787268591500844,0.434,12/45,18.16%,ATP6V1G1;GSK3A;GRB2;RAB10;RPS6KB1;PTPN2;RAB8A;ATP6V1C1;APPL1;ATP6V1D;ATP6V1A;GSK3B
gsea,sphingolipid biosynthetic process (GO:0030148),-0.5663176011745538,-1.876709470122638,0.002,0.0048734753667294285,0.445,10/24,21.11%,SPTSSA;VAPA;CERS2;ELOVL1;CERS5;SPTLC2;CSNK1G2;CLN8;ELOVL5;SPTLC1
gsea,regulation of gene expression (GO:0010468),-0.3729314198305783,-1.8759629509839078,0.0,0.0049059873354621,0.446,116/258,31.28%,EZH2;NUDT21;TRA2B;HNRNPL;UBE2L3;PCBP2;ID2;PABPN1;MLF2;RNF187;GSK3A;IFNGR1;PDCD5;NKAP;YAF2;PPP2CA;CGGBP1;TCF3;TRIM27;EDF1;SNF8;PRKAG1;PTBP3;KRAS;LIMS1;MAPK1;SAP30L;WWP2;MAPK3;SP3;DAPK3;DTNBP1;MLX;CDK11B;C1D;PDCL3;GLRX2;MAP2K2;MATR3;MSL3;CLK3;CASP8;YTHDF2;CNOT7;MYB;FASTK;RUNX3;LAMTOR5;SNX12;PRDM1;THAP7;DNM2;YY1;GPBP1;CNPY2;DRAP1;ING2;PPP2R1A;LDB1;ZFPL1;ZC3H7A;NDFIP2;FAM50A;TBX21;CXXC1;PHF12;ERP29;DHX36;PSEN1;CRKL;MAPK9;DDRGK1;UBE2V1;CNTF;GSK3B;NSD1;SBNO1;PQBP1;STAP1;ADNP;NR2C2;ATRAID;HMGA2;REXO4;ACTR8;DVL1;TRIM68;STAT3;MECP2;DVL2;SPIN1;RPS6KA4;PRX;MAPK14;ADAM10;TRAPPC2;RELA;NKAPL;CITED1;DMTF1;YTHDC1;PDCD10;SON;CIAO3;CELSR2;BCL6B;MED26;TAPBP;PRKAB1;TGFBR1;MZF1;TAF5L;TESMIN;TFAP2A;SUFU;SLC39A8
gsea,histone H3 acetylation (GO:0043966),-0.6418424691727646,-1.875239454971772,0.005836575875486381,0.004943594067687119,0.449,7/15,18.05%,TAF10;MEAF6;TAF12;TADA1;BRD1;LDB1;PHF14
gsea,ceramide metabolic process (GO:0006672),-0.6040189930980701,-1.8746990968805934,0.0020161290322580645,0.004954555547030665,0.451,9/20,21.11%,SPTSSA;PPP2CA;ORMDL2;CERS2;CERS5;SPTLC2;PPP2R1A;CLN8;SPTLC1
gsea,mitotic nuclear division (GO:0140014),-0.6588919753059846,-1.8734958722185484,0.001968503937007874,0.004986511079356796,0.454,7/15,17.95%,RHOA;PPP2R2D;RAB11A;CHMP2A;MZT1;LSM14A;CHMP7
gsea,positive regulation of cell projection organization (GO:0031346),-0.5104037221085054,-1.8733307444982743,0.002008032128514056,0.004986772723441318,0.454,15/36,32.94%,SNX3;RHOA;TOX;MARK2;RAP1A;CAPRIN2;TWF1;DVL1;DVL2;CBFA2T2;SCARB2;CARMIL1;AMIGO1;LTK;TIAM2
gsea,protein polymerization (GO:0051258),-0.6138915013510883,-1.8697589285117726,0.0,0.005123090304031918,0.462,9/18,19.25%,GPX4;RAC1;UBE2K;CHMP2A;ARL6;WAS;MSRB1;CHMP3;WASHC3
gsea,positive regulation of protein polymerization (GO:0032273),-0.5821737179461252,-1.8683191940356285,0.004073319755600814,0.005169880278088276,0.464,3/22,2.47%,MAPRE1;RAC1;ARF6
gsea,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.5558251299058574,-1.8657119720956679,0.0,0.005267783887695427,0.469,15/30,19.77%,RAC1;CDC42;ACTR3;GRB2;WASF2;MAPK1;MAPK3;ARPC4;CYFIP2;ARPC1A;ARPC2;WAS;ARPC5;PTK2;BRK1
gsea,Fc-gamma receptor signaling pathway (GO:0038094),-0.5558251299058574,-1.8657119720956679,0.0,0.005267783887695427,0.469,15/30,19.77%,RAC1;CDC42;ACTR3;GRB2;WASF2;MAPK1;MAPK3;ARPC4;CYFIP2;ARPC1A;ARPC2;WAS;ARPC5;PTK2;BRK1
gsea,apoptotic process (GO:0006915),-0.4683840805443427,-1.8650800597605095,0.002070393374741201,0.005282688282378763,0.47,21/56,21.64%,BNIP2;PPP2CA;BAG6;RFK;TRAF7;DAPK3;CDK11B;CYFIP2;TRADD;DIABLO;STK11;GLRX2;CASP8;ITGB2;DPF2;NUDT2;PPP2R1A;IRF3;CDK5;PYCARD;FXR1
gsea,positive regulation of translation (GO:0045727),-0.5302625726904887,-1.8628601068516042,0.0,0.005385106398301569,0.479,17/34,16.39%,RBM3;ELAVL1;MPV17L2;POLR2G;KHDRBS1;COA3;RPS6KB1;UQCC2;PCIF1;POLR2D;CIRBP;YTHDF2;YTHDF1;RPS6KB2;POLDIP3;DHX36;UPF3A
gsea,protein localization to organelle (GO:0033365),-0.4606792581568886,-1.8614050775144522,0.0021008403361344537,0.005450939071450772,0.483,26/59,24.76%,EMD;ARF6;VAPA;RAB11A;TOR1A;PAF1;CNEP1R1;WDR83OS;UBE2J2;ARFRP1;ARL6;SGTA;ATP6V1D;TOPORS;CROCC;AUP1;TOR1AIP1;TIA1;TMEM30A;RAB35;DDRGK1;SEC61G;DVL1;SEC61B;WDR35;SYS1
gsea,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.5198303238262456,-1.8609069836494467,0.0019230769230769232,0.005460030975651289,0.485,13/32,21.64%,RAC1;CDC42;ARF6;CAPZB;ATG5;ATG3;TBC1D15;CYLD;TBC1D19;WAS;TBC1D9B;TWF1;FXR1
gsea,ribosomal small subunit biogenesis (GO:0042274),0.7066551282900223,1.8557659332541812,0.003929273084479371,0.016466773068190554,0.476,7/15,3.16%,RPS27;RPS24;RPS7;RPS28;RPS14;RPS16;RPS5
gsea,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.605018644899417,-1.8550335209070163,0.0019646365422396855,0.005826523365043051,0.508,2/19,2.93%,HMGB1;IFNGR1
gsea,negative regulation of signal transduction (GO:0009968),-0.4326396731404808,-1.8542390782842462,0.0,0.005859884845615942,0.51,26/79,26.78%,EZH2;YWHAB;CSNK2A1;CD47;GSK3A;RPS6KB1;PTPN2;GPS2;WWP2;YTHDF2;PDCD6;APPL1;MTMR2;LEPROT;TYRO3;RGS14;PTEN;ARRDC1;CTNNBIP1;NKD1;PIP4K2A;PIP4K2C;GPR108;NFKBIL1;CITED1;DACT3
gsea,inflammatory response (GO:0006954),-0.49886092974441254,-1.8532409602818012,0.002105263157894737,0.005882894284314376,0.513,9/39,25.48%,HMGB1;RAC1;ITGB2;TUSC2;TBK1;STAT3;PXK;LAT;RELA
gsea,regulation of axonogenesis (GO:0050770),-0.6237530663400248,-1.8517482742646716,0.004081632653061225,0.005956372333904566,0.515,6/17,20.92%,RHOA;PAK2;MARK2;GSK3B;CHN1;PTEN
gsea,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.6407936000708337,-1.8514279603805164,0.004081632653061225,0.005968865314845585,0.515,6/15,11.11%,FOXM1;HDAC3;GPS2;GSTP1;NCOR1;CYLD
gsea,regulation of epithelial to mesenchymal transition (GO:0010717),-0.5743331244966967,-1.8505651826305316,0.001953125,0.006001405998180102,0.516,9/24,20.92%,EZH2;MAD2L2;PPP2CA;SMAD2;SDCBP;MCRIP1;ADIPOR1;SDHAF2;PTEN
gsea,protein targeting (GO:0006605),-0.46507742042452427,-1.844758058029474,0.004132231404958678,0.006309610956491379,0.539,25/55,26.30%,DNAJC19;AIP;SPCS1;YIF1B;TIMM10B;MFF;CDC37;TOMM22;BCAP31;TIMM22;ZDHHC3;ATG3;ZFAND6;TOMM7;ARL6;SEC63;SDCBP;TIMM17B;FBXO7;SEC61G;AP4S1;ZDHHC4;TRAK2;PEX19;TOMM34
gsea,mitotic spindle organization (GO:0007052),-0.545300826560863,-1.8435148295508546,0.0020408163265306124,0.0063659547180782835,0.542,19/27,27.23%,MAPRE1;RHOA;PPP1CC;PTPA;PAFAH1B1;SEC13;DYNLL1;RAB11A;MZT1;B9D2;LSM14A;TNKS;EML4;TBCE;MECP2;SBDS;DCTN2;DYNC1LI1;TUBG2
gsea,peptidyl-serine modification (GO:0018209),-0.45799883589574614,-1.8433975197451435,0.0,0.0063471760905913265,0.542,25/60,24.93%,CSNK2A1;PDK3;PAK2;RPS6KB1;MAPK1;PKN2;CSNK1A1;MORC3;RPS6KB2;VRK2;CAMK4;CSNK1G2;MAPK9;MARK2;GSK3B;TBK1;TNKS;CDK5;STK38;PRKACA;TOP1;AKT2;RPS6KA4;TLK1;MAPK14
gsea,positive regulation of cellular biosynthetic process (GO:0031328),-0.4712320171597717,-1.8430257613158536,0.001953125,0.006368278596007807,0.542,21/47,22.82%,RBM3;ARPP19;ELAVL1;RPS6KB1;PTPN2;PCIF1;CNEP1R1;CIRBP;YTHDF1;APPL1;CHP1;LDB1;POLDIP3;NMD3;UPF3A;SREBF1;STN1;ELOVL5;FXR1;AKT2;NR1H2
gsea,protein autoubiquitination (GO:0051865),-0.548376877555371,-1.8403590038360385,0.0,0.006533003231170247,0.549,12/28,22.81%,RNF181;RNF187;UBE2A;RNF4;WWP2;UBE2D3;RNF115;RNF220;UBE3A;AMFR;TRIM68;UHRF2
gsea,regulation of intracellular signal transduction (GO:1902531),-0.3986787572108142,-1.8382165598490512,0.0,0.006647341947661436,0.551,58/137,29.51%,RHOA;TAF10;CSNK2A1;RAC1;MEAF6;CDC42;CSNK2B;TAF12;ANKRD54;PAK2;PRKAR1A;PAK1IP1;PRKAG1;TAF11;MAPK1;ARHGEF1;MAPK3;ARHGAP33;ZFAND6;RALBP1;MAPKAP1;STK11;PPP2R5C;CYLD;ARHGAP18;PRDM1;RMI1;KAT5;ATP6AP2;VRK2;ING2;DEPDC7;RHOT1;ATRIP;TAOK3;PIP4P1;CDK5;TTC5;PYCARD;TAF4;ARHGAP4;CHN1;PTEN;TMBIM4;RNF34;PIP4K2A;PIP4K2C;MAPK14;VAV1;RELA;ARAF;TAF13;ARHGEF6;ARHGAP29;PRKAB1;STARD8;TCP11;RRAGC
gsea,neuron projection morphogenesis (GO:0048812),-0.49063923643310714,-1.8363453439447457,0.0020833333333333333,0.006706807585902624,0.553,15/41,28.42%,CDC42;RAB10;DBNL;RAB8A;DTNBP1;IQGAP1;DNM2;DOCK10;TAOK3;CDK5;PTEN;DVL1;MEF2A;CELSR2;SLC9A6
gsea,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.6033222535496116,-1.836339244695587,0.004,0.006687311052222674,0.553,5/18,17.36%,DBNL;SNX1;DTNBP1;DNM2;TAOK3
gsea,positive regulation of supramolecular fiber organization (GO:1902905),-0.5635146495846682,-1.8343292258590331,0.005988023952095809,0.006800208249958715,0.562,7/23,18.96%,MAPRE1;RAC1;ARF6;WDR1;PSEN1;SLAIN2;PYCARD
gsea,positive regulation of protein transport (GO:0051222),-0.5726246866048944,-1.8332172845850148,0.0021141649048625794,0.006878256982850414,0.567,15/23,26.61%,TPR;TMED10;ARF6;OAZ1;IER3IP1;CHP1;DNM1L;RAB29;ATP2C1;CEP131;VPS28;B3GAT3;EXOC1;GOLPH3L;PDCD10
gsea,protein insertion into membrane (GO:0051205),-0.6269735972761042,-1.833049206905529,0.01016260162601626,0.0068730480591954355,0.569,8/15,22.52%,EMD;VAPA;WDR83OS;UBE2J2;SGTA;SEC61G;MAIP1;SEC61B
gsea,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.6361495161907583,-1.829407910133396,0.008316008316008316,0.007081579283455342,0.58,6/15,17.31%,RHOA;CDC42;WDR1;PDCD6IP;SYNJ2BP;MARK2
gsea,positive regulation of protein-containing complex assembly (GO:0031334),-0.5621574459119528,-1.8287191720980873,0.0,0.0070903470246177795,0.582,12/25,20.07%,RBX1;PSMC3;GTF2H5;TERF1;SH3GLB1;ERCC1;SUMO1;MED25;GSK3B;TIRAP;BRK1;USP50
gsea,Ras protein signal transduction (GO:0007265),-0.4803516024982011,-1.8174665046273197,0.002044989775051125,0.007828288313602638,0.615,20/43,27.99%,RHOA;GNB1;RAC1;GRB2;DBNL;KRAS;ARHGEF1;G3BP2;WAS;CRKL;RAP1A;BRK1;USP50;ARHGAP4;RASSF1;CTNNAL1;MAPK14;LAT;ARHGAP29;RAPGEF6
gsea,synapse organization (GO:0050808),-0.539416898104297,-1.8157249795515842,0.0,0.007887849627113495,0.617,9/26,27.43%,CDC42;DBNL;RAB29;PSEN1;CDK5;PTEN;DVL1;ZC4H2;SNCB
gsea,positive regulation of lymphocyte proliferation (GO:0050671),0.6284281653154953,1.8140228542007413,0.0019723865877712033,0.02439534549895531,0.605,5/16,5.67%,CD3E;CD6;PTPRC;IL18;CD28
gsea,cellular response to starvation (GO:0009267),-0.4491279266156678,-1.8139120531379263,0.004056795131845842,0.007980685519640398,0.619,22/59,20.72%,ATP6V1G1;LAMTOR1;SEC13;RHEB;SH3GLB1;PRKAG1;MAPK1;ATG5;MAPK3;LAMTOR4;ATP6V1C1;STK24;LAMTOR3;LAMTOR5;STK26;ATP6V1D;ATP6V1A;LAMTOR2;SREBF1;NPRL2;WIPI2;BECN1
gsea,regulation of interferon-gamma production (GO:0032649),-0.6276618237372185,-1.813612647263932,0.008016032064128256,0.007977230359432062,0.62,4/15,4.29%,HMGB1;CD47;TRIM27;CEBPG
gsea,cellular respiration (GO:0045333),-0.5920251728939043,-1.813238012635071,0.006036217303822937,0.007983344174657242,0.622,11/20,8.44%,SDHB;UQCR10;NDUFS7;ETFA;UQCRFS1;UQCRB;SDHC;NDUFS8;NDUFS4;SDHAF4;UQCRC2
gsea,endoplasmic reticulum organization (GO:0007029),-0.5280695237118554,-1.8126159191752431,0.00404040404040404,0.007998946100734813,0.622,15/29,26.43%,EMD;VAPA;RAB10;WDR83OS;UBE2J2;RAB18;SGTA;REEP5;DNM1L;SEC61G;LPCAT3;STX18;SEC61B;VAPB;TRAM2
gsea,selective autophagy (GO:0061912),0.5666940785575532,1.811557348708936,0.0,0.023757498269160727,0.611,8/20,6.59%,SQSTM1;MAP1LC3B;UBC;UBA52;RB1CC1;TEX264;NBR1;ACBD5
gsea,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.5407013036692699,-1.8111668440151862,0.004008016032064128,0.008061939406203079,0.628,13/25,18.96%,COMMD1;ARRB2;TAX1BP1;G3BP2;MAP2K5;CYLD;CHP1;BRMS1;RBCK1;AIM2;CCDC22;PSMD10;PYCARD
gsea,protein glycosylation (GO:0006486),-0.4998278749496033,-1.8110125389449983,0.0,0.00804882615011581,0.629,9/34,15.48%,KRTCAP2;DPM3;TMEM258;TUSC3;ALG5;MGAT2;ALG1;TMEM165;DAD1
gsea,regulation of phosphorylation (GO:0042325),-0.4997872381754663,-1.8093979503921618,0.001976284584980237,0.008153820614141064,0.634,14/36,20.08%,TPR;ILK;NUP50;SEC13;PPP2CA;DYNLL1;PRKAG1;NDUFS4;BTBD10;SDCBP;LDB1;PSEN1;PTK2;STAP1
gsea,positive regulation of protein localization to nucleus (GO:1900182),-0.5939121113889343,-1.8075610985977995,0.006036217303822937,0.008267646604781912,0.639,7/17,18.57%,TPR;HDAC3;RBM22;LAMTOR5;NMD3;PSEN1;F2
gsea,positive regulation of tumor necrosis factor production (GO:0032760),-0.6067126565063146,-1.8068139722360896,0.0,0.00833858389151998,0.641,2/18,2.93%,HMGB1;IFNGR1
gsea,glycolipid metabolic process (GO:0006664),-0.5949424404260792,-1.8055875954304779,0.007984031936127744,0.008423174601806794,0.648,4/19,9.90%,GLTP;HEXB;B4GALNT1;ESYT1
gsea,cellular response to cytokine stimulus (GO:0071345),0.40743240199557423,1.8013500768988813,0.0,0.025207151064148423,0.648,55/108,36.34%,TCF7;RPL13A;PTPN18;IRAK2;SELPLG;STAT4;RPS3;TNFRSF1B;IL2RG;UBC;UBA52;IFNAR1;NDUFA13;HIF1A;LGALS9;CDKN1B;IL27RA;MCL1;FOXO1;CRLF2;TGFB1;IL18;FYN;GBA;IL10RB;PTPN4;IL12RB2;JAK1;IRAK4;LDLRAP1;MAPK11;LEF1;IKBKB;INPP5D;RC3H1;PDE2A;HGF;BATF;CEBPA;HYAL1;POMC;IL18BP;IL3RA;IL7;PDE1B;IL1RL2;IL1RAP;SHPK;NR1D1;STX3;FOXC1;FER;STX1A;CRLF1;MME
gsea,positive regulation of mitochondrion organization (GO:0010822),-0.6184022278383636,-1.8006609279709374,0.0019801980198019802,0.008866827017692498,0.661,10/16,25.42%,GSK3A;PDCD5;MFF;RALBP1;DNM1L;FBXO7;GSK3B;PYCARD;MIEF1;MOAP1
gsea,regulation of actin filament polymerization (GO:0030833),-0.5627214309644639,-1.7998707441962936,0.006160164271047228,0.008884307608342709,0.664,8/23,21.63%,ARF6;DBNL;MTPN;ARHGAP18;COTL1;PYCARD;TWF1;KANK3
gsea,RNA transport (GO:0050658),-0.6066468332285789,-1.7989734010990057,0.010040160642570281,0.00892026636598412,0.667,9/16,19.49%,TPR;U2AF1L4;CHTOP;SRSF11;THOC7;RTRAF;POLDIP3;SLU7;CDC40
gsea,regulation of calcium ion transport (GO:0051924),0.6161941359599319,1.7970475663756817,0.0038095238095238095,0.025264698717635647,0.67,3/15,7.04%,SARAF;CD84;SLC8B1
gsea,G1/S transition of mitotic cell cycle (GO:0000082),-0.619125238445097,-1.7967794528127843,0.0,0.009127368854231328,0.677,9/15,20.24%,CCNH;PPP6C;KHDRBS1;BRD4;RPS6KB1;CUL2;CRLF3;CDK5;MNAT1
gsea,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.5407413717294289,-1.7965693837800765,0.007692307692307693,0.009120903403717302,0.678,13/24,24.97%,RHOA;RAC1;CDC42;PAK2;WASF2;CYFIP2;PDCD6;SH2D2A;NCF4;PTK2;BRK1;MAPK14;VAV1
gsea,regulation of apoptotic process (GO:0042981),-0.3728284426661868,-1.796217742330921,0.0,0.009128289973300282,0.679,73/188,27.80%,HMGB1;SAP18;PTPA;BAG1;BNIP2;PDCD5;NAA38;CIAPIN1;MTCH1;YWHAZ;HDAC3;SUDS3;PAK2;RPS6KB1;BABAM2;TAX1BP1;ARHGEF1;SRA1;RPS6;DAPK3;ZFAND6;GSTP1;LCMT1;TRADD;DIABLO;SOD1;CASP8;DNAJC3;IER3IP1;STK26;PRDX2;GLO1;DNM2;TOPORS;IL2RB;BRMS1;CTNNBL1;UFM1;NCSTN;UBE2Z;DNM1L;HYPK;MIEN1;SEMA4D;IRF3;PSEN1;TRIAP1;PSMD10;DDRGK1;GSK3B;CDK5;ING3;PYCARD;PTK2;TFPT;SPTLC1;HMGA2;TMBIM4;JAK3;WFS1;AKT2;VAV1;ADAM10;MOAP1;RELA;ARAF;CITED1;PDCD10;SON;ARHGEF6;HTATIP2;IRAK1;APH1A
gsea,regulation of actin filament-based process (GO:0032970),-0.5476396499653737,-1.7952720751182034,0.0020833333333333333,0.00915860179918341,0.682,5/23,19.52%,RHOA;RAC1;ARHGAP18;IQGAP1;CDK10
gsea,macroautophagy (GO:0016236),-0.43309332376799886,-1.7912923118769866,0.002136752136752137,0.009491071096039002,0.694,29/67,24.73%,CSNK2A1;TSG101;VPS36;CSNK2B;DYNLL1;TOMM22;SNF8;TOMM6;PRKAG1;ATG5;ATG3;ARL8B;CHMP6;TOMM7;CHMP2A;VTI1B;ATG4B;VPS4B;MVB12A;VTA1;VPS4A;PGAM5;CHMP3;WIPI2;BECN1;VPS28;ATG101;PIP4K2A;SNAP29
gsea,endomembrane system organization (GO:0010256),-0.43950103897289355,-1.7851310448741324,0.0019646365422396855,0.010091270169668173,0.712,31/61,26.37%,TMED10;CDC42;LAMTOR1;VAPA;TOR1A;RAB2A;PLEKHJ1;CSNK1A1;TMED3;RAB1A;REEP5;VPS4A;TJAP1;DNM1L;RAB29;TMED7;COG4;RNF26;TMED5;VMP1;USP50;SURF4;VPS51;TANGO2;GOLGA5;TRAPPC8;TMED9;SUN1;VAPB;COG2;GOLPH3L
gsea,regulation of macromolecule metabolic process (GO:0060255),-0.48192575761540485,-1.7828286341071795,0.002070393374741201,0.010282755068383803,0.717,20/42,28.34%,PCBP2;RNF187;LAMTOR1;NKAP;CGGBP1;TRIM27;ARF1;C1D;MKLN1;MTMR9;PRDM1;MTMR2;PSEN1;ADNP;ATRAID;TRIM68;NKAPL;CIAO3;TAPBP;SCARB2
gsea,tRNA processing (GO:0008033),-0.6011789906323833,-1.7821005086114827,0.009746588693957114,0.010318724944225085,0.718,7/16,21.17%,ZBTB8OS;RPP21;CDKAL1;RTRAF;POP7;ADAT1;TRPT1
gsea,regulation of cellular metabolic process (GO:0031323),-0.5806487086388203,-1.7808946786146278,0.008385744234800839,0.010422474612616453,0.721,6/17,10.94%,FOXM1;LAMTOR1;PDK3;PANK2;ARF1;MKLN1
gsea,peptidyl-threonine phosphorylation (GO:0018107),-0.5362288886671204,-1.7807910447694184,0.001984126984126984,0.010399126427800698,0.721,10/24,19.52%,CSNK2A1;GSK3A;CSNK2B;MAPK1;MARK2;GSK3B;TBK1;TNKS;CDK5;CDK10
gsea,regulation of RNA metabolic process (GO:0051252),-0.5728275774221939,-1.7790434035965097,0.007532956685499058,0.010488586332738916,0.723,9/20,19.45%,TRA2B;HNRNPL;PCBP2;PTBP3;CLK3;YTHDF2;FASTK;FAM50A;PQBP1
gsea,cellular amide metabolic process (GO:0043603),-0.5300929381455688,-1.7787384010668468,0.00408997955010225,0.010492158641536605,0.724,9/28,17.89%,PPP2CA;PANK2;ORMDL2;ACOT7;ACBD6;PLAAT3;PPP2R1A;DNPEP;CLN8
gsea,regulation of receptor internalization (GO:0002090),-0.602290374593521,-1.7772136260155342,0.004048582995951417,0.01059883091237001,0.726,6/15,13.23%,ARRB2;ARF1;ATAD1;MKLN1;SDCBP;MTMR2
gsea,pattern recognition receptor signaling pathway (GO:0002221),-0.591793289871656,-1.7769086377187624,0.006122448979591836,0.01058867795748569,0.726,1/17,0.04%,HMGB1
gsea,peptidyl-threonine modification (GO:0018210),-0.5122491023869453,-1.7716807917452113,0.003937007874015748,0.011100371874416974,0.741,10/27,19.52%,CSNK2A1;GSK3A;CSNK2B;MAPK1;MARK2;GSK3B;TBK1;TNKS;CDK5;CDK10
gsea,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.5719039283470342,-1.7712895182405588,0.0020964360587002098,0.011120088760028422,0.742,7/20,19.78%,YWHAB;CALM1;GRK6;ZDHHC3;FNTA;GIT2;RGS14
gsea,positive regulation of MAP kinase activity (GO:0043406),-0.5884316966389624,-1.7698914278044227,0.0041753653444676405,0.011232865723200997,0.745,1/18,0.06%,EZH2
gsea,regulation of ATP metabolic process (GO:1903578),-0.6119565140874001,-1.7684934041119658,0.004140786749482402,0.01138045020994909,0.748,6/15,5.73%,TPR;COX7A2;NUP50;SEC13;UQCC2;PRKAG1
gsea,mitotic cytokinetic process (GO:1902410),-0.6001592530298006,-1.7656363190009754,0.004,0.01165524666087658,0.755,9/16,21.27%,RHOA;PDCD6IP;CHMP6;CHMP2A;VPS4B;VPS4A;CHMP3;CHMP7;MITD1
gsea,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.5495837019545875,-1.7634247117631774,0.006289308176100629,0.011831774440670245,0.761,10/23,19.77%,RAC1;CDC42;ACTR3;WASF2;CROCC;ARPC2;MIEN1;ENTR1;WASHC1;BRK1
gsea,T cell activation (GO:0042110),0.5667103356085492,1.762405019473717,0.005836575875486381,0.033689195624386235,0.775,12/26,10.75%,CD3E;CD3G;CD8A;PTPRC;ITK;LFNG;MSN;PTPN22;CD2;CD28;LMBR1L;SOX4
gsea,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5813841399144686,1.7573090968643457,0.0074487895716946,0.033816996174413916,0.784,8/18,24.01%,HCST;IL18;INSR;IGF1R;HGF;TREM2;SRC;FGFR1
gsea,cell projection organization (GO:0030030),-0.5942997727348545,-1.7560872939226657,0.004073319755600814,0.012591290944653898,0.774,2/15,2.25%,RAC1;CDC42
gsea,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.49984870419096583,-1.7448318721247407,0.0038910505836575876,0.01378038274048455,0.798,13/31,17.20%,CENPX;UBE2L3;COMMD1;GSK3A;HDAC3;FKBP1A;DCUN1D5;DERL1;SENP2;PIAS1;NDFIP2;UBE3A;PSMD10
gsea,regulation of cytokine production (GO:0001817),0.5050293461513902,1.743946399228074,0.005917159763313609,0.036510887417840684,0.816,14/31,20.50%,PLD3;SRGN;S100A13;TNFRSF1B;PTPRC;LGALS9;ITK;FOXP1;CD28;NPTN;BATF;IL15;TREM2;CARD9
gsea,integrin-mediated signaling pathway (GO:0007229),-0.5713580509416354,-1.743056346962328,0.004132231404958678,0.01393694803993309,0.799,6/21,10.30%,CDC42;CD47;ILK;PTPRA;CCM2;ITGB2
gsea,regulation of type I interferon production (GO:0032479),-0.4976506811974072,-1.742291356456194,0.001953125,0.014001223509688571,0.802,17/32,27.57%,PCBP2;POLR2K;TAX1BP1;POLR3C;CYLD;UFD1;DHX36;IRF3;RNF26;TBK1;TIRAP;OTUD5;PQBP1;CRCP;LRRFIP1;RELA;IRAK1
gsea,anterograde trans-synaptic signaling (GO:0098916),-0.45542609793790895,-1.7413352801800477,0.006535947712418301,0.014104274636215795,0.806,9/43,19.33%,CALM1;PAFAH1B1;PRKAR1A;MAPK1;SYNJ2BP;SDCBP;CAMK4;CDK5;PRKACA
gsea,ribonucleoprotein complex assembly (GO:0022618),-0.4866896468062194,-1.741198855967407,0.0076045627376425855,0.014085445762702669,0.806,23/41,12.91%,NUDT21;SNRPG;LSM4;SNRPC;PUF60;SNRPD2;LUC7L2;SF1;SF3B1;ISY1;GEMIN7;MRPS11;POLR2D;TRAF7;PRPF18;TGS1;MCTS1;CPSF7;ZRSR2;CRNKL1;ABT1;XAB2;GEMIN4
gsea,negative regulation of protein-containing complex assembly (GO:0031333),-0.5704312862098525,-1.740435614301553,0.01026694045174538,0.014140202482803203,0.808,4/18,11.18%,HMGB1;CDC42;LCMT1;RIOK3
gsea,regulation of protein kinase activity (GO:0045859),-0.4774633190217943,-1.7371975585283386,0.004219409282700422,0.01441458526062705,0.813,14/36,21.66%,TRIM27;ANKRD54;PAK2;PRKAG1;DTNBP1;GSTP1;SOD1;IQGAP1;CHP1;RTRAF;RAP1A;PTK2;CAMK2N2;DVL1
gsea,iron ion transport (GO:0006826),-0.5362994564697706,-1.7370353100516378,0.005928853754940711,0.014403712323447705,0.813,7/23,15.50%,ATP6V1G1;RAB11B;ATP6V1C1;MCOLN1;DNM2;ATP6V1D;ATP6V1A
gsea,mitotic metaphase plate congression (GO:0007080),-0.5753120274448245,-1.7368204196472936,0.007905138339920948,0.01439289457884288,0.815,12/18,26.95%,RAB11A;PDCD6IP;CHMP6;CHMP2A;VPS4B;VPS4A;CHMP3;CHMP7;EML4;BECN1;BOD1;DCTN2
gsea,regulation of telomere maintenance via telomerase (GO:0032210),-0.5890167811185032,-1.7351071088071786,0.010040160642570281,0.014566133886452627,0.819,10/17,23.76%,TERF1;MAPK1;MAPK3;PNKP;SMG5;STN1;TNKS;ACD;DCP2;MAP2K7
gsea,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.5387533347962967,-1.7336879341239977,0.0,0.014665936860801929,0.821,8/24,19.94%,HMGB1;KLHDC10;EMC10;SDCBP;TAOK3;TIRAP;PYCARD;MAP4K2
gsea,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.380671016114045,-1.7318336569580137,0.003913894324853229,0.014867418620662284,0.827,54/112,31.71%,EZH2;RBM3;UBE2L3;MLF2;YAF2;PPP2CA;TCF3;EDF1;PCIF1;MTPN;SAP30L;SP3;DAPK3;MLX;CDK11B;GLRX2;MSL3;MYB;RUNX3;THAP7;DNM2;GPBP1;DRAP1;ING2;PPP2R1A;LDB1;ZFPL1;TBX21;CXXC1;PHF12;UBE2V1;NSD1;SBNO1;PQBP1;NR2C2;HMGA2;REXO4;ACTR8;DVL1;STAT3;DVL2;SPIN1;RPS6KA4;TRAPPC2;RELA;DMTF1;CELSR2;TGFBR1;MZF1;TAF5L;TESMIN;SUFU;SLC39A8;WTIP
gsea,glycosphingolipid metabolic process (GO:0006687),-0.5890190409765839,-1.730887974069461,0.010101010101010102,0.014948975603431175,0.83,4/18,9.90%,GLTP;HEXB;B4GALNT1;ESYT1
gsea,regulation of actin cytoskeleton organization (GO:0032956),-0.4960599158384011,-1.7293509608986959,0.004140786749482402,0.015106375816480517,0.833,8/29,23.29%,RHOA;RAC1;DAPK3;ARHGAP18;IQGAP1;CDK10;TWF1;PHPT1
gsea,regulation of vesicle-mediated transport (GO:0060627),-0.47485972494315265,-1.7267200111205654,0.0039603960396039604,0.015410886208972992,0.842,15/37,21.12%,AP2S1;RAB11B;RAB10;RAB11A;MAPK1;RAB8A;MAPK3;MAP2K2;RAB5C;SNX17;SNX12;SCFD1;RAB4B;CHMP3;CPLANE2
gsea,regulation of interleukin-8 production (GO:0032677),-0.5522745126911701,-1.7193979234796366,0.006224066390041493,0.01642201397251559,0.854,6/20,18.96%,HMGB1;MAP2K5;LAMTOR5;RAB1A;TIRAP;PYCARD
gsea,regulation of proteolysis (GO:0030162),-0.5267982277489252,-1.7186897521219693,0.012244897959183673,0.016503096901077006,0.855,10/22,18.86%,AURKAIP1;BAG6;NEDD8;CYFIP2;SPOP;CASP8;CLN8;CDK5;F2;DNAJC1
gsea,membrane fusion (GO:0061025),-0.5967119871297079,-1.7161800089839274,0.017509727626459144,0.01682284554467506,0.863,10/15,25.12%,VAPA;VTI1B;DNM2;CHP1;NAPA;VAMP3;DNM1L;RABEP1;SNAP29;NAPG
gsea,regulation of macroautophagy (GO:0016241),-0.44057473004624037,-1.7120809413168832,0.0020491803278688526,0.017354384858521983,0.875,21/52,22.70%,ATP6V1G1;LAMTOR1;RHEB;SH3GLB1;SNX6;PRKAG1;LAMTOR4;PAFAH1B2;ATP6V1C1;LAMTOR3;LAMTOR5;ATP6V1D;EXOC7;ATP6V1A;LAMTOR2;TBK1;CDK5;GNAI3;PRKACA;ATG101;UBQLN2
gsea,transferrin transport (GO:0033572),-0.5557157297723088,-1.7109360900717678,0.015904572564612324,0.017516034330685364,0.876,7/20,15.50%,ATP6V1G1;RAB11B;ATP6V1C1;MCOLN1;DNM2;ATP6V1D;ATP6V1A
gsea,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.45444938302181354,-1.709392358349657,0.006224066390041493,0.017685213871909636,0.88,21/40,27.60%,RBX1;DDA1;COMMD1;GSK3A;UBXN1;ELOB;BAG6;CSNK1A1;SUMO1;SDCBP;PIAS1;PSMD10;DDRGK1;GSK3B;BBS7;HECTD1;DVL1;FBXO22;ARAF;DET1;RCHY1
gsea,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.5079115318220527,-1.7089804380744704,0.014799154334038054,0.017720667440624754,0.88,16/27,24.02%,CBFB;IFNGR1;CDC37;PTPN2;TAX1BP1;TRADD;SUMO1;CASP8;CYLD;RBCK1;VRK2;SPPL2A;PIAS1;PYCARD;SHARPIN;OTULIN
gsea,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.564574488906101,1.7057460969910652,0.011881188118811881,0.04928679439886197,0.877,4/17,0.78%,LAPTM5;RPS7;RPL23;RPL11
gsea,regulation of reactive oxygen species metabolic process (GO:2000377),-0.5501350626552529,-1.7054925812524158,0.012096774193548387,0.01819922448104495,0.883,7/17,18.57%,FOXM1;RAC1;PDK3;GRB2;ROMO1;DHRS4;F2
gsea,regulation of cytosolic calcium ion concentration (GO:0051480),-0.4996880848959459,-1.705381846928808,0.006097560975609756,0.018183656143537917,0.883,5/27,21.79%,HMGB1;BCAP31;F2;PRKACA;SELENOT
gsea,regulation of cellular catabolic process (GO:0031329),-0.5007732548708146,-1.7052502349861836,0.007920792079207921,0.01816816374914068,0.883,9/26,29.51%,VPS29;RAB8A;DAPK3;CISD2;PIP4K2A;PIP4K2C;WDR91;SCARB2;RRAGC
gsea,cell morphogenesis involved in differentiation (GO:0000904),-0.5417266256741204,-1.7050987089665957,0.006160164271047228,0.018156859282432786,0.883,7/20,19.48%,RHOA;RAC1;ILK;YTHDF2;TBCD;VAMP3;TYRO3
gsea,positive regulation of type I interferon production (GO:0032481),-0.584966582368089,-1.7050914626811988,0.011131725417439703,0.018112789235630762,0.883,11/16,27.57%,POLR2K;POLR3C;RIOK3;DHX36;IRF3;TBK1;PQBP1;CRCP;LRRFIP1;RELA;IRAK1
gsea,positive regulation of cell population proliferation (GO:0008284),-0.37866642789714344,-1.703701359770652,0.006211180124223602,0.018236730165211552,0.887,38/102,26.61%,EZH2;FOXM1;ID2;CSNK2A1;RNF187;CD47;UBE2A;CHTOP;GID8;GNAI2;NDUFS4;KRAS;CNOT6;SSR1;RPS6;KDM1A;CNOT7;MCTS1;CNOT8;ROMO1;SDCBP;TOX;CRKL;DDRGK1;COPS9;RTKN2;CNTF;EAPP;PTK2;CEP131;PTEN;HMGA2;LRP5;AKT2;MECP2;ADAM10;RELA;PDCD10
gsea,cellular response to DNA damage stimulus (GO:0006974),-0.39720746643888993,-1.7031953648414777,0.004048582995951417,0.018241672947175516,0.887,29/75,21.44%,RAD51B;UBE2A;OTUB1;NABP2;GRB2;BABAM2;INIP;XRCC3;DCUN1D5;MAPK3;ERCC1;STK11;SUMO1;PNKP;FAAP20;TOPORS;KIN;YY1;ALKBH3;HMCES;ATRIP;IRF3;PSEN1;TAOK3;CEP63;MNAT1;SIRT7;POLB;REXO4
gsea,axonogenesis (GO:0007409),-0.4253119662652216,-1.7030621840214482,0.004106776180698152,0.018209935808687315,0.887,16/56,31.99%,GRB2;RAB10;MAPK1;RAB8A;PTPRA;LYPLA2;MAPK3;SEMA4D;CDK5;PTK2;PTEN;RANBP9;SPTB;SLC9A6;NRTN;SPTBN2
gsea,positive regulation of programmed cell death (GO:0043068),-0.3916407172161698,-1.7024644220651057,0.0019157088122605363,0.018300244533234467,0.889,33/81,32.98%,HMGB1;SAP18;PTPA;PDCD5;MTCH1;SUDS3;ARHGEF1;RPS6;DAPK3;TRADD;DIABLO;SOD1;CASP8;DNM2;CTNNBL1;NCSTN;UBE2Z;DNM1L;PSEN1;ING3;PYCARD;TFPT;HMGA2;VAV1;MOAP1;ARHGEF6;HTATIP2;APH1A;BIN1;FGD1;CALHM2;TIAM2;CASP2
gsea,positive regulation of cellular amide metabolic process (GO:0034250),-0.520211019720861,-1.699882960463218,0.010183299389002037,0.018653588892074153,0.893,10/24,16.39%,RBM3;ELAVL1;GSK3A;IFNGR1;RPS6KB1;PCIF1;CIRBP;YTHDF1;POLDIP3;UPF3A
gsea,negative regulation of cell differentiation (GO:0045596),-0.4463430366148094,-1.698547286890348,0.00390625,0.018766666158287967,0.895,16/42,22.82%,ID2;MAD2L2;PPP2CA;PAF1;GPS2;SRA1;YTHDF2;MYB;WDR61;NELFB;SEMA4D;ADIPOR1;SDHAF2;PTEN;LRP5;NR1H2
gsea,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.5605141773124336,-1.6935859133376392,0.005988023952095809,0.019476238322385247,0.901,9/19,18.28%,LEPROTL1;CHMP6;CHMP2A;VPS4B;MVB12A;VTA1;CHMP3;CHMP7;LEPROT
gsea,positive regulation of protein metabolic process (GO:0051247),-0.44533073245691,-1.6927542960127062,0.006147540983606557,0.019582794023231768,0.903,18/42,22.82%,CSNK2A1;GSK3A;SNF8;OAZ1;MTPN;WWP2;MAP2K5;RAB1A;LDB1;SEC22B;PSEN1;RAB1B;GSK3B;VPS28;RANBP9;WFS1;NKD1;NR1H2
gsea,cytosolic transport (GO:0016482),-0.4449664513265218,-1.6901189017355271,0.0020325203252032522,0.01996586844026234,0.907,26/48,27.08%,VPS29;TRIM27;SNX6;SNF8;RAB14;SNX1;PLEKHJ1;GGA1;ARFRP1;AP2A1;VTI1B;VPS13A;GOSR1;VAMP3;RAB29;VTI1A;YKT6;GOSR2;WASHC1;BECN1;VPS51;STX8;WDR91;SYS1;SNX2;MON2
gsea,regulation of glycolytic process (GO:0006110),-0.5295357539294412,-1.6895434949297,0.015053763440860216,0.01995860935607983,0.908,6/20,16.56%,TPR;NUP50;SEC13;PRKAG1;NCOR1;PSEN1
gsea,enzyme linked receptor protein signaling pathway (GO:0007167),0.48776794723686717,1.6890757878192952,0.003838771593090211,0.054482784211621026,0.909,17/33,25.51%,CD3E;CD8A;INSR;FYN;DDR1;ABI1;BMPR2;INSRR;IGF1R;RASGRP4;ZAP70;ACVR1B;SRC;FGFR1;SHC4;EPHA1;TRIO
gsea,nucleus organization (GO:0006997),-0.5362414781615337,-1.6870839713903347,0.003913894324853229,0.020247079058046645,0.909,9/22,17.95%,TPR;TOR1A;PDCD6IP;CHMP6;CHMP2A;VPS4B;VPS4A;CHMP3;CHMP7
gsea,substrate adhesion-dependent cell spreading (GO:0034446),-0.5680295886970762,-1.68613155616514,0.011857707509881422,0.020334865708173486,0.909,7/15,27.76%,RHOA;RAC1;ILK;VAMP3;TYRO3;ATRN;PARVG
gsea,negative regulation of type I interferon production (GO:0032480),-0.5476978856700061,-1.6859947155907242,0.008368200836820083,0.020310881367564013,0.909,10/19,19.26%,PCBP2;TAX1BP1;CYLD;PPM1B;YY1;UFD1;IRF3;TBK1;PYCARD;OTUD5
gsea,negative regulation of binding (GO:0051100),-0.49788824010813576,-1.6845224144125286,0.008421052631578947,0.020485396189530672,0.914,12/25,25.62%,PPP1CA;WAPL;KDM1A;SUMO1;PEX14;STYX;GSK3B;MITD1;HMGA2;DVL1;CTNNBIP1;PEX19
gsea,positive regulation of apoptotic process (GO:0043065),-0.380834539424493,-1.6828373508499301,0.0037174721189591076,0.020686802685494374,0.915,37/91,32.98%,HMGB1;SAP18;PTPA;PDCD5;MTCH1;SUDS3;TRAF7;ARHGEF1;RPS6;DAPK3;TRADD;DIABLO;SOD1;CASP8;DNM2;BRMS1;CTNNBL1;NCSTN;UBE2Z;DNM1L;PSEN1;CDK5;ING3;PYCARD;TFPT;HMGA2;VAV1;MOAP1;ARHGEF6;APH1A;TGFBR1;BIN1;FGD1;TFAP2A;CALHM2;TIAM2;CASP2
gsea,positive regulation of cell motility (GO:2000147),-0.433042666001576,-1.682048042238819,0.002173913043478261,0.020792487459989597,0.915,19/50,30.27%,MAPRE1;CFAP20;CCDC25;TRADD;SDCBP;MIEN1;SEMA4D;DDRGK1;PTK2;WASHC1;AKT2;STAT3;PHPT1;ADAM10;PPP3CA;PDCD10;TGFBR1;CBLL1;CARMIL1
gsea,ERAD pathway (GO:0036503),-0.4686450157221432,-1.6806922050240196,0.009633911368015413,0.020952839319175607,0.916,16/35,22.70%,BAG6;TOR1A;DERL1;FAF2;UBE2J2;RNF121;SGTA;AUP1;UFD1;UBXN8;UBE2J1;FBXO2;AMFR;WFS1;SEC61B;UBQLN2
gsea,regulation of RNA splicing (GO:0043484),-0.5124358167494145,-1.6767327886098597,0.0196078431372549,0.02155269742797174,0.924,12/23,19.45%,TRA2B;HNRNPL;SF1;KHDRBS1;PTBP3;CLK3;FASTK;RBM22;FAM50A;TIA1;RBM39;PQBP1
gsea,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4950032706524682,-1.6765986258257246,0.021231422505307854,0.021557594995148928,0.925,15/31,19.77%,RAC1;CDC42;ACTR3;GRB2;WASF2;MAPK1;MAPK3;ARPC4;CYFIP2;ARPC1A;ARPC2;WAS;ARPC5;PTK2;BRK1
gsea,positive regulation of cellular metabolic process (GO:0031325),-0.49532739470975967,-1.6760595197331938,0.013565891472868217,0.021621159245748596,0.925,14/26,24.93%,GRB2;CHCHD2;ARRB2;GHITM;ATAD1;ROMO1;RAB1A;VAMP3;RAB29;DHRS4;RAB1B;F2;NR1H2;MAPK14
gsea,cellular response to organic substance (GO:0071310),-0.46037362703218015,-1.6743623129648932,0.009900990099009901,0.021836669818907733,0.927,9/36,23.03%,RHOA;EMD;DCPS;RPS6KB1;PTPN2;CDK9;MAP2K5;TBK1;STAT3
gsea,establishment of protein localization to membrane (GO:0090150),-0.4928008630261546,-1.6737208407558024,0.0064516129032258064,0.02196940079651772,0.929,9/27,12.22%,RAB11B;YIF1B;RAB10;RAB11A;ZDHHC3;ATG3;ARL6;SEC63;SDCBP
gsea,water-soluble vitamin metabolic process (GO:0006767),-0.5584720999584281,-1.67364931694869,0.018072289156626505,0.021922782067080954,0.929,4/16,14.62%,PANK2;RFK;CYB5R3;MMAA
gsea,protein secretion (GO:0009306),-0.5396360910411402,-1.672418851548852,0.013618677042801557,0.022163255071203074,0.931,3/19,6.58%,RAB10;PREB;RAB8A
gsea,central nervous system development (GO:0007417),-0.4075568677748762,-1.6714016194356975,0.0019723865877712033,0.022267252518776915,0.931,30/66,31.37%,SH3GL1;BAG6;TMX2;NDUFS4;PAFAH1B2;GSTP1;UGP2;EIF2B2;RAB18;IER3IP1;COX7B;UFM1;ATP6AP2;UFC1;UBE3A;ALDH5A1;EOMES;DNAJC30;CDK5;PTEN;STAT3;NHEJ1;TAGLN3;TBR1;SZT2;PKD2;NIPBL;FOXJ1;CDK5RAP3;AMIGO1
gsea,actin cytoskeleton reorganization (GO:0031532),-0.5525453865934852,-1.6687390407959861,0.014314928425357873,0.02276053674203297,0.934,8/17,27.76%,RHOA;GRB2;DTNBP1;MKLN1;ATP2C1;CDC42BPG;CDC42BPA;PARVG
gsea,insulin receptor signaling pathway (GO:0008286),-0.4822826969005471,-1.6679416290986586,0.006012024048096192,0.022831897960681597,0.935,10/30,22.06%,ATP6V1G1;GSK3A;GRB2;PTPN2;ATP6V1C1;APPL1;ATP6V1D;ATP6V1A;GSK3B;AKT2
gsea,negative regulation of cell cycle (GO:0045786),0.533302433202912,1.667218654893895,0.019342359767891684,0.06221002766952109,0.937,12/21,30.14%,BTG1;CDKN1B;TGFB1;RNF167;HECA;CHMP1A;CEBPA;APC;HEXIM2;RPS6KA2;PPP1R13B;BTG3
gsea,positive regulation of lamellipodium organization (GO:1902745),-0.5964299796312873,-1.667086655328661,0.02834008097165992,0.02293750817702663,0.935,6/15,19.77%,RAC1;CDC42;ACTR3;WASF2;ARPC2;BRK1
gsea,protein K63-linked ubiquitination (GO:0070534),-0.5706411162099867,-1.6656209669200668,0.016913319238900635,0.023107796599546777,0.937,7/16,19.35%,TRIM27;RNF4;WWP2;RNF115;UBE2G1;UBE2V1;HECTD1
gsea,regulation of cellular localization (GO:0060341),-0.5540637614539851,-1.6630450568051938,0.019230769230769232,0.023571770411212466,0.944,7/16,21.66%,KDM1A;REEP5;GOSR1;PARD6A;STXBP2;LRP5;DVL1
gsea,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4205675166483578,1.6624829871760178,0.011627906976744186,0.06234725567173327,0.94,19/50,20.50%,IRAK2;RPS3;UBC;UBA52;LGALS9;CFLAR;PRKCQ;CAPN3;TRIM13;NOD1;IL18;PRKCH;IKBKB;TICAM1;TRIM62;AGER;ZBTB7A;NOD2;CARD9
gsea,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.5025676172044133,-1.661553061264599,0.02620967741935484,0.023789459412311822,0.946,15/24,28.22%,CBFB;MED31;MED27;SUB1;MED6;PPM1D;MED25;DHX36;MED17;PTEN;MED10;MECP2;RELA;MED15;MED26
gsea,regulation of nucleic acid-templated transcription (GO:1903506),-0.36811572346842136,-1.660613250567653,0.005952380952380952,0.023949064673827705,0.947,52/107,31.71%,EZH2;RALY;UBE2L3;MLF2;YAF2;PPP2CA;TCF3;EDF1;SAP30L;SP3;DAPK3;MLX;CDK11B;GLRX2;MSL3;MYB;RUNX3;THAP7;DNM2;GPBP1;DRAP1;ING2;PPP2R1A;LDB1;ZFPL1;TBX21;CXXC1;PHF12;UBE2V1;NSD1;SBNO1;PQBP1;NR2C2;HMGA2;REXO4;ACTR8;DVL1;STAT3;DVL2;SPIN1;RPS6KA4;TRAPPC2;RELA;DMTF1;CELSR2;TGFBR1;MZF1;TAF5L;TESMIN;SUFU;SLC39A8;WTIP
gsea,negative regulation of apoptotic process (GO:0043066),-0.361191061034522,-1.6593358237325944,0.006147540983606557,0.024092759318514075,0.948,52/128,27.57%,BEX3;CSNK2A1;BAG1;BNIP2;NAA38;CIAPIN1;YWHAZ;HDAC3;TRIM27;PAK2;SNX6;RPS6KB1;BABAM2;MAPK1;TAX1BP1;MAPK3;ZFAND6;GSTP1;MAEA;MAP2K5;SOD1;DNAJC3;LAMTOR5;PRDX2;GLO1;TOPORS;IL2RB;UFM1;UBE2Z;HYPK;MIEN1;SEMA4D;PSEN1;TRIAP1;PSMD10;DDRGK1;CNTF;GSK3B;PTK2;TYRO3;HMGA2;TMBIM4;WFS1;AKT2;ADAM10;RELA;ARAF;CITED1;PDCD10;SON;HTATIP2;IRAK1
gsea,negative regulation of phosphorylation (GO:0042326),-0.521080287915912,-1.6589396967748835,0.013671875,0.024137274635691472,0.948,9/22,20.92%,DYNLL1;FKBP8;NCOR1;CHP1;PPP1R15B;CRKL;NPRL2;STAP1;PTEN
gsea,positive regulation of neurogenesis (GO:0050769),-0.5158718628006742,-1.6575123872405424,0.01764705882352941,0.024363094509823706,0.948,5/22,19.78%,RHOA;KDM1A;SNW1;CAPRIN2;RGS14
gsea,toll-like receptor signaling pathway (GO:0002224),-0.49654564659023864,-1.6562575880904145,0.011904761904761904,0.02456149604871278,0.948,5/25,12.62%,HMGB1;UBE2D3;CASP8;ITGB2;NMI
gsea,ubiquitin-dependent ERAD pathway (GO:0030433),-0.4884170016398747,-1.6555766483032452,0.011881188118811881,0.024600905494680254,0.948,16/31,22.70%,BAG6;DERL1;FAF2;UBE2J2;EDEM2;RNF121;SGTA;AUP1;UFD1;UBXN8;UBE2J1;FBXO2;AMFR;WFS1;SEC61B;UBQLN2
gsea,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.5301307677906401,-1.6555230280030662,0.01652892561983471,0.024553749053543298,0.948,15/19,27.23%,MAPRE1;PPP1CC;PTPA;PAFAH1B1;SEC13;DYNLL1;B9D2;TNKS;EML4;TBCE;MECP2;SBDS;DCTN2;DYNC1LI1;TUBG2
gsea,protein localization to nucleus (GO:0034504),-0.47294217376837283,-1.6542754076085868,0.012072434607645875,0.024735416949136394,0.948,16/30,25.52%,TPR;NUP50;SEC13;TOR1A;PAF1;CNEP1R1;MORC3;APPL1;TOPORS;NXT2;TOR1AIP1;DVL1;SUPT7L;STAT3;RANBP17;NUP62CL
gsea,cellular macromolecule catabolic process (GO:0044265),-0.5286978254465087,-1.6536128990051788,0.024096385542168676,0.02477791954610652,0.948,6/19,19.88%,RNASEH2C;XRN2;SKIV2L;UBE2G1;NGLY1;FBXO2
gsea,negative regulation of cytokine production (GO:0001818),-0.41933781119116675,-1.6530767130233497,0.005964214711729622,0.024797847030177997,0.948,18/52,21.58%,HMGB1;PCBP2;RAC1;TRIM27;PPP1R11;TAX1BP1;MAP2K5;CUEDC2;CYLD;KAT5;UFD1;TBX21;IRF3;TBK1;F2;PYCARD;OTUD5;JAK3
gsea,establishment of protein localization to extracellular region (GO:0035592),-0.550757269353312,-1.651413212714775,0.015748031496062992,0.025044791271991416,0.95,3/17,6.58%,RAB10;PREB;RAB8A
gsea,axon guidance (GO:0007411),-0.42601539380605435,-1.6492108148010831,0.008213552361396304,0.025342657844349258,0.951,13/49,31.99%,RAC1;GRB2;MAPK1;PTPRA;LYPLA2;MAPK3;SEMA4D;PTK2;CHN1;RANBP9;SPTB;NRTN;SPTBN2
gsea,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.4999979782209031,-1.6491726335248784,0.010460251046025104,0.02530561532157135,0.951,2/24,4.80%,HMGB1;BCAP31
gsea,positive regulation of catabolic process (GO:0009896),-0.4719827274080489,-1.6486861817627179,0.004246284501061571,0.025331610860941073,0.951,9/28,22.32%,CSNK2A1;GSK3A;SNF8;OAZ1;WWP2;SEC22B;GSK3B;VPS28;NKD1
gsea,positive regulation of growth (GO:0045927),-0.5623199007767979,-1.6477384745855137,0.015414258188824663,0.025460827157262635,0.951,7/16,25.08%,CSNK2A1;CDC42;MTPN;SDCBP;PSMD10;WFS1;ADAM10
gsea,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.5532357832714676,-1.6473847995083915,0.01016260162601626,0.025464276457278157,0.951,6/16,18.96%,GSTP1;CASP8;RIOK3;PPM1B;CCDC22;PYCARD
gsea,regulation of cell migration (GO:0030334),-0.3819409137996113,-1.645421502548905,0.004329004329004329,0.025783714673969903,0.954,26/91,30.27%,MAPRE1;RHOA;RAC1;TRADD;STK24;STK26;APPL1;SDCBP;LDB1;MIEN1;SEMA4D;DOCK10;DDRGK1;PTK2;WASHC1;ARHGAP4;PTEN;AKT2;NKD1;STAT3;ADAM10;PPP3CA;PDCD10;TGFBR1;CBLL1;CARMIL1
gsea,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.5084511701990502,1.6441125432008359,0.018072289156626505,0.06927008987617285,0.953,7/21,10.75%,SQSTM1;RPL11;RPS3;OGT;CAPN3;SVBP;SOX4
gsea,glycerophospholipid biosynthetic process (GO:0046474),-0.4096940281017239,-1.6426821583423992,0.010309278350515464,0.026288758208740517,0.959,25/58,34.66%,CSNK2A1;CSNK2B;IMPA1;RAB14;ARF1;MTMR9;MTMR2;CEPT1;ARF3;CDS2;CHKB;PCYT1B;LPCAT3;PTEN;MBOAT7;ABHD5;PIP4K2A;PIP4K2C;PTDSS1;PEMT;PHOSPHO1;PLA2G4C;AGPAT3;MTMR6;GPAM
gsea,regulation of response to external stimulus (GO:0032101),-0.47480524597871654,-1.6422056204375624,0.01818181818181818,0.026326978625560625,0.959,14/30,32.02%,CALM1;BRD4;STK24;CASP8;CYLD;APPL1;FNTA;F2;TIRAP;RELA;P2RY12;BCL6B;DAGLB;MGLL
gsea,organic anion transport (GO:0015711),-0.526587252754549,-1.6420641085663465,0.016563146997929608,0.026310274111049192,0.959,6/20,18.70%,SLC35B2;MFSD10;LRRC8C;SLC2A8;SLC25A4;SLC35B4
gsea,mitochondrion disassembly (GO:0061726),0.5050204147354842,1.6404460050726464,0.014112903225806451,0.06892534410907591,0.954,9/22,8.95%,SQSTM1;MAP1LC3B;RB1CC1;GABARAP;GABARAPL1;MAP1LC3A;ATG12;FIS1;GABARAPL2
gsea,fatty acid beta-oxidation (GO:0006635),-0.5196334242535651,-1.64004656440696,0.02033271719038817,0.026690705457755814,0.959,6/20,12.64%,ETFA;AUH;ECHS1;ACAT1;HADHB;HADHA
gsea,cilium organization (GO:0044782),-0.37793883351543467,-1.6352135645441397,0.005988023952095809,0.027429360961381766,0.962,32/82,31.65%,CFAP20;ACTR3;DYNLL1;RAB11A;RAB8A;NUDCD3;BBIP1;ARL6;RAB1A;ATP6V1D;B9D2;EXOC7;EXOC3;FAM161B;BBS7;EXOC5;CEP131;INTU;CPLANE2;BBS5;WDPCP;EXOC6;WDR35;SNAP29;CCDC96;EXOC1;CDC14B;RFX2;PKD2;TCTN2;FOXJ1;TTC8
gsea,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.560608981834992,1.632672378162364,0.015873015873015872,0.0708270942385874,0.966,4/15,5.54%,IRAK2;UBC;UBA52;NOD1
gsea,Golgi to plasma membrane transport (GO:0006893),-0.4776829268485996,-1.6311478660356478,0.019693654266958426,0.028153964809467327,0.966,14/27,28.37%,COMMD1;RAB10;GGA1;ARFRP1;CCDC22;EXOC5;RABEP1;VPS35L;EXOC6;SYS1;EXOC1;VAMP4;GOLPH3L;GOPC
gsea,autophagy of mitochondrion (GO:0000422),0.4963455628217229,1.630316679851999,0.007984031936127744,0.0700000629935697,0.967,12/23,19.98%,SQSTM1;MAP1LC3B;RB1CC1;GABARAP;GABARAPL1;MAP1LC3A;ATG12;FIS1;GABARAPL2;ATG13;ATG9A;FUNDC1
gsea,defense response to bacterium (GO:0042742),-0.5163027013345091,-1.627958901826906,0.02564102564102564,0.028774122607319798,0.97,7/21,21.97%,HMGB2;PPP1R11;ROMO1;RAB1A;TIRAP;PYCARD;GSDMD
gsea,sensory perception of mechanical stimulus (GO:0050954),-0.5239830591268475,-1.622952777965624,0.02092050209205021,0.029835863447611986,0.974,8/19,31.29%,NDUFB9;WDR1;SOD1;WFS1;EML2;NIPBL;TFAP2A;EYA1
gsea,regulation of stress-activated MAPK cascade (GO:0032872),-0.5029871242881594,-1.622125753321495,0.030425963488843813,0.029974068846498454,0.975,9/22,26.61%,FOXM1;MAPK1;MAPK3;KLHDC10;GSTP1;MAP2K2;TAOK3;STK25;PDCD10
gsea,sensory perception of sound (GO:0007605),-0.5116211991697182,-1.6175070780729,0.020618556701030927,0.030877694634527265,0.98,8/20,31.29%,NDUFB9;WDR1;SOD1;WFS1;EML2;NIPBL;TFAP2A;EYA1
gsea,cellular response to light stimulus (GO:0071482),-0.4983131153398675,-1.6154242469817364,0.031746031746031744,0.031239186080083248,0.98,8/21,24.07%,GNB1;KDM1A;YY1;DHX36;TRIAP1;COPS9;SDE2;TMEM161A
gsea,negative regulation of multicellular organismal process (GO:0051241),-0.4129408311329417,-1.6152412625151908,0.005952380952380952,0.03123029809233813,0.98,14/52,24.20%,MAD2L2;GSK3A;IFNGR1;PPP2CA;RHEB;PPP1R11;STK11;PGAM5;ADIPOR1;GSK3B;SDHAF2;PTEN;NR1H2;RPS6KA4
gsea,regulation of neuron projection development (GO:0010975),-0.4099777566237092,-1.6136658515608908,0.00998003992015968,0.031528766502577334,0.981,22/49,35.87%,SNX3;GSK3A;PAK2;TOX;RAB29;PSEN1;MARK2;FBXO7;RAP1A;GSK3B;CDK5;CHN1;PTEN;TWF1;LZTS3;CBFA2T2;SCARB2;TBR1;LTK;CIB1;LRRC4C;ATP1B2
gsea,lysosome localization (GO:0032418),0.5375570975611027,1.613356801912571,0.022727272727272728,0.07805771026645648,0.977,11/17,18.70%,NR4A3;S100A13;BLOC1S1;BORCS6;SNAPIN;TMEM106B;FLCN;NDEL1;KXD1;RAB3A;HPS6
gsea,negative regulation of gene expression (GO:0010629),-0.36647471595448666,-1.6082689853346683,0.005825242718446602,0.03266040449128956,0.982,38/88,26.61%,EZH2;LSM5;LSM6;ID2;TRIM27;PPP1R11;PTBP3;PCIF1;WWP2;DAPK3;MPHOSPH8;MAP2K2;NCOR1;YTHDF2;CNOT7;MALSU1;CNOT8;SNX12;PPM1D;YY1;EIF4E2;CNPY2;LSM14A;NDFIP2;ERP29;DHX36;PSEN1;CRKL;RNH1;DDRGK1;SAMD4B;FXR1;RBM4;MECP2;DCP2;RPS6KA4;ADAM10;PDCD10
gsea,nervous system development (GO:0007399),-0.3603258272256002,-1.605711329464071,0.0020242914979757085,0.03313964371908631,0.982,39/100,33.44%,NDUFV2;SH3GL1;ATXN10;BTBD1;DBNL;NDUFS2;GSTP1;EIF2B2;COX7B;DPF2;LDB1;RAB29;ESS2;ALDH5A1;CLN8;CDK5;TYRO3;NR2C2;DPF3;PTEN;INTU;DVL1;WDPCP;STAT3;ZC4H2;TRAK2;PRX;NHEJ1;TAGLN3;TGFBR1;SZT2;PKD2;CSPG5;NRTN;DAGLB;NAV2;NUMBL;NINJ2;ADAM22
gsea,regulation of hydrolase activity (GO:0051336),-0.4920257178877812,-1.6056497662303062,0.02100840336134454,0.03308067547697598,0.982,12/23,33.10%,PAFAH1B1;RALBP1;SOD1;TBC1D15;PTK2;CHN1;VAV1;RAPGEF6;SCARB2;FGD1;CDK5RAP3;FBXW11
gsea,positive regulation of phosphorylation (GO:0042327),-0.3872558257072548,-1.6052819666623264,0.007984031936127744,0.033085737631787376,0.982,18/60,24.01%,RAC1;ILK;HDAC3;KRAS;MAPK3;BTBD10;RALBP1;SDCBP;ERP29;SEMA4D;PSEN1;CRKL;F2;PTK2;TYRO3;FXR1;AKT2;DVL2
gsea,positive regulation of protein secretion (GO:0050714),-0.5550535529015688,-1.6045737985586437,0.0311284046692607,0.03319686146115129,0.983,5/16,15.05%,TMED10;ARF6;PSMD9;IER3IP1;DNM1L
gsea,protein autophosphorylation (GO:0046777),-0.4169764134728815,-1.602858924609716,0.012320328542094456,0.03351218665763355,0.984,19/46,27.57%,PAK2;MAPK3;DAPK3;STK11;STK16;STK24;MAP2K2;STK26;VRK2;CAMK4;MARK2;TAOK3;GSK3B;PTK2;TYRO3;EIF2AK1;STK25;HTATIP2;IRAK1
gsea,cellular transition metal ion homeostasis (GO:0046916),-0.478313463945911,-1.6013320450882371,0.014112903225806451,0.03383324072201181,0.984,11/28,16.55%,ATP6V1G1;BOLA2;LCK;ARF1;NEDD8;SOD1;ERFE;ISCU;ATP6V1A;SLC30A5;CCDC22
gsea,purine ribonucleotide biosynthetic process (GO:0009152),-0.5329310817476757,-1.6009148261195076,0.026804123711340205,0.033833182154669766,0.984,6/16,15.21%,PANK2;SLC35B2;ACOT7;ACAT1;NUDT2;SLC25A16
gsea,cellular amino acid catabolic process (GO:0009063),-0.5224358686677907,-1.5981383685246207,0.036072144288577156,0.03440472407747947,0.986,8/17,27.31%,QDPR;AUH;ECHS1;ACAT1;ALDH5A1;HMGCL;HYKK;HDC
gsea,cellular response to growth factor stimulus (GO:0071363),-0.4217547761632985,-1.597279191532945,0.01609657947686117,0.03455396061141023,0.986,19/44,34.57%,EMD;PDCD5;RPS6KB1;LIMS1;MAP2K5;IQGAP1;APPL1;RAB35;CRKL;RAP1A;ACAP2;MAPK14;RELA;NR4A1;TGFBR1;CIB1;MAPT;CORO1B;BMPR1A
gsea,mRNA catabolic process (GO:0006402),-0.5315207582825868,-1.5972117265134056,0.031936127744510975,0.034493044908648164,0.986,6/17,16.64%,LSM5;LSM6;XRN2;YTHDF2;PDE12;RNH1
gsea,long-chain fatty acid metabolic process (GO:0001676),-0.5080612325175141,-1.595953497250907,0.027722772277227723,0.03476346098547443,0.986,10/20,34.31%,GPX4;LTA4H;GSTP1;ELOVL1;ELOVL5;ACOT8;DAGLB;MGLL;PLA2G4C;HSD17B4
gsea,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.5039705276049907,-1.5942731012326572,0.028,0.03509884410794947,0.986,8/21,17.18%,FOXM1;CNOT11;CNOT6;CNOT7;CNOT8;KAT5;CNOT3;TRIAP1
gsea,regulation of signal transduction (GO:0009966),-0.3804940009526799,-1.5936796325422944,0.008064516129032258,0.035148248683094026,0.986,27/73,33.13%,SNX3;CBFB;ILK;PPP2CA;MTCH1;ANKRD54;PTPN2;GRK6;ZDHHC3;DTNBP1;GLRX2;SNW1;SYNJ2BP;SENP2;PPP2R1A;CSK;GIT2;RGS14;RFNG;INTU;AMFR;SHARPIN;IRAK1;ZFAND2B;BRAP;MGLL;GIT1
gsea,muscle contraction (GO:0006936),-0.44217023326429206,-1.5915689700812616,0.018480492813141684,0.03570660500845127,0.987,5/33,13.98%,EMD;CALM1;PABPN1;TMOD3;TLN1
gsea,regulation of innate immune response (GO:0045088),-0.5494853494868831,-1.5879118840982651,0.046370967741935484,0.03660487622748988,0.99,8/16,19.48%,CDC37;CASP8;POLR3C;RIOK3;APPL1;NMI;TIRAP;TYRO3
gsea,IRE1-mediated unfolded protein response (GO:0036498),-0.4877846075295821,-1.5852678953657746,0.023166023166023165,0.03730975870270826,0.99,10/23,25.57%,GSK3A;PREB;SSR1;YIF1A;DNAJC3;TLN1;CXXC1;GOSR2;WFS1;VAPB
gsea,transport across blood-brain barrier (GO:0150104),0.5510322267073052,1.5812813071170488,0.046875,0.09421300896327499,0.985,7/16,25.25%,INSR;SLC29A4;SLC28A2;SLC24A3;AGER;LRP1;SLC2A10
gsea,vascular transport (GO:0010232),0.5510322267073052,1.5812813071170488,0.046875,0.09421300896327499,0.985,7/16,25.25%,INSR;SLC29A4;SLC28A2;SLC24A3;AGER;LRP1;SLC2A10
gsea,chromatin remodeling (GO:0006338),-0.4641506030754687,-1.5801552311592542,0.027450980392156862,0.03850404338635341,0.991,11/26,21.60%,GATAD1;MBD2;SMARCD2;SMARCE1;SMARCD1;MYB;SMARCAD1;CHRAC1;TOP1;HMGA2;ACTR8
gsea,regulation of cellular component movement (GO:0051270),-0.49178044804892374,-1.5766482146497263,0.028112449799196786,0.03931557105082179,0.992,5/21,11.46%,RHOA;PKN2;DAPK3;YTHDF1;ARHGAP18
gsea,regulation of signal transduction by p53 class mediator (GO:1901796),-0.417476787661286,-1.57374973364226,0.022222222222222223,0.04003466535604359,0.992,24/42,26.24%,TAF10;CSNK2A1;MEAF6;CSNK2B;TAF12;PAK1IP1;PRKAG1;TAF11;MAPKAP1;STK11;PPP2R5C;PRDM1;RMI1;KAT5;ING2;ATRIP;PIP4P1;CDK5;TTC5;TAF4;RNF34;PIP4K2A;MAPK14;TAF13
gsea,regulation of protein binding (GO:0043393),-0.4126490961122684,-1.5662326798441473,0.030800821355236138,0.04214342561762157,0.995,18/38,21.94%,PPP1CA;PPP2CA;BTBD1;FKBP1A;KDM1A;DERL1;PEX14;NMD3;PSEN1;MARK2;STYX;GSK3B;PRKACA;CAPRIN2;MITD1;AMFR;DVL1;CTNNBIP1
gsea,amyloid fibril formation (GO:1990000),0.5374800457325686,1.5645592914896882,0.04073319755600815,0.10370491001580194,0.988,6/16,9.72%,B2M;UBC;UBA52;ITM2B;TSPAN14;SORL1
gsea,protein homooligomerization (GO:0051260),-0.45718234494965265,-1.5643020937563603,0.03359683794466403,0.04257048541178526,0.995,13/29,30.10%,ELAVL1;SSBP1;G3BP2;PDCD6IP;MPP2;CHMP2A;MCOLN1;MICU1;PYCARD;GSDMD;USP16;ACOT13;PKD2
gsea,cellular response to organonitrogen compound (GO:0071417),-0.45468632209398896,-1.5631087600770166,0.010482180293501049,0.04277091042766481,0.995,11/28,30.10%,LAMTOR1;LAMTOR4;LAMTOR3;LAMTOR5;LAMTOR2;RAP1A;HCN2;RELA;P2RY12;RRAGC;PKD2
gsea,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.4965911504294076,-1.5618597221708506,0.036511156186612576,0.04299093437899182,0.996,13/19,24.02%,UBE2K;PTPN2;GPS2;TAX1BP1;GSTP1;TRADD;CASP8;CYLD;RBCK1;SPPL2A;PYCARD;SHARPIN;OTULIN
gsea,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.4231143922886604,-1.5615864503677366,0.014344262295081968,0.04297927703448287,0.996,19/34,27.60%,RBX1;DDA1;GSK3A;ELOB;CSNK1A1;SUMO1;PIAS1;CCDC22;PSMD10;DDRGK1;GSK3B;BBS7;PTK2;HECTD1;PTEN;DVL1;FBXO22;DET1;RCHY1
gsea,negative regulation of autophagy (GO:0010507),0.5226034719877313,1.5559829844876008,0.046875,0.10721806611864873,0.989,10/17,20.00%,CTSA;MCL1;PTPN22;RRAGA;BMF;SIRT2;NRBP2;HGF;QSOX1;TREM2
gsea,metal ion transport (GO:0030001),0.45780089311620614,1.5537040556424409,0.013565891472868217,0.10592886095965476,0.989,4/28,6.71%,TPT1;NDFIP1;SELENOK;FYN
gsea,positive regulation of cellular process (GO:0048522),-0.3330526556199691,-1.5523885279368612,0.00851063829787234,0.04550474029085715,0.996,46/134,29.03%,EZH2;FOXM1;CSNK2A1;RAC1;CDC42;RNF187;CD47;UBE2A;CHTOP;GID8;GNAI2;KRAS;MTPN;CNOT6;SSR1;RPS6;CNOT7;MCTS1;CNOT8;ROMO1;SDCBP;IL2RB;DHX36;CRKL;PSMD10;DDRGK1;COPS9;RTKN2;CNTF;PYCARD;EAPP;PTK2;CEP131;PTEN;HMGA2;LRP5;FXR1;AKT2;MECP2;DVL2;ADAM10;PPP3CA;RELA;PDCD10;TULP1;TGFBR1
gsea,phospholipid metabolic process (GO:0006644),-0.4833954595231859,-1.5490513706402065,0.0465587044534413,0.046438024426139174,0.996,10/22,36.08%,GPX4;PLAAT3;PIP4P1;CLN8;ABHD12;PIP4K2A;PLA2G4C;AGPAT3;GPAM;FITM2
gsea,regulation of cell growth (GO:0001558),-0.3873778572410728,-1.5476386762201146,0.013861386138613862,0.046780548729493464,0.996,28/55,33.80%,CSNK2A1;MAD2L2;CDC42;LAMTOR1;PPP2CA;NDUFS3;DCUN1D5;MTPN;CDK11B;STK11;SDCBP;CRLF3;PPP2R1A;LAMTOR2;PSMD10;CAPRIN2;SIPA1;NDRG3;ADAM10;NAIF1;DACT3;LTBP4;TGFBR1;RPS6KA1;MUL1;CIB1;SERTAD3;EGLN2
gsea,plasma membrane bounded cell projection assembly (GO:0120031),-0.34619798204339214,-1.5444135594005939,0.0081799591002045,0.04766380164545474,0.996,41/103,31.65%,CFAP20;RAC1;ARF6;ACTR3;DYNLL1;RAB11A;RAB8A;NUDCD3;BBIP1;STK26;ARL6;SDCBP;RAB1A;ATP6V1D;B9D2;EXOC7;EXOC3;RAP1A;BBS7;EXOC5;CEP131;INTU;CPLANE2;BBS5;WDPCP;EXOC6;AIF1L;WDR35;SNAP29;CCDC96;EXOC1;ARHGEF6;P2RY12;CDC14B;RAPGEF6;RFX2;TCTN2;CARMIL1;FOXJ1;FGD1;TTC8
gsea,regulation of epithelial cell proliferation (GO:0050678),0.5311914681323083,1.5420354858470466,0.03636363636363636,0.11191524547654273,0.992,3/16,4.83%,B2M;NR4A3;TGFB1
gsea,glycoprotein biosynthetic process (GO:0009101),-0.4743851909476885,-1.539224766024068,0.04417670682730924,0.049249215053241424,0.997,5/22,18.68%,ALG5;ALG1;CANT1;DAD1;CHST12
gsea,positive regulation of GTPase activity (GO:0043547),-0.3836200763023033,-1.5365872468290132,0.027139874739039668,0.050177723690846984,0.997,19/57,30.98%,EZH2;LIMS1;ZC3H15;RALBP1;TBC1D15;MAPRE2;SEMA4D;DOCK10;RALGAPA1;RAP1A;GSK3B;TBC1D9B;SIPA1;RABGAP1L;ARHGAP29;RAPGEF6;TBC1D10A;FOXJ1;TBC1D2B
gsea,hemopoiesis (GO:0030097),0.4668959083072908,1.5357752288632214,0.03187250996015936,0.11366468448815387,0.993,11/26,17.98%,SELPLG;PTPRC;CD164;TGFBR2;RRAS;TGFB1;FLCN;PRKX;RASGRP4;CEBPA;RUNX2
gsea,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5185532930430152,-1.535602770653605,0.03762376237623762,0.05041306552344419,0.997,5/16,17.18%,BEX3;CSNK2A1;MAP2K5;LAMTOR5;TRIAP1
gsea,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.4660637683274607,-1.533032424396054,0.0499001996007984,0.05106502989117052,0.997,13/23,28.22%,CBFB;MED31;MED27;MED6;PPM1D;MED25;MED17;PTEN;MED10;MECP2;RELA;MED15;MED26
gsea,inositol lipid-mediated signaling (GO:0048017),-0.5225590045807427,-1.5316686963870085,0.0515695067264574,0.05140437590890236,0.997,2/15,5.09%,RHOA;RPS6KB1
gsea,actomyosin structure organization (GO:0031032),-0.4858073831991528,-1.5296081681150466,0.034013605442176874,0.051981949405678074,0.997,6/20,27.72%,RHOA;WDR1;TMOD3;PDCD10;CDC42BPG;CDC42BPA
gsea,activation of protein kinase activity (GO:0032147),-0.44744638348917987,-1.5282941942389354,0.02729044834307992,0.052407820438579215,0.997,9/29,19.33%,PAK2;PRKAR1A;MAPKAP1;STK11;COPS8;MARK2;TAOK3;TIRAP;PRKACA
gsea,regulation of cytokine production involved in inflammatory response (GO:1900015),0.5319168169084146,1.5269611076838574,0.04563492063492063,0.11795121708766378,0.993,8/16,20.50%,PLD3;CD6;HIF1A;ADCY7;TICAM1;NOD2;TREM2;CARD9
gsea,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.43202028945295834,1.5242475702003964,0.025440313111545987,0.11719707516347654,0.994,11/33,29.72%,CD6;CD84;CD164;TGFBR2;ITGAL;NPTN;FAT4;MAG;CDH24;PCDHGB4;CDH15
gsea,positive regulation of gene expression (GO:0010628),-0.3259950146844234,-1.5215098207286604,0.006355932203389831,0.054585245108638346,0.997,47/120,30.79%,RBM3;ID2;POLR2K;SF3B1;ELAVL1;GSK3A;IFNGR1;PDCD5;RPS6KB1;SNF8;PRKAG1;KRAS;PCIF1;LIMS1;MAPK1;CIRBP;MAPK3;DTNBP1;PDCL3;SOD1;MAP2K2;RBM22;YTHDF1;LAMTOR5;WBP2;POLDIP3;ERP29;DHX36;UPF3A;PSEN1;MAPK9;DDRGK1;CNTF;GSK3B;STAP1;HMGA2;FXR1;STAT3;LURAP1;MAPK14;CITED1;PDCD10;MED26;PRKAB1;TGFBR1;SCAMP5;TFAP2A
gsea,epithelial cell differentiation (GO:0030855),-0.5160315809176588,-1.5180675809228628,0.04054054054054054,0.055626209328697634,0.998,4/16,26.04%,RAB10;EDF1;AKT2;CITED1
gsea,phagosome maturation (GO:0090382),-0.5123042345905435,-1.5167014235634628,0.058027079303675046,0.05603916605200261,0.998,6/17,15.50%,ATP6V1G1;RAB14;ATP6V1C1;MCOLN1;ATP6V1D;ATP6V1A
gsea,positive regulation of developmental growth (GO:0048639),-0.5155464186637496,-1.5149549046098865,0.05,0.05651640962985706,0.998,4/16,17.46%,DBNL;PPIB;SEMA4D;ITSN2
gsea,extrinsic apoptotic signaling pathway (GO:0097191),0.4460775453906061,1.5140757155369637,0.03621730382293763,0.12249440060881274,0.995,9/27,21.83%,CD27;ITGAV;TNFRSF1B;GABARAP;MCL1;TGFB1;DEDD2;BCL2L2;ACVR1B
gsea,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.43002450923780106,-1.512217848326318,0.043052837573385516,0.05735023519880184,0.998,14/30,22.06%,RBM3;ELAVL1;RPS6KB1;PCIF1;CIRBP;MTPN;YTHDF1;LDB1;POLDIP3;NMD3;UPF3A;STN1;FXR1;AKT2
gsea,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.5110717371634542,1.5088077551076535,0.0465587044534413,0.12402350570380549,0.996,7/17,7.92%,RPS7;RPL23;RPL11;OGT;NOP53;FHIT;EIF3H
gsea,regulation of organelle organization (GO:0033043),-0.4110549796730387,-1.5078055210900148,0.024844720496894408,0.058925846964713875,0.998,16/39,21.67%,MFF;PAK2;MAPK1;PREB;MAPK3;SAR1B;SAR1A;RHOT1;DNM1L;MARK2;PTK2;SIRT7;STX18;SURF4;CPLANE2;TMED9
gsea,positive regulation of macromolecule metabolic process (GO:0010604),0.3359291867848107,1.506255334794409,0.0108499095840868,0.12317453496608369,0.997,101/101,98.38%,LAPTM5;RPS7;CD3E;RPL23;RPL11;RPS3;TNRC6B;HIF1A;LGALS9;ETS1;MSN;PTPN1;TGFB1;PTPN22;CD28;INSR;GBA;TTBK1;MAPK11;LEF1;SLC24A3;TICAM1;PDE2A;SRPK2;FOXD1;AGO3;AGO4;TREM2;ZBTB7B;SLC2A10;TNRC6C;DGKQ;LAMP3;EMILIN1;HPN;FGF23;ANK3;OCLN;GATA2;POU3F1;MAGI2;ITCH;NOS3;PIK3R3;POU4F1;RBPJ;HEY1;CD46;FGF20;EPHX2;STOX1;TLR6;SMO;BRAF;EGF;AVPR2;MYD88;ATF2;EGR1;MBIP;WNT16;MAP2K1;TFAP2A;TGFBR1;PRKAB1;MED26;PDCD10;KLF2;CITED1;MAPK14;STAT3;WFS1;HMGA2;STAP1;GSK3B;CNTF;DDRGK1;MAPK9;PSEN1;DHX36;ERP29;RAB29;VAMP3;LAMTOR5;ATAD1;PDCL3;MAP2K5;MPHOSPH8;DTNBP1;MAPK3;MTPN;MAPK1;LIMS1;KRAS;PRKAG1;ARRB2;SNF8;PDCD5;IFNGR1;GSK3A;ID2
gsea,B cell activation (GO:0042113),-0.5021102513206968,-1.5000373616693858,0.05454545454545454,0.06163201442447692,0.999,7/15,25.31%,TCF3;CEBPG;PTPN2;GPS2;CASP8;JAK3;NHEJ1
gsea,positive regulation of intracellular signal transduction (GO:1902533),-0.31451913964345984,-1.4996162172837622,0.00881057268722467,0.06165011622760949,0.999,56/151,31.40%,HMGB1;RHOA;RAC1;ILK;LAMTOR1;SEC13;RHEB;HDAC3;TRIM27;GOLT1B;GRB2;VAPA;BCAP31;BRD4;SLC35B2;FKBP1A;LIMS1;TRAF7;LCK;LAMTOR4;TRADD;CASP8;LAMTOR3;LAMTOR5;IQGAP1;NMI;RBCK1;CANT1;DNM1L;NDFIP2;DHX36;LAMTOR2;SEMA4D;CCDC22;UBE2V1;RTKN2;TBK1;ATP2C1;TIRAP;PTK2;BECN1;AKT2;TRIM68;ZCCHC3;SHARPIN;LURAP1;VAV1;RELA;P2RY12;IRAK1;OSBPL8;TGFBR1;RRAGC;TFG;CDK5RAP3;MUL1
gsea,protein targeting to membrane (GO:0006612),-0.40178134290775114,-1.498312209522068,0.03418803418803419,0.0619911888648244,0.999,15/39,26.42%,YIF1B;SRP19;SSR1;ZDHHC3;ATG3;ATAD1;ARL6;SGTA;SEC63;SDCBP;PEX14;PEX11B;ZDHHC4;PEX19;PXMP4
gsea,Rho protein signal transduction (GO:0007266),-0.4882025286145565,-1.4954582513915469,0.051440329218107,0.0629432162441051,1.0,6/19,22.48%,RHOA;CDC42;ARHGEF1;WAS;ARHGAP4;CTNNAL1
gsea,positive regulation of cell-substrate adhesion (GO:0010811),-0.4700935481180507,-1.4945678747871953,0.06560636182902585,0.06318297570817258,1.0,12/22,36.11%,RAC1;CDC42;ILK;LIMS1;CRKL;GSK3B;SKAP1;CARMIL1;CSPG5;CIB1;ECM2;LIMS2
gsea,protein tetramerization (GO:0051262),-0.5080985391896068,-1.4918560812471862,0.05947955390334572,0.06408688574197971,1.0,4/16,11.76%,NUDT21;SSBP1;CPSF7;MCOLN1
gsea,amide biosynthetic process (GO:0043604),-0.5025478943327022,-1.4897873317279198,0.058212058212058215,0.06483514494404495,1.0,6/17,21.11%,SPTSSA;CERS2;CERS5;SPTLC2;CLN8;SPTLC1
gsea,cholesterol homeostasis (GO:0042632),-0.47430240918034994,-1.4897817363873977,0.05465587044534413,0.06458768255876235,1.0,6/18,26.17%,RALY;LAMTOR1;TTC39B;LRP5;NR1H2;CYP39A1
gsea,sterol homeostasis (GO:0055092),-0.47430240918034994,-1.4897817363873977,0.05465587044534413,0.06458768255876235,1.0,6/18,26.17%,RALY;LAMTOR1;TTC39B;LRP5;NR1H2;CYP39A1
gsea,phosphatidylinositol metabolic process (GO:0046488),-0.4009862583665986,-1.488512460448717,0.039014373716632446,0.06501519811017548,1.0,20/38,38.90%,IMPA1;RAB14;ARF1;MTMR9;MTMR2;PLAAT3;ARF3;PIP4P1;PTEN;MBOAT7;PIP4P2;PIP4K2A;PIP4K2C;PLA2G4C;PLCB3;MTMR6;PIK3C2B;OCRL;PIGW;PLEKHA4
gsea,negative regulation of intracellular signal transduction (GO:1902532),-0.3599651627729783,-1.4867885228354136,0.02608695652173913,0.06557926474339987,1.0,28/63,33.43%,GSK3A;NDUFS3;ARRB2;GSTP1;CASP8;PDCD6;PPP2R5C;CYLD;RIOK3;NMI;PPM1B;SLA2;CCDC22;NPRL2;PSMD10;ADIPOR1;RTKN2;PYCARD;PTEN;RNF34;MAPK14;RELA;MUL1;ZMYND11;WTIP;MARK3;PPM1A;CIB1
gsea,protein import into nucleus (GO:0006606),-0.4988063918695994,-1.485480512167809,0.05622489959839357,0.06601931284542051,1.0,9/16,25.52%,TPR;NUP50;SEC13;APPL1;NXT2;KPNA4;STAT3;RANBP17;NUP62CL
gsea,sulfur compound catabolic process (GO:0044273),-0.4877746581495108,-1.483260528372155,0.06719367588932806,0.06680022652961741,1.0,8/16,36.08%,HEXB;ACAT1;MPST;OGN;OMD;CSPG5;TST;FITM2
gsea,regulation of endocytosis (GO:0030100),-0.46383074378025674,-1.4822280342928758,0.05263157894736842,0.06709890987147585,1.0,6/22,15.41%,AP2S1;RAB5C;SNX17;SNX12;MTMR2;RAB4B
gsea,regulation of programmed cell death (GO:0043067),0.4024678977558389,1.4807582633531977,0.041666666666666664,0.1419287120982546,0.998,13/40,17.99%,CD3E;TPT1;BNIP3L;RPS3;NOP53;RAF1;CASP6;IKZF3;BCL2L14;RTN4;MARK4;ZBTB7A;HS1BP3
gsea,response to interleukin-1 (GO:0070555),0.4847550537626938,1.4800446341876412,0.05273069679849341,0.1395670486145776,0.998,8/18,23.00%,IRAK2;HIF1A;LGALS9;IGBP1;MAPK11;RC3H1;HYAL1;SRC
gsea,positive regulation of cellular catabolic process (GO:0031331),-0.38894770076531376,-1.4797373148722195,0.026,0.06792586625655943,1.0,16/47,25.16%,HMGB1;GSK3A;TRIM27;SH3GLB1;GTPBP1;STK11;CNOT7;CNOT8;KAT5;PSEN1;NPRL2;GSK3B;AKT2;TRIM68;ABHD5;PNPLA2
gsea,sodium ion transport (GO:0006814),-0.5026826226989315,-1.4784017492497852,0.03837953091684435,0.06837409604132279,1.0,6/16,33.00%,NDUFA9;ATP1B3;HCN2;PKD2;SLC5A2;SLC24A1
gsea,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.47278912841988285,-1.4767346550605436,0.046464646464646465,0.06898267633078203,1.0,7/18,18.96%,BEX3;MTCH1;LCK;TRADD;DIABLO;CASP8;PYCARD
gsea,chemical synaptic transmission (GO:0007268),-0.3533590052625112,-1.4756297429727243,0.029350104821802937,0.06934161884741236,1.0,23/66,39.23%,CALM1;PAFAH1B1;PRKAR1A;MAPK1;SYNJ2BP;SDCBP;NAPA;CAMK4;DNAJC5;CDK5;PRKACA;PTEN;STXBP2;DVL1;SNCB;RPS6KA1;TBC1D24;DLG1;SLC1A1;BSN;GALR3;NQO1;AMPH
gsea,negative regulation of growth (GO:0045926),0.41639899452474444,1.4711024957648347,0.02531645569620253,0.144728460856667,0.998,14/33,21.83%,BTG1;VGLL4;NDUFA13;CDKN1B;TGFB1;FLCN;SERTAD2;ING4;BMPR2;PRDM11;RTN4;HYAL1;SMAD4;ACVR1B
gsea,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.414714761614143,-1.4696629649398636,0.032520325203252036,0.07164902253585115,1.0,14/32,29.03%,RHOA;PDCD5;ARRB2;FKBP1A;LIMS1;SMAD2;APPL1;FNTA;CRKL;PARD6A;PTK2;CITED1;ZFYVE9;TGFBR1
gsea,regulation of protein ubiquitination (GO:0031396),-0.3811383568066573,-1.466703783317584,0.044897959183673466,0.07276304329588154,1.0,19/45,21.87%,CENPX;UBE2L3;COMMD1;GSK3A;UBXN1;HDAC3;ARRB2;FKBP1A;DERL1;USP4;SENP2;CHP1;NDFIP2;UBE3A;PSMD10;WASHC1;SIRT7;VPS28;WFS1
gsea,positive regulation of apoptotic signaling pathway (GO:2001235),-0.46983534494819457,-1.46658630016225,0.08125,0.07271558817361809,1.0,8/20,20.72%,PAK2;BCAP31;TRAF7;LCK;CYLD;DNM1L;PYCARD;BECN1
gsea,regulation of translation (GO:0006417),-0.3897753101770827,-1.4660566238266484,0.04483430799220273,0.07279106563313116,1.0,24/45,23.08%,RBM3;ELAVL1;RPS6KB1;PCIF1;CIRBP;MTPN;DAPK3;EIF1B;CNOT7;EIF2B2;MALSU1;YTHDF1;EIF1;CNOT8;EIF4E2;LSM14A;POLDIP3;DHX36;UPF3A;SAMD4B;MTRF1;FXR1;PAIP1;RBM4
gsea,phosphatidylinositol biosynthetic process (GO:0006661),-0.3773050483887387,-1.462415655188282,0.035343035343035345,0.07428004330875373,1.0,17/46,24.40%,IMPA1;RAB14;ARF1;DPM3;MTMR9;MTMR2;ARF3;DPM2;SLA2;EFR3B;PIGO;EFR3A;PTEN;MBOAT7;DPM1;PIP4K2A;PIP4K2C
gsea,positive regulation of cell adhesion (GO:0045785),-0.4598294660244864,-1.4623083593914545,0.06756756756756757,0.07420181468728844,1.0,9/21,36.39%,RAC1;CD47;LIMS1;PPP3CA;P2RY12;MAGI1;CIB1;ECM2;ZFHX3
gsea,positive regulation of T cell activation (GO:0050870),0.48501535902242665,1.4615121087747702,0.0670611439842209,0.1506200376647935,0.998,9/21,19.32%,CD3E;CD6;PTPRC;LGALS9;PRKCQ;CD28;ZAP70;IL15;NOD2
gsea,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.4864225691599919,-1.459658853381464,0.062,0.0753258338398755,1.0,4/17,18.01%,CALM1;GNB1;GNG2;PPP3R1
gsea,negative regulation of cellular process (GO:0048523),-0.31230285585207984,-1.458740188867464,0.008064516129032258,0.07558338718476222,1.0,54/143,34.51%,FOXM1;SNX3;CSNK2B;PDCD5;PPP2CA;CTBP1;NDUFS3;PTPN2;ATG5;TXNDC12;STK11;CNOT7;CHMP2A;MALSU1;RUNX3;PPP2R5C;PPM1D;NMI;VPS4B;CRLF3;PPP2R1A;COPS8;ANXA6;VAMP3;PDE12;SEMA4D;CDK10;LPCAT3;CAPRIN2;SIRT7;SIPA1;BECN1;PTEN;WFS1;NR1H2;NDRG3;PIP4P2;CASK;ADAM10;NAIF1;TMEM115;DACT3;NR4A1;CBLL1;PKD2;TFAP2A;MUL1;PIWIL4;MAP2K1;CIB1;ADAM22;SERTAD3;WNT16;PTPRU
gsea,response to reactive oxygen species (GO:0000302),-0.4403917478207683,-1.4575034171596504,0.05942622950819672,0.07596161355451918,1.0,12/24,30.10%,MAPK1;MAPK3;GSTP1;STK24;SOD1;GLRX2;STK26;ROMO1;MAPK9;STK25;PDCD10;PKD2
gsea,positive regulation of T cell proliferation (GO:0042102),-0.4854760840966994,-1.4565444753972698,0.0673469387755102,0.0762637394886664,1.0,5/17,24.70%,HMGB1;PNP;PYCARD;JAK3;IL12RB1
gsea,innate immune response (GO:0045087),-0.3754036077926257,-1.45528438515132,0.027253668763102725,0.0766548600908024,1.0,14/50,27.57%,HMGB1;RNF187;TRIM27;CAPZA1;LCK;CYLD;MSRB1;TBK1;PTK2;TRIM68;OTULIN;RELA;CITED1;IRAK1
gsea,protein localization to plasma membrane (GO:0072659),-0.3712483394719977,-1.449937338315042,0.038135593220338986,0.07895499704078192,1.0,12/46,27.99%,RAB10;RAB11A;RAB8A;ZDHHC3;ATP1B3;PPIL2;RAP1A;EFR3B;EFR3A;ASB3;KCNB1;RAPGEF6
gsea,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.42537881797302995,-1.448411043544802,0.06625258799171843,0.07946977542293192,1.0,8/28,29.03%,CSNK2B;STK11;SNW1;SMAD2;SDCBP;ING2;CITED1;TGFBR1
gsea,cellular iron ion homeostasis (GO:0006879),-0.4803847383727231,-1.4469541010017621,0.08754863813229571,0.08001975213256636,1.0,7/18,15.50%,ATP6V1G1;BOLA2;NEDD8;SOD1;ERFE;ISCU;ATP6V1A
gsea,regulation of cell adhesion (GO:0030155),0.4014864693309008,1.4455939850990585,0.05357142857142857,0.162998588562572,0.999,16/35,36.82%,ITGAV;CD164;ARHGDIB;RAC2;IL18;FLCN;PRKX;PPP1R12A;RHOD;HYAL1;SRC;RND1;CYTIP;MDK;STX3;PLXNA3
gsea,response to insulin (GO:0032868),-0.4310159963996669,-1.4426648387067942,0.04468085106382979,0.08201739159329052,1.0,10/25,36.76%,GSK3A;RAB10;RPS6KB1;RAB8A;AKT2;CITED1;USF1;MEAK7;GCK;SYAP1
gsea,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.44671644436028235,-1.4363726130089578,0.06504065040650407,0.0848821288913033,1.0,7/20,27.38%,RAB10;RAB8A;TBCD;CDK5;DVL1;MEF2A;CELSR2
gsea,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.49396722184672137,-1.4359406938540384,0.06756756756756757,0.08491833541418184,1.0,7/15,18.57%,GRB2;GSTP1;SOD1;ITGB2;ROMO1;DHRS4;F2
gsea,positive regulation of epithelial cell migration (GO:0010634),-0.43563212543431673,-1.4298145800911441,0.07453416149068323,0.08789624916995707,1.0,6/23,14.96%,RAC1;ARF6;RAB11A;EMC10;PDCD6;MAPRE2
gsea,cellular response to nutrient levels (GO:0031669),0.4519762029994306,1.4268513481175058,0.06868686868686869,0.17886582831674858,1.0,7/20,16.39%,MAP1LC3B;FOXO1;FLCN;RRAGA;MAP1LC3A;BMPR2;LAMP2
gsea,regulation of protein-containing complex assembly (GO:0043254),-0.42810893176495063,-1.4258360628414979,0.047619047619047616,0.08979165468380285,1.0,12/27,19.77%,CDC42;SH3GLB1;PREB;LCMT1;SAR1B;SUMO1;SAR1A;RIOK3;NAPA;GSK3B;TIRAP;BRK1
gsea,peroxisome organization (GO:0007031),-0.4805271187896745,-1.4250350494068682,0.08057851239669421,0.09006942113605546,1.0,7/15,25.62%,MFF;PLAAT3;DNM1L;PEX14;PEX11B;ACOT8;PEX19
gsea,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4552177031544222,1.4226741092096407,0.07827788649706457,0.17976558380124674,1.0,6/19,22.07%,IRAK2;UBC;UBA52;IKBKB;TICAM1;NKIRAS1
gsea,cytoskeleton-dependent cytokinesis (GO:0061640),-0.44451318154989417,-1.421646536854814,0.09467455621301775,0.09165201242850286,1.0,7/20,26.75%,RHOA;DCTN3;PDCD6IP;VPS4A;RAB35;MITD1;SON
gsea,tight junction assembly (GO:0120192),-0.46167575417886886,-1.4190941557782888,0.07524752475247524,0.09269289237483641,1.0,5/16,24.74%,PAK2;PDCD6IP;TBCD;PARD6A;CLDN7
gsea,bicellular tight junction assembly (GO:0070830),-0.46967241661619025,-1.41771731700469,0.08282828282828283,0.09324362426624812,1.0,5/15,24.74%,PAK2;PDCD6IP;TBCD;PARD6A;CLDN7
gsea,positive regulation of cellular protein metabolic process (GO:0032270),-0.38373066189577215,-1.417406132012774,0.04633204633204633,0.09326739867504485,1.0,14/36,22.82%,RBM3;AURKAIP1;ELAVL1;RPS6KB1;PCIF1;CIRBP;CYFIP2;CASP8;YTHDF1;ASPSCR1;POLDIP3;UPF3A;FXR1;NR1H2
gsea,phosphatidylinositol-mediated signaling (GO:0048015),-0.42847722639342856,-1.4152918405629067,0.0823045267489712,0.09423617584466236,1.0,8/22,36.44%,RHOA;RPS6KB1;TYRO3;PTEN;EXOC1;LTK;PLCB3;PIK3C2B
gsea,positive regulation of vasculature development (GO:1904018),0.47883438268061457,1.414906894787605,0.0817490494296578,0.1845681131009701,1.0,8/17,35.88%,BTG1;HIF1A;ETS1;RRAS;HYAL1;EPHA1;SASH1;GATA2
gsea,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.4903669798573561,-1.4134931424542077,0.09202453987730061,0.0949384241983553,1.0,7/15,22.82%,PTPN2;GPS2;GSTP1;YTHDF2;CNOT7;STAP1;NR1H2
gsea,supramolecular fiber organization (GO:0097435),-0.3309414017195219,-1.4124948592172195,0.03909465020576132,0.09534840678080944,1.0,32/79,38.97%,RHOA;RAC1;MAD2L2;CDC42;FKBP1A;GGA1;PPIB;CHP1;NCSTN;VPS4B;TMOD3;SLAIN2;KATNA1;CRIPT;KATNAL1;ADAM10;APH1A;TGFBR1;KATNAL2;CARMIL1;COL23A1;TLE6;TPM2;CIB1;MAPT;CORO1B;DLG1;LOXL3;BIN3;SIAH2;BMP1;COL5A1
gsea,regulation of organelle assembly (GO:1902115),-0.40144998952666905,-1.4110339020129576,0.06342494714587738,0.09593167766512363,1.0,18/31,34.38%,TSG101;RNF4;ATG5;ATG3;PDCD6IP;TBC1D15;CYLD;TBC1D19;RAB1B;NPRL2;TBC1D9B;STX18;UBQLN2;SENP6;TBC1D10A;TBC1D2B;TBC1D24;RABEP2
gsea,response to cytokine (GO:0034097),0.3802657807257335,1.4103967631161451,0.05813953488372093,0.18593477852580995,1.0,16/38,29.04%,PTPN18;IRAK2;LGALS9;SP100;IGBP1;MCL1;PTPN4;LDLRAP1;LEF1;MAP4K3;IL18BP;SRC;GGT7;LAMP3;TRIM32;IL1RL2
gsea,regulated exocytosis (GO:0045055),-0.36941449529615417,-1.4087650265827698,0.05543710021321962,0.09697904596833044,1.0,15/45,22.72%,CALM1;TMED10;RAB11B;RAB10;WDR1;SOD1;VTI1B;DNAJC5;TLN1;CD109;CDK5;GTPBP2;APOOL;STXBP2;RIMS3
gsea,regulation of cation channel activity (GO:2001257),-0.449911138190192,-1.408051058674341,0.08974358974358974,0.09723611027262824,1.0,9/19,40.76%,CALM1;FKBP1A;PRKACA;DMD;CACNG8;DLG1;CACNG7;CAPN1;PDE4D
gsea,sterol metabolic process (GO:0016125),-0.47848512242655206,-1.4064660416078845,0.08806262230919765,0.09789085114742978,1.0,6/16,26.17%,EBP;PIP4P1;CLN8;STARD3;OSBPL1A;CYP39A1
gsea,negative regulation of protein ubiquitination (GO:0031397),0.4595455803466252,1.4059642407037911,0.09533468559837728,0.18738972054470002,1.0,5/17,10.75%,SQSTM1;RPS3;OGT;SVBP;SOX4
gsea,positive regulation of angiogenesis (GO:0045766),0.45384194872462796,1.4049820172898115,0.08015267175572519,0.18513507875682084,1.0,10/20,35.88%,BTG1;HIF1A;ETS1;RRAS;JAK1;HYAL1;EPHA1;SASH1;MDK;GATA2
gsea,neurotransmitter transport (GO:0006836),0.45349035275471444,1.4044801917337575,0.07222222222222222,0.1824029991427082,1.0,7/20,17.96%,VAMP2;SNAPIN;TSPOAP1;SLC29A4;SLC28A2;LIN7C;RAB3A
gsea,JNK cascade (GO:0007254),0.4474366054573365,1.3965714981001962,0.09166666666666666,0.18757022498577844,1.0,8/21,25.68%,IRAK2;UBC;UBA52;NOD1;MAP4K3;NOD2;MAP3K10;DUSP9
gsea,protein localization to cell periphery (GO:1990778),-0.3525947060033604,-1.3960995787341908,0.0614406779661017,0.10359309363629057,1.0,22/49,42.88%,RAB10;RAB11A;RAB8A;ZDHHC3;ATP1B3;RAB29;PPIL2;RAP1A;EFR3B;EFR3A;RABEP1;KCNB1;RAPGEF6;PDZK1;DLG1;ARL3;KCNIP3;PIGW;SLC9A3R1;RAB3B;TMEM88;PRAM1
gsea,positive regulation of mRNA catabolic process (GO:0061014),-0.47682005629504504,-1.3889271869222286,0.08113207547169811,0.10742665874665085,1.0,7/15,16.09%,POLR2G;GTPBP1;YTHDF2;CNOT7;YTHDF1;CNOT8;DHX36
gsea,positive regulation of intracellular transport (GO:0032388),-0.455133674836571,-1.3857575520936851,0.10736842105263159,0.10913612050212586,1.0,9/17,26.61%,TPR;OAZ1;STK11;RAB29;CEP131;STX18;B3GAT3;EIPR1;PDCD10
gsea,positive regulation of secretion by cell (GO:1903532),-0.44528445562650937,-1.3835136971122621,0.09645669291338582,0.11024142754755277,1.0,10/19,30.76%,TMED10;ARF6;DTNBP1;IER3IP1;DNM1L;EXOC1;GOLPH3L;ATP6AP1;KCNB1;UNC13D
gsea,protein processing (GO:0016485),-0.4044029325361239,-1.3780873690342899,0.1,0.1132766896173935,1.0,14/27,32.98%,SEC11C;SPCS1;SEC11A;RCE1;NCSTN;PSEN1;TMEM208;ECE2;SDE2;PCSK7;ADAM10;APH1A;SPCS2;CASP2
gsea,negative regulation of protein binding (GO:0032091),-0.4347676125680552,-1.3780339717701189,0.0899581589958159,0.11310761215300377,1.0,9/19,21.94%,PPP1CA;ARRB2;KDM1A;PEX14;STYX;GSK3B;MITD1;DVL1;CTNNBIP1
gsea,negative regulation of immune response (GO:0050777),-0.3594858286647457,-1.377576877604531,0.06753812636165578,0.11315521885640747,1.0,11/45,24.93%,PCBP2;GNB1;TRIM27;PRKAR1A;NMI;PPM1B;GNG2;RNF26;PRKACA;TYRO3;MAPK14
gsea,cell-matrix adhesion (GO:0007160),-0.3749941265651224,-1.374237865516587,0.07991360691144708,0.11510567177508191,1.0,13/35,40.72%,RAC1;ILK;TIMM10B;ITGB2;MKLN1;TESK2;PARVG;THSD1;ECM2;PKD1;ZYX;VWA2;STRC
gsea,second-messenger-mediated signaling (GO:0019932),-0.4733245853798363,-1.3741290665751849,0.11949685534591195,0.11496083607624051,1.0,4/15,27.25%,PPP2CA;PPP2R1A;LAT;P2RY12
gsea,regulation of small GTPase mediated signal transduction (GO:0051056),-0.34748282239789596,-1.3705257641828414,0.08024691358024691,0.117060360711788,1.0,20/53,36.99%,FOXM1;RHOA;RAC1;CDC42;ARHGEF1;ARHGAP33;RALBP1;ARHGAP18;DEPDC7;RHOT1;ARHGAP4;CHN1;VAV1;ARHGEF6;ARHGAP29;STARD8;FGD1;TIAM2;ARHGEF16;OCRL
gsea,protein-containing complex subunit organization (GO:0043933),-0.37921722332338786,-1.370254236144899,0.08842105263157894,0.1170213934679855,1.0,16/35,28.31%,TPR;GPAA1;ELOB;CAPZA1;IL2RB;PPP2R1A;SKAP2;VAMP3;DNM1L;PEX14;WAS;MNAT1;RANBP9;NAPG;DET1;TAPBP
gsea,cellular response to UV (GO:0034644),-0.4003796490643987,-1.3684386964439315,0.10547667342799188,0.11788344316235243,1.0,11/24,32.59%,KDM1A;ERCC1;STK11;YY1;DHX36;TRIAP1;COPS9;SDE2;TMEM161A;OPN1SW;ACTR5
gsea,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.39136270928095573,1.3669363276533673,0.09601449275362318,0.216950649420309,1.0,13/32,24.01%,HCST;NOP53;IL18;INSR;PIP5K1A;LIME1;IGF1R;HGF;FBXL2;TREM2;PPP2R5B;SRC;FGFR1
gsea,protein stabilization (GO:0050821),-0.3427799097750737,-1.366507908403558,0.06465517241379311,0.11886846824796164,1.0,24/55,31.40%,BAG1;CCNH;CDC37;BAG6;SUGT1;ATP1B3;PDCL3;SUMO1;MORC3;STX12;PPIB;MTMR9;CHP1;DNLZ;HYPK;PTEN;DVL1;WFS1;NAPG;PEX19;PDCD10;CDC37L1;HPS4;MUL1
gsea,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.45468345699148854,-1.3664051888997018,0.1148936170212766,0.11873592130858474,1.0,8/17,20.72%,NDUFS3;BCAP31;LCK;CYLD;DNM1L;RTKN2;PYCARD;BECN1
gsea,regulation of cell cycle (GO:0051726),-0.31939695712702304,-1.3633501031742405,0.041749502982107355,0.12026489307483149,1.0,40/83,33.75%,FOXM1;ID2;CSNK2A1;CTBP1;CDK9;SRA1;DAPK3;CDK11B;MAEA;STK11;RUNX3;CYLD;IQGAP1;SDCBP;CRLF3;CDC26;MED25;LIN52;PRCC;CDK5;PRKACA;CDK10;SIPA1;RASSF1;HMGA2;AKT2;UHRF2;STAT3;LIN37;ADAM10;FBXL6;SON;CDC14B;NR4A1;TGFBR1;BIN1;PKD2;CDK5RAP3;MAP2K1;USP51
gsea,fatty acid oxidation (GO:0019395),-0.4267723991293708,-1.363258155101475,0.10404624277456648,0.12011291018390756,1.0,6/21,17.40%,AUH;ECHS1;ACAT1;HADHB;HADHA;ADIPOR1
gsea,erythrocyte differentiation (GO:0030218),-0.47868260773439714,-1.3622866889509297,0.11478599221789883,0.12049092746723371,1.0,4/15,9.18%,ID2;CEBPG;PTPN2;ACIN1
gsea,cholesterol metabolic process (GO:0008203),-0.45063212979553546,-1.3622724296280075,0.10211946050096339,0.12028970681348079,1.0,6/18,20.37%,EBP;SNX17;PIP4P1;CLN8;STARD3;OSBPL1A
gsea,negative regulation of macromolecule metabolic process (GO:0010605),0.3376620861472022,1.3580122277733941,0.0735009671179884,0.22389884029962304,1.0,30/57,37.47%,CD3E;NDFIP1;TNRC6B;HIF1A;LGALS9;FOXP1;TGFB1;PTPN22;CD28;FLCN;TTBK1;SFMBT2;SLC24A3;ANKRD13D;RIN3;DLG4;AGO3;AGO4;ANKRD13B;ESR1;VHL;TERT;ATOH8;SLC2A10;TNRC6C;DGKQ;EMILIN1;OCLN;GATA2;LRPAP1
gsea,regulation of insulin receptor signaling pathway (GO:0046626),-0.44618131914110004,-1.356900654620625,0.1079913606911447,0.12346098573425669,1.0,6/18,24.40%,GSK3A;RPS6KB1;PTPN2;ERFE;PIP4K2A;PIP4K2C
gsea,cellular response to interferon-gamma (GO:0071346),0.43698328712387186,1.3526518486092125,0.11740890688259109,0.22660524289417375,1.0,7/20,12.12%,RPL13A;B2M;LGALS9;SP100;JAK1;IRF9;TRIM62
gsea,cellular response to peptide hormone stimulus (GO:0071375),-0.38070285837537243,-1.3520385173837404,0.08641975308641975,0.12630303444628393,1.0,13/32,39.45%,GSK3A;PRKAR1A;RAB10;RPS6KB1;RAB8A;PRKACA;AKT2;RELA;NR4A1;USF1;GCK;SYAP1;ADCY3
gsea,positive regulation of multicellular organismal process (GO:0051240),-0.31445200690597197,-1.3519310239654234,0.05421686746987952,0.12618536877836178,1.0,28/76,43.07%,EZH2;MAD2L2;HDAC3;KDM1A;SOD1;PPIB;SMAD2;SDCBP;CNOT3;HMCES;ADIPOR1;NR2C2;LURAP1;SNX4;PRKAB1;PEMT;TGFBR1;SCAMP5;FOXJ1;TLE6;BMPR1A;ADIPOR2;UCP2;BMP1;AVPR2;EGF;RPS19;SMO
gsea,negative regulation of programmed cell death (GO:0043069),-0.30905199706871234,-1.3509206485472804,0.06134969325153374,0.12665652059099733,1.0,47/97,33.43%,GPX4;DCPS;BAG1;BNIP2;NAA38;CIAPIN1;YWHAZ;HDAC3;PAK2;RPS6KB1;BABAM2;TAX1BP1;ZFAND6;GSTP1;DNAJC3;PRDX2;GLO1;TOPORS;IL2RB;UFM1;UBE2Z;HYPK;MIEN1;SEMA4D;PSEN1;TRIAP1;PSMD10;DDRGK1;GSK3B;PTK2;HMGA2;TMBIM4;WFS1;AKT2;ADAM10;RELA;ARAF;PDCD10;SON;HTATIP2;IRAK1;COMP;RPS6KA1;TFAP2A;LTK;CASP2;CIB1
gsea,cellular protein catabolic process (GO:0044257),-0.43236536658480074,-1.3489158452515713,0.12103174603174603,0.12766740895010867,1.0,7/20,24.25%,AP2S1;AP2M1;CLTA;AP2A1;CASP8;UBE2G1;RSPRY1
gsea,regulation of secretion by cell (GO:1903530),-0.4550656903877254,-1.3450620914005316,0.14392523364485982,0.12998566774360243,1.0,6/15,21.19%,RAB10;RAB8A;VAMP3;DNAJC1;CPLANE2;ARFIP1
gsea,cellular response to oxidative stress (GO:0034599),-0.37277043157725775,-1.339582627402116,0.11042944785276074,0.13351567732879546,1.0,17/35,34.17%,CHCHD2;MAPK1;MAPK3;GSTP1;SOD1;ROMO1;PRDX2;NUDT2;VRK2;PRDX6;MAPK9;NCF4;MSRA;TMEM161A;PKD2;MAPT;WNT16
gsea,positive regulation of cytokine production (GO:0001819),-0.325010790286326,-1.3393198653715166,0.08134920634920635,0.13344121590120564,1.0,26/72,29.42%,HMGB1;TMED10;POLR2K;TRIM27;CEBPG;PNP;SOD1;POLR3C;LAMTOR5;APPL1;RAB1A;DHX36;IRF3;TBK1;TIRAP;PYCARD;PQBP1;CRCP;LRRFIP1;STAT3;LURAP1;IL12RB1;MAPK14;RELA;IRAK1;SCAMP5
gsea,cellular calcium ion homeostasis (GO:0006874),-0.3896113472180407,-1.3382720569443418,0.08764940239043825,0.1338503445970046,1.0,15/28,25.57%,TMCO1;SMDT1;SLC10A7;MICU2;MICU1;ANXA6;TMEM165;PSEN1;F2;ATP2C1;MAIP1;PRKACA;STIM1;WFS1;VAPB
gsea,lymphocyte differentiation (GO:0030098),-0.4413090949267588,-1.3369706207298404,0.11042944785276074,0.1345664481571499,1.0,8/18,25.31%,TCF3;CEBPG;PTPN2;GPS2;LCK;TOX;JAK3;NHEJ1
gsea,carbohydrate homeostasis (GO:0033500),-0.4135241787540205,-1.3347505282917975,0.10980392156862745,0.1358701575615199,1.0,10/22,28.24%,PTPN2;RPS6;STK11;ADIPOR1;CRTC2;SELENOT;WFS1;STAT3;KCNB1;USF1
gsea,regulation of angiogenesis (GO:0045765),0.38654039404119367,1.3345850766433354,0.11005692599620494,0.24516169594907117,1.0,17/32,42.03%,BTG1;HIF1A;SP100;ETS1;RRAS;KRIT1;HYAL1;EPHA1;EMILIN1;CTNNB1;SASH1;SEMA3E;FOXC1;GATA2;YJEFN3;MINAR1;PPP1R16B
gsea,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.41059324667579383,1.334574480869367,0.11608961303462322,0.24140491042814421,1.0,13/24,26.46%,PTPRC;ARL2BP;PTPN1;TGFB1;IL18;TNFRSF14;DLG3;HGF;IL15;DLG4;TREM2;SRC;DGKQ
gsea,nitrogen compound transport (GO:0071705),0.35865453103387623,1.3267708294194476,0.10820895522388059,0.2472967605177035,1.0,17/39,31.83%,CD3G;ARL6IP5;VAMP2;TOM1;CHMP1B;SLC29A4;SLC36A1;CHMP1A;RD3;CHMP2B;SLC6A19;SLC18A1;RILP;PPT1;SLC7A4;ARRDC2;SLC18A2
gsea,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.3240808583072148,-1.3263621481104906,0.08921161825726141,0.1417479586309638,1.0,30/61,37.77%,RHOA;TRIM27;GOLT1B;VAPA;BRD4;SLC35B2;FKBP1A;TRADD;CASP8;LAMTOR5;RBCK1;CANT1;NDFIP2;DHX36;CCDC22;UBE2V1;TBK1;ATP2C1;TIRAP;TRIM68;SHARPIN;LURAP1;RELA;IRAK1;TFG;MUL1;PPM1A;TMEM9B;TNFRSF19;TAB2
gsea,negative regulation of MAPK cascade (GO:0043409),-0.38744662421440856,-1.322753757012161,0.11422845691382766,0.1440578904347728,1.0,9/28,21.14%,FOXM1;PTPN2;GSTP1;SYNJ2BP;PSMD10;STK38;RGS14;PTEN;RANBP9
gsea,cellular response to chemical stress (GO:0062197),-0.40812266646850726,-1.3164152962300013,0.13807531380753138,0.1484587076750254,1.0,10/24,24.07%,CHCHD2;GSTP1;SOD1;PRDX2;NUDT2;VRK2;PRDX6;NCF4;MSRA;TMEM161A
gsea,negative regulation of metabolic process (GO:0009892),-0.4279905537004151,-1.3149836424665489,0.12394957983193278,0.14928024387623334,1.0,6/19,28.63%,RHEB;GSTP1;STK11;PGAM5;NR1H2;ACOT13
gsea,cellular response to peptide (GO:1901653),0.4429630018535846,1.3144842348941137,0.1316270566727605,0.2595560840142819,1.0,11/18,23.00%,RPL23;PTPN22;NOD1;FYN;IGF1R;AGER;CACNB1;NOD2;TREM2;LRP1;SRC
gsea,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.45563565558925584,1.3131648685712114,0.15145631067961166,0.257490035958606,1.0,9/15,27.54%,TPT1;NDUFA13;MCL1;TMBIM6;PTTG1IP;SNAI1;BCL2L2;SRC;TRIM32
gsea,lipid transport (GO:0006869),-0.4047095775993517,-1.3111847004682293,0.11394891944990176,0.15173558225000014,1.0,7/23,28.61%,GLTP;PITPNA;TRIAP1;CLN8;SLC10A1;PEX19;OSBPL8
gsea,negative regulation of cell growth (GO:0030308),0.36275139311333465,1.3078965091934658,0.12550607287449392,0.26072625144704803,1.0,18/35,34.53%,BTG1;VGLL4;NDUFA13;CDKN1B;TGFB1;FLCN;SERTAD2;RNF6;BMPR2;PRDM11;RTN4;HYAL1;SMAD4;ACVR1B;MAG;PPT1;DIP2B;ADAM15
gsea,response to UV (GO:0009411),-0.38470265447450075,-1.3048224917829794,0.12298387096774194,0.15625673972146784,1.0,12/26,28.24%,UBE2A;CIRBP;KDM1A;YY1;DHX36;TRIAP1;COPS9;SDE2;MAP2K7;TMEM161A;RELA;USF1
gsea,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.4466706462927999,-1.30437395905153,0.13549618320610687,0.1563202770744742,1.0,7/15,25.64%,CNOT11;CNOT6;CNOT7;CNOT8;CNOT3;TRIAP1;CNOT2
gsea,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.42901774067234044,-1.3020854644561415,0.1431297709923664,0.15768855743140953,1.0,8/17,25.64%,CNOT11;CNOT6;CNOT7;CNOT8;CNOT3;TRIAP1;SDE2;CNOT2
gsea,protein maturation (GO:0051604),-0.36998047892192193,-1.3013219791939212,0.1419753086419753,0.15810889470883308,1.0,12/29,27.80%,CIAO2B;BOLA2;CIAO2A;NFU1;NCSTN;ISCA1;PSEN1;ECE2;SDE2;PCSK7;ADAM10;APH1A
gsea,polyol metabolic process (GO:0019751),-0.42012148871858424,-1.2994922054313105,0.1278825995807128,0.15900416081940458,1.0,7/18,28.05%,CALM1;IMPA1;IMPA2;MINPP1;PTEN;NUDT3;ITPKA
gsea,inositol phosphate metabolic process (GO:0043647),-0.42012148871858424,-1.2994922054313105,0.1278825995807128,0.15900416081940458,1.0,7/18,28.05%,CALM1;IMPA1;IMPA2;MINPP1;PTEN;NUDT3;ITPKA
gsea,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4126051037032394,1.2967753472138057,0.16306483300589392,0.27187544857787993,1.0,11/21,34.17%,LAPTM5;CD27;RPS3;LGALS9;NOD1;AGER;NR3C2;NOD2;IFI35;SASH1;EP300
gsea,Golgi to plasma membrane protein transport (GO:0043001),-0.41992245756497104,-1.293105226292607,0.15845824411134904,0.16390709395165096,1.0,6/18,26.37%,RAB10;GGA1;ARFRP1;SYS1;VAMP4;GOLPH3L
gsea,vesicle organization (GO:0016050),0.4374488276308821,1.290872544924943,0.18497109826589594,0.27567004718754484,1.0,8/16,28.05%,SQSTM1;SRGN;WASL;PHETA1;SNX33;CHMP2B;RAB22A;PI4K2A
gsea,regulation of Rho protein signal transduction (GO:0035023),0.4425384802530116,1.289538780116275,0.14285714285714285,0.2735623798887236,1.0,8/16,30.52%,P2RY10;ARHGDIB;AKAP13;FLCN;RAF1;LPAR6;PRAG1;F11R
gsea,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3030847761152628,1.2890585439526112,0.10192307692307692,0.270479769951082,1.0,70/70,96.78%,IRAK2;RPS3;UBC;UBA52;LGALS9;CFLAR;PRKCQ;CAPN3;TRIM13;NOD1;IL18;PRKCH;CRTC3;LPAR5;ARID5B;IKBKB;TICAM1;TRIM62;AGER;ZBTB7A;CRTC1;NOD2;CARD9;ESR1;TRIM32;CTNNB1;IL1RAP;RIPK4;TRIM26;EP300;FER;BCL10;NTRK1;TRAF6;TNFRSF11A;STK36;RNF31;TLR6;ABRA;SMO;HCLS1;RNF25;MYD88;ATF2;TSSK4;TAB2;CIB1;IRAK1;RELA;RPS6KA4;DVL2;STAT3;TRIM68;PTEN;CRTC2;PYCARD;TIRAP;RTKN2;UBE2V1;DDRGK1;AIM2;RBCK1;LAMTOR5;TRADD;KDM1A;MTPN;CEBPG;TRIM27;TCF3;TAF12
gsea,positive regulation of developmental process (GO:0051094),-0.3288799310280435,-1.2873006171720365,0.11482254697286012,0.16826110912491116,1.0,17/46,34.57%,MAD2L2;MFF;ANAPC2;RALBP1;HMCES;DNM1L;PSEN1;NR2C2;DVL1;DVL2;MIEF1;RPS6KA1;TMEM79;MUL1;TLE6;CORO1B;BMPR1A
gsea,negative regulation of cell population proliferation (GO:0008285),-0.29330968379622935,-1.287234805993652,0.07889546351084813,0.16804795380560333,1.0,37/92,44.97%,EMD;CSNK2B;PDCD5;CTBP1;PTPN2;GSTP1;STK11;MORC3;CNOT7;RUNX3;PPP2R5C;PPM1D;NMI;MED25;COPS8;CDK10;OGN;PTEN;ATRAID;CTNNBIP1;TMEM115;MCC;PKD2;TFAP2A;MAP2K1;CIB1;PTPRU;RNF41;TENM1;SLC9A3R1;AVPR2;RBM5;CDKN1C;AQP11;IL12A;B4GALT7;MYO16
gsea,mitotic DNA damage checkpoint signaling (GO:0044773),-0.43974335048691315,-1.286933190546437,0.17647058823529413,0.16800786103088944,1.0,9/15,37.22%,BABAM1;BABAM2;TAOK3;SDE2;HMGA2;CDC14B;CDK5RAP3;UIMC1;RAD9B
gsea,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.3916284140749745,-1.2847120746669451,0.13976377952755906,0.16940281134429955,1.0,10/23,31.48%,PAK2;BCL2L12;GSTP1;TRADD;CASP8;CYLD;PYCARD;RELA;TGFBR1;ZMYND11
gsea,regulation of protein targeting to membrane (GO:0090313),-0.45048653372751707,-1.282729554669117,0.16632016632016633,0.1706934353850511,1.0,8/15,34.28%,MFF;ITGB2;CHP1;AKT2;MIEF1;KCNB1;CIB1;PDZK1
gsea,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.44348604973605826,-1.2823817961938277,0.17130620985010706,0.17069623803767048,1.0,7/15,27.04%,RAC1;ARF6;SDCBP;MTMR2;PSEN1;UBQLN2;ANKRD13A
gsea,positive regulation of Ras protein signal transduction (GO:0046579),-0.44391209882652655,-1.2820268095201752,0.1623931623931624,0.17069626967918403,1.0,6/15,24.97%,RAC1;GRB2;MAPRE2;CRKL;STK19;VAV1
gsea,calcium ion transmembrane transport (GO:0070588),-0.3797827838075803,-1.279913216262301,0.129979035639413,0.17205567311195116,1.0,10/27,21.31%,TMCO1;SMDT1;FKBP1A;MCOLN1;MICU2;MICU1;TMEM165;ATP2C1;MAIP1;TRPM7
gsea,regulation of cell-matrix adhesion (GO:0001952),-0.419355866374184,-1.2798696522370479,0.1530398322851153,0.17180573356031406,1.0,8/18,25.78%,RHOA;PTPRA;DAPK3;LDB1;GSK3B;PTK2;CASK;SKAP1
gsea,histone H4 acetylation (GO:0043967),-0.426724030943343,-1.2781839775702548,0.188715953307393,0.17291705475242952,1.0,6/16,24.33%,MEAF6;MORF4L1;YEATS4;MSL3;ING3;KANSL3
gsea,establishment of protein localization to plasma membrane (GO:0061951),-0.40471000985465966,-1.2734550892852992,0.16367713004484305,0.1767412465845203,1.0,6/20,26.37%,RAB10;GGA1;ARFRP1;SYS1;VAMP4;GOLPH3L
gsea,positive regulation of proteolysis (GO:0045862),0.41796620762928915,1.272847830786519,0.17794970986460348,0.2884759661401485,1.0,7/16,17.50%,TNFRSF1B;OGT;NDUFA13;CAPN3;GBA;SNX33;IST1
gsea,negative regulation of cell death (GO:0060548),-0.3762789313272862,-1.2727471254065348,0.16049382716049382,0.17705473810487576,1.0,11/27,21.87%,DCPS;ATG5;BTBD10;TXNDC12;CHMP2A;VPS4B;PDE12;GSK3B;CDK5;BECN1;WFS1
gsea,positive regulation of transport (GO:0051050),-0.40261846966587395,-1.2703099259303552,0.15113871635610765,0.17895900721265265,1.0,9/22,29.16%,CD47;GSK3A;CHP1;IL2RB;GSK3B;PYCARD;AKT2;TULP1;CBLL1
gsea,canonical Wnt signaling pathway (GO:0060070),0.3944330794642787,1.2689857360630934,0.16182572614107885,0.28995733905690224,1.0,13/23,34.30%,TCF7;NR4A2;RAB5A;FRAT1;LEF1;AMER1;BCL9;FZD6;FZD5;APC;CTNNB1;DVL3;FZD9
gsea,regulation of apoptotic signaling pathway (GO:2001233),-0.42799426137832147,-1.2687665106450907,0.17408906882591094,0.17983587188739936,1.0,5/16,18.96%,CSNK2A1;BCL2L12;TRAF7;CYLD;PYCARD
gsea,negative regulation of proteasomal protein catabolic process (GO:1901799),0.4223737033699173,1.2669919823856124,0.1680327868852459,0.2889007636901622,1.0,9/17,30.53%,RPL11;OGT;NOP53;FHIT;EIF3H;GABARAPL2;RYBP;LAMP3;WAC
gsea,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.29789514383854404,-1.2662087484851594,0.11422413793103449,0.18186037082678122,1.0,42/78,44.77%,RHOA;TRIM27;GOLT1B;VAPA;BRD4;SLC35B2;FKBP1A;ZFAND6;GSTP1;TRADD;CASP8;RIOK3;LAMTOR5;PPM1B;RBCK1;CANT1;NDFIP2;DHX36;CCDC22;UBE2V1;TBK1;ATP2C1;TIRAP;PYCARD;TRIM68;SHARPIN;LURAP1;RELA;IRAK1;TFG;MUL1;ZMYND11;PPM1A;TMEM9B;TNFRSF19;TAB2;CARD19;MYD88;TMED4;MIER1;TLR6;RNF31
gsea,organic substance transport (GO:0071702),0.35733909915235773,1.2651366147760066,0.17333333333333334,0.2877623826432973,1.0,16/33,31.83%,CD3G;ARL6IP5;VAMP2;TOM1;ABCA3;CHMP1B;SLC29A4;CHMP1A;RD3;CHMP2B;SLC18A1;RILP;ABCA5;PPT1;ARRDC2;SLC18A2
gsea,fatty acid catabolic process (GO:0009062),-0.36362714366952087,-1.2651128975210315,0.16030534351145037,0.18234868384005126,1.0,8/30,34.31%,AUH;ECHS1;ACAT1;HADHB;HADHA;MMAA;ACOT8;HSD17B4
gsea,negative regulation of kinase activity (GO:0033673),-0.37483694574351756,-1.26406306811406,0.16115702479338842,0.18303380051707493,1.0,9/26,21.66%,TRIM27;PAK2;DTNBP1;GSTP1;CHP1;RTRAF;NPRL2;CAMK2N2;DVL1
gsea,regulation of cilium assembly (GO:1902017),-0.37197965651886017,-1.2585220432648498,0.1510204081632653,0.18760457212186793,1.0,14/26,34.38%,ATG5;ATG3;TBC1D15;CYLD;CROCC;TBC1D19;ENTR1;CDK10;TBC1D9B;LIMK2;TBC1D10A;TBC1D2B;TBC1D24;RABEP2
gsea,ERBB signaling pathway (GO:0038127),-0.4165355967313279,-1.257382925274715,0.1843687374749499,0.18830344867034643,1.0,5/15,19.30%,CDC37;GRB2;MAPK1;IQGAP1;PTK2
gsea,axon development (GO:0061564),-0.37647022706125766,-1.2571420895140475,0.1601642710472279,0.18817794951559239,1.0,9/23,40.73%,RAB10;RAB8A;MARK2;CDK5;AMIGO1;MAPT;BRSK2;ATL1;MAP1B
gsea,positive regulation of protein binding (GO:0032092),0.4128426709729248,1.2569201547040292,0.17254901960784313,0.2952644840009925,1.0,17/17,96.54%,B2M;RPL11;LRP1;TERT;DACT1;STK4;PKD1;SPPL3;MARK3;AMFR;CAPRIN2;GSK3B;PSEN1;NMD3;DERL1;FKBP1A;PPP2CA
gsea,skeletal system development (GO:0001501),-0.3573987309854876,-1.2568538784713206,0.15560165975103735,0.18816895499094233,1.0,15/32,38.78%,EBP;SLC10A7;PPIB;UFD1;DDRGK1;ANKRD11;DEAF1;TRAPPC2;TGFBR1;COMP;SUFU;PAPSS1;TRIP11;BMP1;PKD1
gsea,regulation of inflammatory response (GO:0050727),-0.32821668405308035,-1.2562431763081452,0.12525667351129363,0.18841069661264156,1.0,20/45,34.61%,CD47;SNX6;BRD4;PTPN2;GPS2;TRADD;CYLD;NMI;VAMP3;TYRO3;LPCAT3;SHARPIN;OTULIN;RELA;DDT;BCL6B;FNDC4;DAGLB;MGLL;NAPEPLD
gsea,calcium ion transport (GO:0006816),0.36646794445885505,1.2534839165276963,0.14173228346456693,0.2961671775437252,1.0,13/33,29.79%,TPT1;ITGAV;SELENOK;MCUR1;FYN;ORAI3;MCOLN3;SLC24A3;TRPM4;TRPM6;TRPC4AP;RYR3;CHRNB2
gsea,regulation of NIK/NF-kappaB signaling (GO:1901222),0.37100617546641146,1.2522483559170954,0.1724137931034483,0.29427289940235185,1.0,15/28,48.28%,LAPTM5;CD27;RPS3;LGALS9;PTPN22;NOD1;LIME1;AGER;NR3C2;NOD2;IFI35;SASH1;EP300;TRIP6;TRAF6
gsea,negative regulation of supramolecular fiber organization (GO:1902904),-0.39184291930736914,-1.2497831804201989,0.1812227074235808,0.19371435437178328,1.0,7/23,27.95%,MAPRE1;PFDN2;PFDN1;TBCD;TWF1;KANK3;EML2
gsea,neuron differentiation (GO:0030182),-0.3497507200289262,-1.2487630539607089,0.16326530612244897,0.19431465854628796,1.0,15/34,40.57%,ID2;DTNB;MTPN;RUNX3;LHX2;LDB1;UGDH;CDK5;TGFBR1;MAP2K1;WNT16;BRSK2;FZD3;TENM1;PITX2
gsea,monocarboxylic acid metabolic process (GO:0032787),-0.3605775159860536,-1.2463579459861538,0.17288801571709234,0.1961418444521722,1.0,10/28,40.37%,PANK2;ACOT7;GLO1;PDHB;AMACR;MTHFS;GPAM;AASDH;SLC6A8;ACSF3
gsea,intracellular pH reduction (GO:0051452),-0.4377502770362882,-1.245695709704025,0.19960474308300397,0.19643102818854188,1.0,4/15,15.50%,ATP6V1G1;ATP6V1C1;ATP6V1D;ATP6V1A
gsea,intrinsic apoptotic signaling pathway (GO:0097193),0.3735201632050649,1.2388336254586865,0.17073170731707318,0.3092577585495656,1.0,26/26,95.30%,TNFRSF1B;ARL6IP5;SELENOK;DDX5;MCL1;FHIT;GSKIP;BCL2L2;PPP1R13B;PRODH;BAD;PRKCD;POU4F1;CASP9;ATP2A1;BRSK2;FNIP2;CASP2;MOAP1;PYCARD;TOPORS;CUL2;STK24;STK11;DIABLO;BAG6
gsea,defense response to virus (GO:0051607),0.42781575663666216,1.2375553149548884,0.18217821782178217,0.30734868306287183,1.0,7/15,31.97%,BNIP3L;PTPRC;NLRC5;ZDHHC1;RNF135;SERINC5;IRF2
gsea,proteolysis (GO:0006508),0.2909400221064694,1.2334308929236926,0.14145383104125736,0.3091147785906744,1.0,40/75,45.39%,SRGN;CTSW;OGT;CTSA;CTSE;FBXO6;CAPN3;CTSO;CPQ;RNPEPL1;SVBP;LNPEP;CASP6;CPA2;DPP7;TPP1;LONP2;HGF;APH1B;FBXL2;VHL;CTSF;PM20D2;PSENEN;RNF123;TMPRSS3;HPN;HGFAC;CAPN5;CAPN7;MME;HTRA4;CELA1;PGPEP1;GGT5;BACE1;CTSC;F12;CTSB;GGT1
gsea,regulation of Ras protein signal transduction (GO:0046578),-0.3524415837756044,-1.2323064595096966,0.17494600431965443,0.20844409315809176,1.0,12/29,28.97%,FOXM1;ARF6;GRB2;KBTBD6;MAPKAP1;LZTR1;DENND1A;CRKL;STK19;VAV1;PDCD10;STARD8
gsea,negative regulation of apoptotic signaling pathway (GO:2001234),0.36286132710541696,1.2304516077937677,0.18774703557312253,0.30969871081904476,1.0,27/27,98.10%,ITGAV;NR4A2;NDUFA13;CFLAR;MCL1;TMBIM6;HGF;BCL2L2;SRC;ACAA2;TMEM14A;FZD9;ASAH2;MAPK8IP2;NOL3;PELI3;SIAH2;ZMYND11;TGFBR1;RELA;RTKN2;PSMD10;TRIAP1;GHITM;GSTP1;NDUFS3;CSNK2A1
gsea,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.3681411520959662,-1.226499320683512,0.16041666666666668,0.21394924289872772,1.0,11/26,29.03%,RHOA;ARRB2;FKBP1A;SMAD2;APPL1;FNTA;PARD6A;PTK2;CITED1;ZFYVE9;TGFBR1
gsea,positive regulation of synaptic transmission (GO:0050806),0.43351126891935166,1.224648351214297,0.20722433460076045,0.31410958120132493,1.0,5/15,18.22%,SQSTM1;VAMP2;NPTN;AGER;DLG4
gsea,circulatory system development (GO:0072359),0.3627008610573852,1.2223345924287354,0.17953667953667954,0.31374527140296377,1.0,16/28,47.50%,BORCS8;CDKN1B;TGFBR2;TGFB1;AKAP13;POU6F1;PDLIM2;SOX4;KDM6A;NOTCH4;FOXC1;PRICKLE4;CXADR;DNAAF4;ERBB3;POU4F1
gsea,mesenchymal cell differentiation (GO:0048762),0.4022536906678613,1.2217041022495785,0.19521178637200737,0.31107617075994926,1.0,11/19,30.07%,HIF1A;DDX5;TGFB1;LEF1;FBXL17;DDX17;HGF;SNAI1;FGFR1;CTNNB1;NOTCH4
gsea,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.41123035505137145,-1.2198041497177237,0.21544715447154472,0.2201755123833242,1.0,9/16,35.98%,CBFB;KDM1A;UFM1;DDRGK1;TRIM68;UBA5;KCTD6;GPAM;PKN1
gsea,positive regulation of protein catabolic process (GO:0045732),-0.34193313087513333,-1.2158409513624702,0.21649484536082475,0.2237150314152016,1.0,12/33,40.82%,CSNK2A1;GSK3A;SNF8;OAZ1;WWP2;SEC22B;GSK3B;VPS28;NKD1;EGLN2;RNF41;NEDD4L
gsea,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.3712033051956827,-1.2124760349007255,0.2094017094017094,0.22675175809802914,1.0,8/22,26.03%,RBX1;GTF2H5;XRN2;ERCC1;PDE12;EDC3;REXO4;EXD2
gsea,negative regulation of cellular protein metabolic process (GO:0032269),-0.3624679180584188,-1.2072126199481752,0.21541501976284586,0.23168944091983917,1.0,17/26,23.08%,BAG6;PCIF1;DAPK3;CNOT7;MALSU1;CNOT8;EIF4E2;LSM14A;DHX36;CLN8;CDK5;F2;DNAJC1;SAMD4B;ATRAID;FXR1;RBM4
gsea,modulation of chemical synaptic transmission (GO:0050804),-0.38091719827160975,-1.20620180618581,0.22016460905349794,0.2324231015853113,1.0,8/20,35.74%,CDK5;NPTXR;PTEN;EIF4EBP2;RIMS3;PXK;DLGAP3;LRRC4C
gsea,phospholipid transport (GO:0015914),0.4090087637691392,1.205662722241436,0.22868217054263565,0.3303953057289338,1.0,7/17,25.42%,NPC2;ABCA3;PITPNC1;SCP2;ATP8A2;PITPNM1;MTTP
gsea,negative regulation of protein kinase activity (GO:0006469),-0.3428550626247105,-1.2045143994918477,0.23588709677419356,0.233707303187243,1.0,10/31,21.66%,TRIM27;PAK2;DTNBP1;GSTP1;CHP1;RTRAF;PYCARD;LRP5;CAMK2N2;DVL1
gsea,regulation of exocytosis (GO:0017157),-0.4008791847919933,-1.2041133572027134,0.20907297830374755,0.2337620578778135,1.0,7/16,30.76%,RAB10;RAB8A;CHMP6;CHMP3;CPLANE2;ATP6AP1;UNC13D
gsea,cellular response to organic cyclic compound (GO:0071407),0.329164802245041,1.2018912751278301,0.18473895582329317,0.3322268998984484,1.0,38/38,99.15%,NR4A3;FAM210B;ARL6IP5;MSN;NR3C1;TGFB1;IL18;CASP6;PDE2A;ESR1;RYR3;CTNNB1;GOLPH3;ADCY5;INPP5K;HCN3;GPBAR1;AKAP9;POU4F1;EPG5;P2RY1;RAP1B;RAPGEF3;ADCY3;EGR1;SLC1A1;SLC26A6;PKD2;LCOR;P2RY12;HCN2;RAP1A;PDE12;GNG2;KAT5;RIOK3;GNB1;UBE2L3
gsea,negative regulation of mitotic cell cycle (GO:0045930),0.41106240339432887,1.2008770643782132,0.22920892494929007,0.3299770657240803,1.0,10/17,34.61%,BTG1;CDKN1B;TGFB1;CHFR;HECA;TOM1L2;TOM1L1;CTNNB1;BTG3;FOXC1
gsea,regulation of fat cell differentiation (GO:0045598),-0.380245140049132,-1.1985897967422574,0.20987654320987653,0.23915636609561583,1.0,5/20,36.76%,ID2;GPS2;LRP5;ASXL2;SYAP1
gsea,regulation of myeloid cell differentiation (GO:0045637),0.4094642405066682,1.1963596179467564,0.23715415019762845,0.33306718390578244,1.0,9/15,34.17%,NR4A3;TNRC6B;KMT2E;PRKCQ;NFE2;AGO3;AGO4;TNRC6C;EP300
gsea,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3704591400327202,1.195538401561773,0.2032854209445585,0.3306531511874751,1.0,13/22,37.51%,UBC;UBA52;TGFBR2;TGFB1;LDLRAD4;ZBTB7A;SMURF2;WFIKKN1;SLC2A10;EMILIN1;TGFB1I1;HTRA4;SMURF1
gsea,regulation of defense response (GO:0031347),-0.37818128300269066,-1.19253446739368,0.21357285429141717,0.24503673319261685,1.0,9/21,32.02%,BRD4;CASP8;CYLD;APPL1;TIRAP;RELA;BCL6B;DAGLB;MGLL
gsea,negative regulation of inflammatory response (GO:0050728),-0.3061933677523496,-1.1900758611263216,0.18518518518518517,0.24742104103070547,1.0,18/46,42.95%,GNB1;PRKAR1A;PTPN2;GPS2;GSTP1;GNG2;PRKACA;TYRO3;LPCAT3;SHARPIN;OTULIN;MAPK14;FNDC4;GIT1;ADCY3;AVPR2;INSL3;RPS19
gsea,negative regulation of cell migration (GO:0030336),-0.34911151265273604,-1.1885141813242268,0.21956521739130436,0.24860636796688687,1.0,11/30,39.10%,RAC1;STK24;STK26;ADIPOR1;ARHGAP4;PTEN;MCC;PTPRU;BMPR1A;ATP1B2;RNF41
gsea,myeloid cell differentiation (GO:0030099),0.3914523482949087,1.1884155114262054,0.23214285714285715,0.33722854813756525,1.0,6/17,17.82%,RPS14;KMT2E;PRKX;RASGRP4;CEBPA;SLC25A38
gsea,cellular response to reactive oxygen species (GO:0034614),-0.40088677141114654,-1.185318711486321,0.24748490945674045,0.251611920912725,1.0,8/15,33.82%,MAPK1;MAPK3;ROMO1;OSER1;MAPK9;RELA;PKD2;MAPT
gsea,cellular response to metal ion (GO:0071248),0.36264869739949557,1.1848406752444813,0.23669724770642203,0.3387661118993989,1.0,23/23,93.80%,B2M;CDKN1B;ADCY7;CAPN3;GUCA1A;DLG4;TFR2;RYR3;ANK3;SYT5;GPLD1;BRAF;KCNH1;CARF;TFAP2A;PKD2;MEF2A;MAPK9;MCOLN1;IQGAP1;SUMO1;MAPK3;MAPK1
gsea,activation of GTPase activity (GO:0090630),0.33700798255617936,1.1829204076866404,0.21223709369024857,0.33802351474477366,1.0,14/32,36.21%,ARHGAP45;TBC1D10C;PIP5K1A;TBC1D17;RUNDC1;TBC1D12;RAP1GAP2;TBC1D2;RAP1GAP;TBC1D16;EPHA1;GMIP;TBC1D22A;SYDE1
gsea,negative regulation of cold-induced thermogenesis (GO:0120163),-0.4073978625960509,-1.1811333947231668,0.2623655913978495,0.2556364498899522,1.0,5/16,28.63%,RHEB;STK11;PGAM5;NR1H2;ACOT13
gsea,cell-cell junction organization (GO:0045216),-0.3707358868848366,-1.172646830814464,0.23029045643153526,0.2644711162511044,1.0,10/20,37.35%,LIMS1;TLN1;CSK;PARD6A;TLN2;ARVCF;NECTIN1;GJC1;LIMS2;TJP3
gsea,negative regulation of translation (GO:0017148),-0.3495436887773794,-1.171328117650909,0.23865877712031558,0.2655002189634174,1.0,15/27,23.08%,TPR;PCIF1;DAPK3;YTHDF2;CNOT7;MALSU1;YTHDF1;CNOT8;EIF4E2;LSM14A;DHX36;SAMD4B;FXR1;EIF4EBP2;RBM4
gsea,negative regulation of cellular component organization (GO:0051129),-0.3636309028340437,-1.1610389337596796,0.24634655532359082,0.27670152843375945,1.0,8/21,30.27%,CDC42;LCMT1;RIOK3;DNM2;MTMR2;GSK3B;SCAMP5;CARMIL1
gsea,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.31186824457835216,-1.1567786413721795,0.23504273504273504,0.2813361926892557,1.0,14/39,34.57%,RHOA;ARRB2;FKBP1A;MAPK3;SMAD2;APPL1;FNTA;PARD6A;PTK2;CITED1;ZFYVE9;TGFBR1;RGMA;BMPR1A
gsea,gland development (GO:0048732),-0.3964256276798453,-1.1551195338181175,0.256198347107438,0.28277343742229455,1.0,5/15,31.21%,CEBPG;SOD1;TGFBR1;PKD2;CDK5RAP3
gsea,negative regulation of neuron death (GO:1901215),-0.3306402215373187,-1.1524060233037001,0.23123732251521298,0.2856683945475935,1.0,10/30,26.04%,SNX6;BTBD10;SOD1;FBXO7;CNTF;GSK3B;CDK5;TYRO3;WFS1;CITED1
gsea,regulation of insulin secretion (GO:0050796),-0.35075632602583573,-1.1522366393366006,0.2398286937901499,0.28543799927159713,1.0,7/23,27.54%,UQCC2;PSMD9;RAP1A;LRP5;ENSA;EIPR1;KCNB1
gsea,regulation of protein localization to plasma membrane (GO:1903076),0.3541198898864654,1.1515329741736333,0.2608695652173913,0.3809312438813028,1.0,24/24,97.56%,SQSTM1;TGFB1;PRKCH;TMEM59;LDLRAP1;PPP2R5A;TREM2;LRP1;STX3;STAC3;NUMB;RHOG;STX7;ZDHHC7;ARHGEF16;DLG1;CIB1;STX8;CDK5;VPS4A;APPL1;VTI1B;AP2M1;ARF6
gsea,stress-activated MAPK cascade (GO:0051403),0.3366482320874578,1.1509008815654793,0.27459016393442626,0.3779347284728364,1.0,29/29,94.34%,IRAK2;UBC;UBA52;LGALS9;NOD1;MAPK11;IKBKB;MAP4K3;NOD2;MAP3K10;DUSP9;TRAF6;TAB2;MAP3K12;TNFRSF19;MAP2K4;FBXW11;IRAK1;ARHGEF6;MAPK14;MAP2K7;MAP4K2;UBE2V1;MAPK9;CRKL;CCM2;MAPK3;MAPK1;GPS2
gsea,iron ion homeostasis (GO:0055072),-0.3762405346218758,-1.1495397595692651,0.2757281553398058,0.28816754442120823,1.0,9/19,27.46%,ATP6V1G1;BOLA2;NEDD8;SOD1;ERFE;ISCU;ATP6V1A;SLC11A2;ATP6AP1
gsea,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3456641975527376,-1.1475741332859197,0.2619047619047619,0.2900991099392077,1.0,11/25,41.36%,BAG6;NEDD8;PDCD6IP;CASP8;ATE1;NGLY1;VPS4B;VPS4A;RSPRY1;RNF41;ZRANB1
gsea,regulation of protein kinase B signaling (GO:0051896),-0.29100389484203865,-1.144783191997374,0.24261603375527427,0.2929523646735376,1.0,21/49,46.28%,RAC1;GRB2;ARRB2;LCK;PDCD6;PPP2R5C;PTK2;PTEN;AKT2;VAV1;P2RY12;OSBPL8;TGFBR1;MUL1;CIB1;RNF41;SLC9A3R1;HCLS1;EGF;FGFR3;FGF20
gsea,negative regulation of transport (GO:0051051),0.3690793208537158,1.141632556230234,0.26459143968871596,0.3883868949950066,1.0,19/19,99.31%,NDFIP1;ITGAV;ARL6IP5;SNX33;LRSAM1;CTTNBP2NL;ERBB3;RUBCN;EGF;SCAMP5;PXK;PIP4P2;NR1H2;PTEN;NDFIP2;MTMR2;SNX12;WWP2;SNX3
gsea,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.3917045189951145,-1.1412877545585862,0.26859504132231404,0.29657131163234257,1.0,8/15,44.45%,CCNH;CDC37;MNAT1;CDK5RAP3;CCNT2;CCNT1;CDKN1C;STOX1
gsea,positive regulation of macroautophagy (GO:0016239),-0.39683713658030373,-1.1401214382571383,0.2871900826446281,0.2974383765708223,1.0,9/15,24.40%,SH3GLB1;PAFAH1B2;SPTLC2;SLC25A4;TBK1;GNAI3;SPTLC1;PIP4K2A;PIP4K2C
gsea,Wnt signaling pathway (GO:0016055),0.3192509557096852,1.1386845464149908,0.27848101265822783,0.3890065073467635,1.0,34/34,99.58%,TCF7;NR4A2;UBC;UBA52;FRAT1;LEF1;AMER1;BCL9;RAC3;FZD6;FZD5;APC;CSNK1G3;CTNNB1;DVL3;FZD9;TCF7L1;VPS26A;ZRANB1;FZD3;WNT16;KLHL12;CELSR2;DVL2;DVL1;LRP5;PTEN;GSK3B;CSNK1G2;ARL6;CSNK1A1;VPS29;SNX3;RBX1
gsea,regulation of intracellular protein transport (GO:0033157),-0.3945421193431643,-1.138153777721428,0.3060796645702306,0.2991723031234898,1.0,7/16,26.61%,TPR;OAZ1;RAB29;CEP131;SIRT7;B3GAT3;PDCD10
gsea,negative regulation of cellular amide metabolic process (GO:0034249),0.3430200812939691,1.1337809847491023,0.29045643153526973,0.39268094065214965,1.0,24/24,95.01%,RPL13A;RPS3;PAIP2;DDX6;ORMDL3;SORL1;RNF139;RTN4;CPEB3;ORMDL1;RTN2;BIN1;RBM4;FXR1;SAMD4B;DHX36;LSM14A;EIF4E2;CNOT8;MALSU1;CNOT7;DAPK3;PCIF1;ORMDL2
gsea,endosome organization (GO:0007032),-0.38462092883009547,-1.1329534745495917,0.3030927835051546,0.30501136452584093,1.0,5/15,20.07%,SNX3;LAMTOR1;PLEKHJ1;RNF26;USP50
gsea,DNA replication (GO:0006260),-0.37608424984628264,-1.1315801091497837,0.29239766081871343,0.30616857949650517,1.0,11/16,24.18%,RBMS1;PNKP;KIN;RMI1;KAT5;ATRIP;NT5M;TOP1;POLB;ORC4;POLL
gsea,regulation of endothelial cell migration (GO:0010594),0.36822846552826427,1.1311514976661097,0.2922794117647059,0.3927524410476031,1.0,18/18,97.94%,SP100;ETS1;RRAS;FOXP1;KRIT1;SVBP;BMPR2;ATOH8;SASH1;ITGB1BP1;GPLD1;AAMP;EGF;PTK2;SYNJ2BP;PDCD6;EMC10;RAC1
gsea,regulation of neuron apoptotic process (GO:0043523),-0.31836208038823194,-1.12917842034538,0.27615062761506276,0.3087087147329645,1.0,10/31,33.80%,SNX6;SOD1;CNTF;CDK5;TYRO3;WFS1;CITED1;KCNB1;TFAP2A;EGLN2
gsea,protein-containing complex disassembly (GO:0032984),0.3232736446406239,1.1270704938169733,0.2903846153846154,0.3955028935269729,1.0,29/29,99.52%,RPL23;MAP1LC3B;GABARAP;GABARAPL1;MAP1LC3A;FRAT1;GABARAPL2;AMER1;LAMP2;FZD5;APC;RUBCNL;CTNNB1;DVL3;UVRAG;EPG5;VIPAS39;LIX1L;SNAP29;DVL2;DVL1;GSK3B;WIPI2;CHMP3;VPS4A;VTI1B;CSNK1A1;TSG101;PPP1CA
gsea,positive regulation of protein kinase B signaling (GO:0051897),-0.31489892330462427,-1.1190785325132886,0.3171247357293869,0.3208447845578088,1.0,13/33,46.28%,RAC1;GRB2;LCK;PTK2;AKT2;VAV1;P2RY12;OSBPL8;TGFBR1;HCLS1;EGF;FGFR3;FGF20
gsea,peptidyl-tyrosine phosphorylation (GO:0018108),0.3565909986717065,1.1139964437132988,0.32884615384615384,0.4120401560337058,1.0,13/21,25.22%,ITK;INSR;FYN;DDR1;TTBK1;ABI1;IGF1R;ZAP70;IL15;SRC;PKDCC;FGFR1;EPHA1
gsea,autophagosome organization (GO:1905037),0.3144399837330856,1.104331557205922,0.3135245901639344,0.42345909609464916,1.0,31/31,93.26%,MAP1LC3B;RB1CC1;GABARAP;GABARAPL1;MAP1LC3A;ATG12;GABARAPL2;RAB43;RAB19;ATG13;ATG9A;WIPI1;PIK3C3;WDR45;ULK3;UBXN2A;ATG16L1;ATG16L2;WDR45B;UBQLN2;ATG101;BECN1;VMP1;WIPI2;RAB1B;RAB1A;EMC6;STX12;ATG3;TMEM41B;ATG5
gsea,glycosaminoglycan biosynthetic process (GO:0006024),-0.3242552343318688,-1.1031490794274246,0.30268199233716475,0.3407464489788464,1.0,16/28,41.47%,SLC10A7;UGDH;CHST12;B4GALT3;OGN;OMD;B3GAT3;B4GALT2;EXT2;HAS3;CSPG5;HS3ST6;B3GNT4;XYLT2;B3GNT2;AGRN
gsea,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.3305700582993989,-1.1022818824491039,0.30985915492957744,0.34129903509007925,1.0,14/26,42.33%,MAD2L2;TBK1;NSD1;CAPRIN2;PTEN;ARAF;PDCD10;DMD;FNIP2;IL11;TENM1;PDE4D;HCLS1;BRAF
gsea,organonitrogen compound catabolic process (GO:1901565),0.38350967026746285,1.0994476244945335,0.3326612903225806,0.42720049319561265,1.0,8/15,26.49%,USE1;CAPN3;CPQ;LNPEP;TPP1;GNPDA2;LRSAM1;PPT1
gsea,positive regulation of cell death (GO:0010942),0.3846396861806045,1.0982277407750793,0.3339449541284404,0.425285556160908,1.0,7/15,22.84%,CDKN1B;TRIM13;FYN;MARK4;SARM1;LRP1;APC
gsea,anion transmembrane transport (GO:0098656),-0.3525342320761006,-1.093805943453855,0.29306930693069305,0.3519407243695977,1.0,10/19,39.42%,SLC25A11;SLC25A12;LRRC8C;SLC25A4;PRAF2;SLC35B4;MFSD12;SLC39A8;SLC1A1;SLC6A8
gsea,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.34622894464386267,-1.092795554958204,0.3433734939759036,0.35280937346923835,1.0,8/20,31.21%,PRKAR1A;GSTP1;STK38;PYCARD;RGS14;PTEN;LRP5;CDK5RAP3
gsea,positive regulation of signal transduction (GO:0009967),-0.2670768242939704,-1.0873534180587712,0.2795031055900621,0.35960902128059336,1.0,27/63,50.50%,CSNK2A1;ILK;GPS2;LIMS1;TRAF7;ERFE;SNW1;ATP6AP2;PTEN;TM2D3;STAT3;SPIN1;KLF2;PDCD10;ASXL2;TGFBR1;PKD2;LOXL3;LIMS2;ZRANB1;SMO;CDKN2AIP;DACT1;STK36;RBPJ;ITGB1BP1;NLGN3
gsea,heart development (GO:0007507),0.29328168964316964,1.0845344569873188,0.32894736842105265,0.44357207821509587,1.0,39/39,98.38%,BORCS8;CDKN1B;TGFBR2;TGFB1;AKAP13;POU6F1;INSR;PDLIM2;BMPR2;SOX4;MEF2D;CRELD1;KDM6A;LEFTY1;FOXC1;PRICKLE4;NDRG4;CXADR;DNAAF4;ERBB3;POU4F1;DAND5;IFT122;MESP2;PKD1;TAB2;TBX19;NIPBL;PKD2;TGFBR1;MEF2A;DVL2;PTEN;TCF25;PTK2;CASP8;FKBP1A;NDUFV2;ID2
gsea,ion transport (GO:0006811),0.32737230042242127,1.080114505723149,0.349609375,0.44685854766125993,1.0,13/25,39.55%,TSPO;SLC8B1;SLC36A1;SLC17A5;SLC24A3;LRRC8A;CHRNB1;SLC9A7;SLC25A26;CTNS;CHRNB2;CHRNA2;PKD1L3
gsea,visual perception (GO:0007601),-0.3193146429875676,-1.0792379649274846,0.32051282051282054,0.370319633422575,1.0,11/25,42.71%,DNAJC19;PITPNA;WFS1;EML2;TULP1;SLC24A1;GNAT2;RABGGTA;DRAM2;CRYBB3;CABP1
gsea,autophagosome assembly (GO:0000045),0.3055335224873044,1.078806817822038,0.33601609657947684,0.4446942655173012,1.0,32/32,93.26%,MAP1LC3B;RB1CC1;GABARAP;GABARAPL1;MAP1LC3A;ATG12;GABARAPL2;RAB43;RAB19;ATG13;ATG9A;WIPI1;PIK3C3;WDR45;SMURF1;UBXN2A;ATG16L1;ATG16L2;WDR45B;UBQLN2;ATG101;TRAPPC8;BECN1;VMP1;WIPI2;RAB1B;RAB1A;EMC6;STX12;ATG3;TMEM41B;ATG5
gsea,positive regulation of kinase activity (GO:0033674),0.318211368371778,1.0777339169185396,0.3435114503816794,0.4422634362085748,1.0,13/28,29.55%,PTPRC;MAPRE3;INSR;DDR1;JTB;DSTYK;INSRR;IGF1R;TREM2;FGFR1;EPHA1;CAMKK1;EPHB6
gsea,phospholipid dephosphorylation (GO:0046839),-0.3597444014207805,-1.0762236064595885,0.33472803347280333,0.37396480085014805,1.0,8/17,36.99%,MTMR9;MTMR2;PIP4P1;PTEN;PIP4P2;SGPP1;MTMR6;OCRL
gsea,positive regulation of defense response (GO:0031349),-0.3633260742001394,-1.07482673848047,0.3724696356275304,0.37528161723888703,1.0,7/18,34.61%,CD47;TRADD;POLR3C;RIOK3;NMI;DDT;NAPEPLD
gsea,regulation of interleukin-1 beta production (GO:0032651),-0.3506195972067675,-1.073386579252792,0.3405511811023622,0.37664985021101316,1.0,8/18,23.03%,GSTP1;CASP8;AIM2;PYCARD;USP50;GSDMD;PANX1;STAT3
gsea,epithelial to mesenchymal transition (GO:0001837),0.3490905971807389,1.0685743725391796,0.3712121212121212,0.4538704856964455,1.0,10/19,30.07%,HIF1A;DDX5;TGFB1;LEF1;DDX17;HGF;SNAI1;FGFR1;CTNNB1;NOTCH4
gsea,epithelium development (GO:0060429),0.3372654947347719,1.0642029668820154,0.3465346534653465,0.4568118575266201,1.0,10/21,47.57%,TGFB1;CASP6;TPP1;ACADVL;RIPK4;NDRG4;SIX1;CTSB;GRHL2;TOLLIP
gsea,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.2960629786629937,1.0628553444030089,0.34860557768924305,0.45491956514055026,1.0,22/34,37.51%,UBC;UBA52;TGFBR2;TGFB1;BMPR2;SORL1;UBE2D1;LDLRAD4;ZBTB7A;SMURF2;SMAD4;WFIKKN1;SLC2A10;EMILIN1;NBL1;TGFB1I1;ACVR2A;LEMD2;HTRA4;ACVR2B;MAGI2;SMURF1
gsea,autophagosome maturation (GO:0097352),-0.34685530649128776,-1.0604959766869386,0.36,0.39433387920391316,1.0,7/18,24.73%,CALM1;TSG101;VTI1B;CHMP3;WIPI2;VMP1;SNAP29
gsea,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3243692126830785,1.057148190687954,0.37,0.46032605843193697,1.0,23/23,91.70%,ITGAV;CFLAR;MCL1;EYA2;SRC;TERT;RFFL;UNC5B;NOS3;NOL3;PELI3;SIAH2;FAIM;ZMYND11;EYA1;TGFBR1;RELA;RNF34;GSK3B;CASP8;MAP2K5;TRADD;GSTP1
gsea,positive regulation of interleukin-1 beta production (GO:0032731),-0.3642040951867797,-1.0557077935952932,0.36960985626283366,0.4004120240819194,1.0,7/15,23.03%,CASP8;AIM2;PYCARD;USP50;GSDMD;PANX1;STAT3
gsea,fatty acid metabolic process (GO:0006631),-0.3140741396890482,-1.0550498855704702,0.3902439024390244,0.4008329731781941,1.0,10/26,47.40%,GPX4;ACOT7;ADIPOR1;ACOT8;GPAM;AASDH;ADIPOR2;ACSF3;CPT1C;PON2
gsea,purine ribonucleotide metabolic process (GO:0009150),-0.3557365941181177,-1.0545099903041573,0.3860369609856263,0.4009676341143707,1.0,7/16,28.63%,GTPBP1;ACOT7;ACAT1;ACBD6;GNAI3;ACOT8;ACOT13
gsea,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.28600156537360044,-1.0518308340051121,0.36863543788187375,0.404242722776493,1.0,14/37,50.09%,SNX6;FKBP1A;STK11;SNW1;SMAD2;SDCBP;ING2;CD109;CITED1;LTBP4;TGFBR1;PPM1A;CDKN1C;FAM89B
gsea,organic acid transport (GO:0015849),-0.33597065884152744,-1.0517235007281536,0.38293650793650796,0.40379108852831,1.0,6/19,35.41%,SLC25A11;SLC43A1;SLC10A1;SLC25A47;SFXN5;SLC26A6
gsea,regulation of cell death (GO:0010941),0.3047180405156774,1.051345351173871,0.3935969868173258,0.4658861085467082,1.0,28/28,93.26%,BNIP3L;TNFRSF1B;CDKN1B;TRIM13;SOX4;CHMP4B;SARM1;LRP1;APC;PRODH;PDE8A;NCK1;LRPAP1;PARP16;ACER2;SPEF1;RILPL1;WNT16;SNCB;BECN1;TBK1;PDE12;RAB29;VPS4B;CHP1;CHMP2A;TXNDC12;ATG5
gsea,kidney development (GO:0001822),-0.3601705382760055,-1.0509656183378175,0.396484375,0.40432406900420426,1.0,11/17,42.62%,BAG6;WFS1;C1GALT1;CITED1;TGFBR1;NIPBL;TFAP2A;ARL3;PKD1;NPHP3;GREB1L
gsea,glycerophospholipid metabolic process (GO:0006650),-0.31327453369492436,-1.0499974131183545,0.3885480572597137,0.40511399124799075,1.0,9/25,38.46%,PAFAH1B1;PIGX;DPM2;PRDX6;ABHD12;PLA2G4C;PIGM;PLCB3;PIGW
gsea,myeloid leukocyte differentiation (GO:0002573),-0.3361775024001628,-1.0499745030500596,0.37601626016260165,0.4045439303723186,1.0,6/20,36.42%,CDC42;CASP8;GLO1;CAMK4;MAPK14;PIR
gsea,regulation of Notch signaling pathway (GO:0008593),-0.2967134714684023,-1.0497706709219823,0.3893617021276596,0.4042754249133998,1.0,9/33,26.61%,WWP2;YTHDF2;SNW1;SYNJ2BP;RFNG;ARRDC1;TM2D3;STAT3;PDCD10
gsea,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.34325390791256516,-1.0490472039907872,0.4,0.40479715060340354,1.0,7/18,49.18%,GNB1;GNG2;PTGER1;LPAR2;ADCY3;PTGER3;ADCY9
gsea,sensory perception of light stimulus (GO:0050953),-0.3043137422724024,-1.0459764823904127,0.3771186440677966,0.4086904443702358,1.0,11/26,42.71%,DNAJC19;PITPNA;WFS1;EML2;TULP1;SLC24A1;GNAT2;RABGGTA;DRAM2;CRYBB3;CABP1
gsea,negative regulation of cell motility (GO:2000146),-0.313042849945375,-1.0419467971103002,0.39447731755424065,0.4139615864993957,1.0,9/24,44.02%,STK24;STK26;WAS;ARHGAP4;PTEN;PTPRU;RNF41;RNF20;CRK
gsea,positive regulation of cellular protein localization (GO:1903829),-0.31672972926025245,-1.0416371970963596,0.40756302521008403,0.41379672284778046,1.0,13/24,34.28%,LAMTOR5;CROCC;DDRGK1;GSK3B;F2;ENTR1;PARD6A;VPS28;LIMK2;CDK5RAP3;MEAK7;MAPT;PDZK1
gsea,regulation of anatomical structure morphogenesis (GO:0022603),-0.30322073207357064,-1.0389762375737075,0.378,0.41709649768724166,1.0,17/30,41.36%,CAPZB;PAK2;SEMA4D;RNH1;MARK2;GSK3B;CDK5;CHN1;LZTS3;HTATIP2;WTIP;MAPT;LRRC4C;FITM2;BRSK2;NEDD4L;ZRANB1
gsea,negative regulation of neuron apoptotic process (GO:0043524),-0.322869739789484,-1.038904644157898,0.40376569037656906,0.41663274507797005,1.0,6/21,26.04%,SNX6;SOD1;CNTF;TYRO3;WFS1;CITED1
gsea,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.3524689354096552,-1.0297922084388735,0.41312741312741313,0.42922871212124203,1.0,6/16,21.14%,PTPN2;GSTP1;SYNJ2BP;RGS14;PTEN;RANBP9
gsea,negative regulation of cell adhesion (GO:0007162),0.31995324462515634,1.025736520081738,0.4097087378640777,0.5057102908352107,1.0,23/23,99.28%,PTPRC;CD164;ARHGDIB;TGFB1;SPINT2;RND1;MDK;PLXNA3;JAG1;ACER2;ERBB3;PLXNB1;PODXL;ITGB1BP1;ADAM22;JAM3;CBLL1;ADAM10;SIPA1;PTK2;SEMA4D;TBCD;RHOA
gsea,positive regulation of cellular component organization (GO:0051130),-0.30194455174995527,-1.0241088994536347,0.40643863179074446,0.43718774004687744,1.0,13/29,33.73%,SH3GLB1;ANAPC2;SUMO1;TMEM30A;GSK3B;TIRAP;BRK1;SURF4;TMED9;HAS3;TGFBR1;CBLL1;FNIP2
gsea,cation transport (GO:0006812),0.2858936536660853,1.0207906799865063,0.4157509157509158,0.5101734907174577,1.0,21/36,42.39%,NDFIP1;SLC8B1;SLC29A4;SLC36A1;TAF7;TRPM4;KCNA4;TRPM6;CHRNB1;KCNIP2;SLC36A3;KCNK6;KCNA3;KCNK3;KCNJ13;SLC18A2;SLC38A7;KCNAB3;PKD1L3;SLC5A6;SCN3B
gsea,positive regulation of cell migration (GO:0030335),-0.2495300428672968,-1.0179126365674311,0.4061224489795918,0.44573525613029846,1.0,26/64,43.76%,MAPRE1;RAB11A;TRADD;SDCBP;MIEN1;SEMA4D;CRKL;DDRGK1;PTK2;WASHC1;AKT2;STAT3;ADAM10;PPP3CA;PDCD10;TGFBR1;CBLL1;CARMIL1;NIPBL;CIB1;SEMA6B;SPAG9;EGF;INSL3;SMO;MYLK
gsea,positive regulation of endocytosis (GO:0045807),-0.34171115733420954,-1.0138624443519872,0.45790554414784396,0.4511706689688443,1.0,7/16,45.59%,CDC42;TOR1A;STAP1;VPS28;CBLL1;NEDD4L;CALY
gsea,regulation of neuron death (GO:1901214),-0.31584140542669265,-1.0134186228433661,0.4091816367265469,0.4511781693638554,1.0,12/22,38.54%,BTBD10;ITGB2;CHP1;RAB29;GSK3B;TBK1;CDK5;SNCB;EGLN2;MAPT;RILPL1;EGR1
gsea,Notch signaling pathway (GO:0007219),-0.32493281297476473,-1.007558108041162,0.42531120331950206,0.45955897884110086,1.0,6/20,27.80%,TRAF7;SNW1;NCSTN;PSEN1;ADAM10;APH1A
gsea,platelet degranulation (GO:0002576),-0.29317080705817705,-1.0057457872901552,0.4350515463917526,0.461563236176165,1.0,10/28,31.09%,CALM1;WDR1;SOD1;VTI1B;TLN1;CD109;GTPBP2;APOOL;STXBP2;CDC37L1
gsea,regulation of mitochondrion organization (GO:0010821),0.32188977149057196,1.0028147295773568,0.4601226993865031,0.537919397267348,1.0,20/20,97.27%,SQSTM1;FLCN;FIS1;PDE2A;TREM2;FZD5;EP300;GOLPH3;MYO19;MIEF2;STOX1;MAPT;MUL1;SIRT7;GSK3B;SREBF1;DNM1L;RHOT1;MFF;GSK3A
gsea,external encapsulating structure organization (GO:0045229),0.28007991499465756,1.0011680751117986,0.46714031971580816,0.5364550776483823,1.0,18/36,38.45%,ITGAV;DDR1;ITGAL;LAMB3;ITGA9;ITGA2;ATP7A;ITGB5;RECK;ICAM5;MMP11;COL8A2;ADAMTSL5;F11R;ADAM15;COL9A3;ITGAD;NID2
gsea,fat cell differentiation (GO:0045444),0.3139248158221546,0.9994855794584224,0.47265625,0.5351364929925014,1.0,22/22,97.39%,NR4A3;NR4A2;FOXO1;FAM120B;ZBTB7A;CEBPA;BSCL2;TRIM32;EP300;BBS2;PER2;BBS9;IL11;OSBPL8;NR4A1;AKT2;HMGA2;BBS7;OSBPL11;SENP2;CTBP1;PSMB8
gsea,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.29355425408850855,0.9970544285550575,0.45454545454545453,0.5305353814699755,1.0,19/30,45.39%,CD3G;ADCY7;FYN;CD247;GPR25;TREM2;POMC;SRC;GPR150;HRH2;GPR176;PTGIR;YES1;VIPR1;ADCY5;PRKACB;GGT5;GPBAR1;GGT1
gsea,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.29355425408850855,0.9970544285550575,0.45454545454545453,0.5305353814699755,1.0,19/30,45.39%,CD3G;ADCY7;FYN;CD247;GPR25;TREM2;POMC;SRC;GPR150;HRH2;GPR176;PTGIR;YES1;VIPR1;ADCY5;PRKACB;GGT5;GPBAR1;GGT1
gsea,negative regulation of neuron projection development (GO:0010977),-0.34327027168700547,-0.9963564126137686,0.44785276073619634,0.47557079092634064,1.0,5/15,33.43%,RHOA;RAB29;PTEN;CBFA2T2;CIB1
gsea,mitotic cytokinesis (GO:0000281),0.3414832857237854,0.9956977194008012,0.4336099585062241,0.5286210586531515,1.0,9/15,32.88%,SNX18;JTB;TTC19;SNX33;KLHDC8B;CHMP4B;APC;UNC119;ANK3
gsea,peptidyl-tyrosine modification (GO:0018212),0.3442304136901101,0.9891478677037769,0.48282442748091603,0.5354811735286114,1.0,9/16,25.22%,INSR;FYN;TTBK1;ABI1;ZAP70;SRC;PKDCC;FGFR1;EPHA1
gsea,cellular divalent inorganic cation homeostasis (GO:0072503),-0.3192393959279838,-0.9864767224450754,0.4887063655030801,0.49035781564873276,1.0,11/20,33.00%,TMCO1;LCK;SLC10A7;TMEM165;SLC30A5;ATP2C1;STIM1;VAPB;SLC30A9;SLC39A8;SLC24A1
gsea,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.32570149180875946,-0.9861368923056856,0.4577603143418468,0.490214679174368,1.0,11/18,44.45%,MAD2L2;TBK1;CAPRIN2;ARAF;PDCD10;FNIP2;IL11;TENM1;HCLS1;BRAF;STOX1
gsea,positive regulation of immune response (GO:0050778),-0.33700257588926813,-0.9818075484832,0.4871287128712871,0.4963566000639809,1.0,8/16,25.78%,MYB;POLR3C;ITGB2;RIOK3;NMI;PYCARD;IL12RB1;SKAP1
gsea,extracellular structure organization (GO:0043062),0.27266971592864175,0.9767244599135024,0.5099457504520796,0.5526988769318754,1.0,19/37,41.42%,ITGAV;DDR1;ITGAL;LAMB3;ITGA9;ITGA2;ATP7A;ITGB5;RECK;ICAM5;MMP11;COL8A2;ADAMTSL5;F11R;ADAM15;COL9A3;ITGAD;NID2;MMP28
gsea,protein O-linked glycosylation (GO:0006493),0.29995601683680717,0.9750691618285393,0.466403162055336,0.5512422639359641,1.0,11/23,44.78%,OGT;POFUT2;GALNT9;GALNT11;C1GALT1C1;LARGE1;GXYLT2;GALNT4;CRPPA;B3GNT8;TMTC3
gsea,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.295687067609108,-0.965384307093416,0.48541666666666666,0.5220951570534123,1.0,12/24,42.24%,CCNH;CDC37;PSMD10;MNAT1;PTEN;PKD2;CDK5RAP3;CCNT2;CCNYL1;CCNT1;PKD1;CDKN1C
gsea,protein lipidation (GO:0006497),0.27910509619610646,0.9634183612223877,0.4915254237288136,0.566953964025931,1.0,26/26,93.26%,SELENOK;ZDHHC18;ZDHHC20;PIGP;ATG12;ZDHHC1;ZDHHC9;MPPE1;ZDHHC23;ZDHHC17;WIPI1;PIK3C3;WDR45;UGCG;GPLD1;ZDHHC7;PIGW;PIGM;WDR45B;DPM1;PIGO;WIPI2;DPM2;DPM3;ZDHHC3;ATG5
gsea,calcium ion homeostasis (GO:0055074),0.330774516847474,0.960911142690201,0.5072765072765073,0.5667762288470608,1.0,17/17,95.59%,TPT1;SLC8B1;SLC24A3;NPTN;GCM2;TPCN2;DMPK;ATP2A1;ATP2B1;SLC24A1;VAPB;WFS1;STIM1;ATP2C1;TMEM165;SLC10A7;TMCO1
gsea,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3220958117651508,-0.9607860032738514,0.523517382413088,0.5289311938869343,1.0,19/19,97.89%,PAK2;PDCL3;CNOT7;ITGB2;SEMA4D;IL11;HCLS1;PRKCD;CADM4;DGKQ;SRC;TREM2;IL15;HGF;TNFRSF14;FYN;TGFB1;SAMSN1;PTPRC
gsea,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.27064209230911995,-0.9548755872573882,0.5338983050847458,0.5378352901271297,1.0,14/33,49.18%,GNAI2;WASF2;GNAI3;P2RY12;PTGER1;LPAR2;GNAT2;GALR3;ADCY3;AVPR2;INSL3;PTGER3;GNAO1;ADCY9
gsea,glucose homeostasis (GO:0042593),-0.2757122253079277,-0.9443021192797263,0.5361216730038023,0.5543334192580223,1.0,12/27,36.14%,PTPN2;RPS6;STK11;ADIPOR1;CRTC2;SELENOT;WFS1;STAT3;KCNB1;USF1;GCK;ADIPOR2
gsea,determination of left/right symmetry (GO:0007368),-0.32175607086462016,-0.9442026636645169,0.5268595041322314,0.5537380880933404,1.0,7/15,43.07%,ARL6;BBS7;PKD2;FOXJ1;NPHP3;PITX2;SMO
gsea,cellular metal ion homeostasis (GO:0006875),0.2939566703838791,0.9440798966866241,0.5370741482965932,0.5920158890998818,1.0,23/23,95.59%,TPT1;SLC8B1;LETM2;SLC24A3;NPTN;TMPRSS3;GCM2;TPCN2;DMPK;ATP2A1;ATP2B1;ATP4A;NEDD4L;ATP1B2;SLC24A1;TESMIN;VAPB;STIM1;ATP2C1;TMEM165;SLC10A7;ATP1B3;TMCO1
gsea,regulation of autophagosome assembly (GO:2000785),-0.32368741819031366,-0.9395165005872642,0.5617529880478087,0.560919611872407,1.0,8/15,24.40%,SH3GLB1;SCFD1;SEC22B;RAB1B;NPRL2;UBQLN2;PIP4K2A;PIP4K2C
gsea,regulation of kinase activity (GO:0043549),0.28785788085167285,0.937210389225653,0.5328185328185329,0.5995525745105933,1.0,13/23,46.50%,CDKN1B;NLRC5;INSR;DDR1;DSTYK;INSRR;IGF1R;TREM2;FGFR1;EPHA1;EPHB6;ERBB3;NTRK1
gsea,protein localization to cilium (GO:0061512),-0.2988464815577891,-0.9330144100877813,0.5543933054393305,0.5710159907974378,1.0,11/19,35.25%,ARL6;ATP6V1D;RAB29;NPHP4;RABEP1;WDR35;TULP1;INVS;TCTN2;CSNK1D;ARL3
gsea,inorganic cation import across plasma membrane (GO:0098659),-0.32429913905702196,-0.9255552173636479,0.5665961945031712,0.5828051416546431,1.0,8/15,35.87%,ATP1B3;HCN2;SLC9A5;SLC9A6;SLC5A2;SLC39A8;SLC24A1;ATP1B2
gsea,glycosaminoglycan catabolic process (GO:0006027),-0.314877975493884,-0.9228573936650084,0.5787321063394683,0.5864224670113954,1.0,6/16,30.64%,HEXB;CHP1;OGN;OMD;FUCA1;CSPG5
gsea,sodium ion transmembrane transport (GO:0035725),-0.30829917760152264,-0.9222632718852292,0.549792531120332,0.5866562333537324,1.0,11/17,42.04%,ATP1B3;HCN2;SLC9A5;SLC9A6;PKD2;SLC5A2;SLC24A1;ATP1B2;ASIC1;SLC6A8;ATP4A
gsea,positive regulation of cold-induced thermogenesis (GO:0120162),-0.3000006727541838,-0.9197454819758936,0.5858585858585859,0.5900627326136992,1.0,8/18,37.41%,HDAC3;KDM1A;CNOT3;ADIPOR1;PRKAB1;PEMT;ADIPOR2;UCP2
gsea,positive regulation of response to external stimulus (GO:0032103),-0.2611707200262257,-0.9068031140838677,0.6077235772357723,0.611084880801432,1.0,12/31,34.61%,CD47;TRADD;POLR3C;RIOK3;NMI;CNTF;F2;ZCCHC3;DDT;P2RY12;USF1;NAPEPLD
gsea,glycoprotein metabolic process (GO:0009100),-0.29689645507581547,-0.9041638108545852,0.5964214711729622,0.6145994342432666,1.0,8/18,38.34%,ERP44;NGLY1;MAN1A2;FBXO2;MAN2B1;NEU4;FBXO27;ENGASE
gsea,positive regulation of metabolic process (GO:0009893),0.2856352779651834,0.9029869715430394,0.58984375,0.6560173020591974,1.0,20/20,95.95%,OGT;IL18;INSR;PRKAB2;IGF1R;BSCL2;APC;ZBTB7B;THRA;PER2;GNAS;ACACB;UCP2;ADIPOR2;PEMT;PRKAB1;ADIPOR1;CNOT3;KDM1A;HDAC3
gsea,protein catabolic process (GO:0030163),-0.27902871306570814,-0.899693321875232,0.6123260437375746,0.6209607287095098,1.0,10/22,39.10%,BAG6;ATE1;UBE2G1;NGLY1;CLN8;FBXO2;NEU4;SIAH2;FBXO27;RNF41
gsea,positive regulation of inflammatory response (GO:0050729),-0.307061326079347,-0.8966647240420655,0.5847953216374269,0.6251262867595976,1.0,7/16,42.95%,CD47;TRADD;NMI;DDT;SNX4;NAPEPLD;RPS19
gsea,negative regulation of cellular catabolic process (GO:0031330),0.2866204125481405,0.8883821358886164,0.624,0.6766590571977836,1.0,20/20,97.27%,MCL1;PTPN22;RRAGA;BMF;RIC1;SORL1;SIRT2;HGF;TREM2;FOXK1;RUBCN;GPLD1;TAB2;CDK5RAP3;STAT3;ATRAID;WASHC1;MTMR2;MTMR9;GSK3A
gsea,inorganic cation transmembrane transport (GO:0098662),-0.21580267592343866,-0.8832150802938195,0.7008547008547008,0.647211063854597,1.0,28/64,45.64%,TMCO1;FKBP1A;ATP1B3;MCOLN1;TMEM165;ATP6V1A;SLC30A5;ATP2C1;HCN2;SLC9A5;TRPM7;SLC11A2;KCNB1;SLC9A6;PKD2;TMEM175;SLC39A8;SLC24A1;UCP2;NNT;PKD1;ASIC1;SLC6A8;KCNH1;SLC25A27;ATP4A;ATP2A1;SLC46A1
gsea,regulation of BMP signaling pathway (GO:0030510),-0.28531281263131253,-0.8767588093376314,0.6452282157676349,0.6569278786514033,1.0,19/19,90.82%,UBE2D3;SMAD2;BMPR1A;XIAP;FSTL3;RBPJ;DAND5;RNF165;SMURF1;ACVR2B;LEMD2;ACVR2A;NBL1;SMAD4;FOXD1;SMURF2;UBE2D1;SORL1;BMPR2
gsea,extracellular matrix organization (GO:0030198),0.22444471912556987,0.8663605090104315,0.7062043795620438,0.7101973993648424,1.0,28/50,45.69%,ITGAV;TGFB1;DDR1;ITGAL;LAMB3;ITGA9;ITGA2;NOXO1;QSOX1;ATP7A;ITGB5;RECK;KIF9;ICAM5;P3H4;MMP11;COL8A2;ADAMTSL5;F11R;ADAM15;COL9A3;ITGAD;NID2;MMP28;CAPNS1;ADAMTS10;COL18A1;LAMB2
gsea,BMP signaling pathway (GO:0030509),0.30220965378962017,0.8647962118220782,0.6576923076923077,0.7024009301643409,1.0,10/15,37.51%,DDX5;TGFB1;BMPR2;RUNX2;SMAD4;BMP8A;LEFTY1;ACVR2A;ACVR2B;SMURF1
gsea,cellular response to BMP stimulus (GO:0071773),0.30220965378962017,0.8647962118220782,0.6576923076923077,0.7024009301643409,1.0,10/15,37.51%,DDX5;TGFB1;BMPR2;RUNX2;SMAD4;BMP8A;LEFTY1;ACVR2A;ACVR2B;SMURF1
gsea,response to tumor necrosis factor (GO:0034612),0.26234243480301284,0.8597518749250106,0.6666666666666666,0.7058173154311863,1.0,14/23,46.31%,RPS3;IGBP1;GBA;IKBKB;MAP4K3;HYAL1;GGT7;TRIM32;NR1D1;INPP5K;HYAL3;GGT5;GGT1;ASAH1
gsea,calcium-mediated signaling (GO:0019722),-0.2818837945387829,-0.8572700036325342,0.6743697478991597,0.6883905060257899,1.0,6/18,27.25%,BCAP31;PPP3CC;PRKACA;PPP3CA;LAT;P2RY12
gsea,intraciliary transport involved in cilium assembly (GO:0035735),-0.288441446126687,-0.8494345211787565,0.6737451737451737,0.7003746608870364,1.0,7/15,42.35%,DYNLL1;DYNLRB1;CEP131;WDR35;TRIP11;TTC26;IFT172
gsea,negative regulation of response to stimulus (GO:0048585),-0.27382454500564624,-0.8340517790998704,0.7055335968379447,0.7243241641641626,1.0,10/17,43.90%,MAP2K5;LPCAT3;HMGA2;WFS1;NR1H2;CASK;BRAP;AQP11;AKT3;MPIG6B
gsea,potassium ion transport (GO:0006813),-0.2309092988564958,-0.7972491988887358,0.7970085470085471,0.7807093071407334,1.0,10/28,40.04%,ATP1B3;CHP1;HCN2;SLC9A5;KCNB1;SLC9A6;PKD2;TMEM175;SLC24A1;KCNH1
gsea,lipid homeostasis (GO:0055088),-0.2581928171186099,-0.793355831119749,0.7615230460921844,0.7854005485311406,1.0,8/19,36.08%,ORMDL2;CLN8;ABHD5;PNPLA2;USF1;USF2;RBP1;FITM2
gsea,plasma membrane organization (GO:0007009),-0.26954631666216,-0.7893003438068306,0.7745302713987474,0.7902075537155272,1.0,9/16,39.59%,ARL8B;ANXA6;PLSCR2;BIN2;BIN1;BIN3;ARV1;COL5A1;SLC9A3R1
gsea,regulation of epithelial cell migration (GO:0010632),0.273304477211487,0.7777665427109344,0.7649484536082474,0.831687201329561,1.0,8/15,31.94%,HIF1A;RREB1;BMPR2;RTN4;HYAL1;SRC;SASH1;CAPN7
gsea,regulation of TORC1 signaling (GO:1903432),0.2556658626173336,0.7713197577060952,0.7897838899803536,0.8349870388545094,1.0,16/16,91.11%,BMT2;FLCN;RRAGA;CASTOR2;GPR137C;GPR137;SIK3;DGKQ;CLEC16A;RRAGD;SZT2;RRAGC;KPTN;PIP4P1;LAMTOR5;STK11
gsea,regulation of osteoblast differentiation (GO:0045667),0.242859018215408,0.761090821722716,0.7946257197696737,0.8432811231641818,1.0,21/21,83.78%,DDX5;NBR1;BMPR2;TRPM4;HGF;RUNX2;FGF23;ACVR2A;ACVR2B;LIMD1;BMPR1A;SUFU;ATP6AP1;CITED1;CTNNBIP1;LRP5;ATRAID;PRKACA;PTK2;SUCO;SEMA4D
gsea,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.2565919791531973,-0.7569525869072523,0.8004032258064516,0.8340103483179028,1.0,7/15,36.44%,SLA2;EFR3B;EFR3A;PIP4K2A;PIP4K2C;ITPKA;PIK3C2B
gsea,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.2429222445510711,-0.744555232576541,0.8385744234800838,0.8487757322362659,1.0,19/19,95.43%,UBE2D3;PDCD6;CASK;BMPR1A;FSTL3;DAND5;SMURF1;ACVR2B;LEMD2;ACVR2A;CADM4;NBL1;EMILIN1;SMAD4;SMURF2;UBE2D1;SORL1;BMPR2;PTPN1
gsea,glycosaminoglycan metabolic process (GO:0030203),0.22770855651652394,0.6896707554997271,0.896484375,0.9184815225787047,1.0,18/18,83.65%,SGSH;HS3ST3B1;EXT1;NDST2;IDUA;NDST1;IDS;GPC2;B4GALT7;GLB1;AGRN;XYLT2;HS3ST6;FUCA1;B3GAT2;EXT2;B3GAT3;UGDH
gsea,cognition (GO:0050890),-0.21700603357171772,-0.6354758079648882,0.9290060851926978,0.9496450275256454,1.0,6/15,31.65%,TUSC3;SETD5;RP9;DGCR2;NIPBL;TTC8
gsea,regulation of smoothened signaling pathway (GO:0008589),0.217780648980569,0.6199607491099061,0.9275929549902152,0.9625759822149732,1.0,7/15,42.06%,FBXL17;HERC4;KIF7;GLIS2;ULK3;TTC23;ARMC9
gsea,chemical homeostasis (GO:0048878),-0.19331543931272005,-0.5772963026980759,0.975609756097561,0.9764473355547624,1.0,9/18,42.30%,CLN8;ABHD5;PNPLA2;USF1;USF2;RBP1;FITM2;NEDD4L;AQP11
gsea,aminoglycan biosynthetic process (GO:0006023),-0.18054464037645346,-0.5459678608461753,0.9900199600798403,0.9846412454401517,1.0,9/18,44.61%,UGDH;B3GAT3;EXT2;HS3ST6;B3GNT4;XYLT2;B3GNT2;AGRN;B4GALT7
gsea,potassium ion transmembrane transport (GO:0071805),0.14913676956657218,0.5127456732865442,1.0,0.9912346458199947,1.0,19/31,44.24%,SLC12A8;SLC24A3;KCNK12;KCNA4;KCNIP2;KCNK6;KCNA3;SLC12A9;SLC9A7;KCNK3;KCNC3;HPN;KCNG3;KCNJ13;KCNH2;KCNAB3;KCND1;HCN3;KCNH4
